Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,42094,-0.208804736176703,0.00910664749147235,-0.226653765259988,-0.190955707093417,4.50088930534307e-114
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42186,0.0742450209061303,0.00332045105313049,0.0677369368419946,0.0807531049702661,1.07254624622832e-108
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,42120,-0.0974028164393932,0.00436612046578722,-0.105960412552336,-0.0888452203264502,3.30501875672862e-108
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42273,0.259754563133038,0.01209935212989,0.236039832958454,0.283469293307623,1.65064624578158e-100
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42120,0.0712860542477095,0.0033319579722639,0.0647554166220722,0.0778166918733467,7.99204511216092e-100
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,41861,-0.263670673625229,0.0126710529285363,-0.28850593736516,-0.238835409885298,1.36267408016385e-94
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,40102,0.0479007236990599,0.00238265531713272,0.0432307192774797,0.05257072812064,2.68171830246804e-88
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,40097,-0.0798878153481839,0.0041308750365196,-0.0879843304197623,-0.0717913002766054,5.8812802999624e-82
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,39706,-0.196798036510129,0.0102769592993026,-0.216940876736762,-0.176655196283496,2.26622438669422e-80
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39804,-0.110141664252437,0.00586998035404942,-0.121646825746374,-0.0986365027585,2.65667739445359e-77
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,40080,-0.142157004316065,0.00834933908237563,-0.158521708917521,-0.125792299714609,3.54741900581675e-64
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,42078,-0.070789219831321,0.00425025162759958,-0.0791197130214162,-0.0624587266412258,1.21987620148958e-61
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42184,0.0460212323572586,0.00278477897115299,0.0405630655737988,0.0514793991407185,9.92656914711856e-61
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,42144,-0.0986702592031396,0.00615163235662644,-0.110727458622127,-0.0866130597841518,2.40554031125419e-57
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,42256,-0.0466256306614183,0.00295027907586892,-0.0524081776501214,-0.0408430836727152,9.61215502600585e-56
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,42140,-0.0531905354669964,0.00348256200695122,-0.0600163570006208,-0.046364713933372,3.27836024478999e-52
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,40102,0.0813939521399496,0.00537714299860337,0.070854751862687,0.0919331524172122,3.05521067084019e-51
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41931,0.0805519757905889,0.00542492977591728,0.0699191134297911,0.0911848381513868,1.84335046395708e-49
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41876,-0.0791216131382914,0.00546962609164481,-0.0898420802779152,-0.0684011459986676,4.72979314078197e-47
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42223,-0.053361116565702,0.00369606352846597,-0.0606054010814953,-0.0461168320499087,6.93328508920585e-47
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,42110,-0.148939011817123,0.010508354845956,-0.169535387315196,-0.128342636319049,2.92283628700498e-45
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,42158,-0.0483564868543607,0.00342043621137705,-0.0550605418286597,-0.0416524318800617,4.81716465686101e-45
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41876,-0.114989477913792,0.00824700639451844,-0.131153610447048,-0.0988253453805361,7.29296960757316e-44
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),39902,0.25317805722149,0.0184347900011242,0.217045868819287,0.289310245623693,1.46223700509524e-42
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,40054,0.050411888648618,0.00372120907145952,0.0431183188685573,0.0577054584286786,1.78728251362529e-41
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,40021,-0.0980277909157489,0.0073024958579263,-0.112340682797284,-0.0837148990342134,9.2746990580672e-41
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42094,-0.049293026200685,0.00368222443564957,-0.0565101860945581,-0.0420758663068118,1.34827139332771e-40
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,40080,-0.118548737968406,0.00904561553372327,-0.136278144414504,-0.100819331522309,6.02172971245266e-39
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,42170,-0.107698882560809,0.0082551561598323,-0.12387898863408,-0.0915187764875378,1.16830315893399e-38
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,42172,0.0361273761171491,0.00287403198162777,0.0304942734331586,0.0417604788011395,4.98737197866756e-36
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,42094,-0.0450303496792609,0.00358408992859345,-0.0520551659393041,-0.0380055334192178,5.4127621466962e-36
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,41829,-0.066504945463918,0.00531790245226578,-0.0769280342703589,-0.0560818566574771,1.12757452480463e-35
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42094,-0.103552772790101,0.00831955045107633,-0.11985909167421,-0.0872464539059912,2.31955458784397e-35
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,40113,0.086278378993739,0.00696381049449004,0.0726293104245385,0.0999274475629395,5.11696950387236e-35
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,42126,-0.0708945144785235,0.005764846532836,-0.0821936136828821,-0.059595415274165,1.45303762569166e-34
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,40020,-0.0682966615832994,0.00556567646362466,-0.0792053874520038,-0.0573879357145951,2.19183850003712e-34
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,40035,-0.103628925323773,0.00861562367785812,-0.120515547732375,-0.0867423029151714,4.11165897431633e-33
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,42121,-0.100292836588635,0.00837604061348882,-0.116709876191074,-0.0838757969861973,7.27460685291866e-33
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39784,-0.152093585170846,0.0127306711594872,-0.177045700643441,-0.127141469698251,1.09115946932836e-32
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42274,0.0751155256151435,0.00632137085736788,0.0627256387347025,0.0875054124955846,2.1344855135636e-32
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,42161,0.0240105098635041,0.00202191682694729,0.0200475528826874,0.0279734668443208,2.34499509194767e-32
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41772,-0.0666781845388,0.00563196450318441,-0.0777168349650415,-0.0556395341125586,3.62493324496529e-32
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42004,-0.0693663581409393,0.00599397790621117,-0.0811145548371132,-0.0576181614447654,8.0669233033513e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,40102,0.0587823339259858,0.00510784797255005,0.0487709518997877,0.0687937159521839,1.79732164408331e-30
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,41841,-0.0701206067893643,0.00610755851578063,-0.0820914214802944,-0.0581497920984343,2.32496371990526e-30
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,42223,0.0420763354199428,0.00367185334467259,0.0348795028643845,0.0492731679755011,2.95361456213301e-30
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,41887,-0.092583587030263,0.00811104886656148,-0.108481242808723,-0.0766859312518025,4.95838258649297e-30
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,40097,-0.0394602594460398,0.00346199851497181,-0.0462457765353845,-0.032674742356695,6.30981459711875e-30
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,42213,-0.159538688177805,0.014070141263571,-0.187116165054404,-0.131961211301206,1.1609310803285e-29
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41739,-0.117366615471811,0.0103589258713436,-0.137670110179644,-0.0970631207639776,1.29807462451899e-29
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,41291,-0.0485535838133274,0.00429264884447066,-0.0569671755484899,-0.0401399920781649,1.63069818095926e-29
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,40097,0.0687083275195793,0.00609689161019456,0.0567584199635979,0.0806582350755606,2.69766948042561e-29
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42197,0.042842086827248,0.00380718594999211,0.0353800023652634,0.0503041712892325,3.05704644679924e-29
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,42127,0.0354504423274664,0.00315091387196507,0.0292746511384149,0.041626233516518,3.13555217863363e-29
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42094,-0.090738772827288,0.0082156880867691,-0.106841521477355,-0.0746360241772206,3.11603440524514e-28
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,42094,-0.0909724177426168,0.0082577340478948,-0.107157576476491,-0.074787259008743,4.23915521689206e-28
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,42193,-0.130888696004217,0.0119310710933512,-0.154273595347186,-0.107503796661249,7.02717422565026e-28
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39784,-0.0480238090951088,0.00450925388032363,-0.0568619467005431,-0.0391856714896745,2.36843901600253e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,42186,-0.0352075556517818,0.00330943848545652,-0.0416940550832766,-0.028721056220287,2.53078014683015e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42120,-0.0578036736001436,0.00545171062236112,-0.0684890264199714,-0.0471183207803158,3.70140281546093e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,42120,-0.0420496236039336,0.00396827520346369,-0.0498274430027225,-0.0342718042051448,3.96131850142482e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,42223,-0.0681957691015147,0.00647790709029319,-0.0808924669984894,-0.0554990712045401,8.19639071889796e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,42173,-0.0697432818048422,0.00672996914645906,-0.0829340213319019,-0.0565525422777824,4.57082832691424e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,42103,-0.0350046819711321,0.00339382517135825,-0.0416565793069943,-0.02835278463527,7.58788574886652e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42193,-0.0429046453349904,0.00419048266605549,-0.0511179913604592,-0.0346912993095217,1.64969040785801e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,42256,-0.0529369974877994,0.00518524415894678,-0.0631000760393351,-0.0427739189362637,2.22747953233982e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,39863,-0.0530758648560318,0.00520767987560439,-0.0632829174122164,-0.0428688122998472,2.78550849009454e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41887,-0.0573712196469477,0.00564059116784831,-0.0684267783359304,-0.046315660957965,3.30337341877847e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41861,-0.0664750337078289,0.00657237077495246,-0.0793568804267357,-0.0535931869889221,5.8855587642754e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42144,-0.0361688416101709,0.00358019897794264,-0.0431860316069384,-0.0291516516134033,6.60565223826377e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,42256,-0.0314240043560305,0.00313128412694242,-0.0375613212448376,-0.0252866874672233,1.29584415668186e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,42194,-0.0638328439594568,0.00640213095871453,-0.0763810206385372,-0.0512846672803763,2.48690309142667e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39858,-0.0468947917439914,0.0047207304898186,-0.0561474235040358,-0.0376421599839469,3.74011583278931e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41985,-0.0740962670009192,0.00746952447505566,-0.0887365349720283,-0.0594559990298101,4.13712204485425e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,39633,0.0434824795023984,0.00438612316377584,0.0348856781013977,0.052079280903399,4.59129895242407e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39863,0.0311373020481463,0.00315901315460368,0.0249456362651231,0.0373289678311695,8.02858421006985e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42296,0.024879762229032,0.00253542101719377,0.0199103370353322,0.0298491874227318,1.18617443164009e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42103,0.0392446036730561,0.00402857233265482,0.0313486019010526,0.0471406054450595,2.39300771327985e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42099,-0.0498828607600272,0.00512306995746862,-0.0599240778766657,-0.0398416436433887,2.50454332468235e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42256,0.0249557385850514,0.00259452938744065,0.0198704609856678,0.0300410161844351,7.88285723293905e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42296,0.0283492046769148,0.00295129851771653,0.0225646595821904,0.0341337497716392,8.92524594369076e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,42120,-0.0398244951262565,0.00416034460407601,-0.0479787705502455,-0.0316702197022675,1.23204117394858e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,42178,-0.0456365606132926,0.00476921793564309,-0.054984227767153,-0.0362888934594321,1.27226321149827e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,42223,-0.0261102851974202,0.00274054500436247,-0.0314817534059706,-0.0207388169888698,1.89398432432268e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,40080,-0.0254254738673134,0.00268921199408682,-0.0306963293757235,-0.0201546183589032,3.90699933534052e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39706,-0.0534377829760473,0.00566989159932102,-0.0645507705107164,-0.0423247954413781,5.21341240210933e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41936,-0.0790574619598199,0.00841807060975335,-0.0955568803549365,-0.0625580435647033,6.91596643013374e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42256,0.0269021555869774,0.00286745864145576,0.0212819366497241,0.0325223745242307,7.53663155844298e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42108,-0.0189454657496719,0.00202543408951878,-0.0229153165651287,-0.0149756149342151,9.83430127770407e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42094,-0.0377711475872286,0.0040468874030604,-0.045703046897227,-0.0298392482772302,1.19110929712993e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39863,-0.0465505490017464,0.00503704182053346,-0.056423150969992,-0.0366779470335009,2.88867559580079e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,42223,-0.0320115822843309,0.00351224466496159,-0.0388955818276556,-0.0251275827410061,9.06417114725381e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,42103,-0.050034197060037,0.00549156304187929,-0.0607976606221205,-0.0392707334979536,9.34353992853926e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,42103,-0.0686277791711538,0.00755072325309225,-0.0834271967472146,-0.053828361595093,1.14478444956306e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,39804,-0.0575498912504016,0.0063316223403389,-0.0699598710374659,-0.0451399114633374,1.1744611499484e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,42159,-0.0297200525919167,0.00329227226148887,-0.0361729062244349,-0.0232671989593985,2.00668492273356e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,39804,-0.0536153866004423,0.00594952892402954,-0.0652764632915402,-0.0419543099093444,2.37703688750214e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,40113,-0.0182113603020857,0.00202330474811364,-0.0221770376083884,-0.014245682995783,2.61180560386463e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42004,-0.0312886364270236,0.00348312366212793,-0.0381155588047943,-0.0244617140492528,3.00167612436308e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,42144,0.0430811807497564,0.00479686261142969,0.0336793300313542,0.0524830314681586,3.04685578409696e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41861,-0.0699320805011781,0.0077964569232713,-0.0852131360707898,-0.0546510249315663,3.3864472048482e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42004,-0.0279250586364708,0.00311778590033746,-0.0340359190011323,-0.0218141982718094,3.80306982521511e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42094,0.0180214954862966,0.00201217411244684,0.0140776342259008,0.0219653567466924,3.81562703725668e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,42144,0.0423577421895263,0.00474097473773325,0.0330654317035692,0.0516500526754835,4.64183250568906e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,42144,-0.078035589633662,0.00876938442384605,-0.0952235831044002,-0.0608475961629237,6.39727543997242e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39784,-0.0618898476694191,0.0069799048132375,-0.0755704611033646,-0.0482092342354736,8.73146988487183e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42172,0.0272130831539894,0.00307630597692018,0.0211835234392259,0.033242642868753,1.02302265290918e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,42144,-0.0627368259080724,0.00710432981240007,-0.0766613123403765,-0.0488123394757683,1.17183686130174e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42103,-0.0465589696856473,0.00527937349846265,-0.0569065417426341,-0.0362113976286605,1.30128435366137e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,42004,-0.0468243720646689,0.00532217942674656,-0.0572558437410921,-0.0363929003882456,1.56990307305235e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39863,-0.0661197430392692,0.00754902476602043,-0.0809158315806692,-0.0513236544978691,2.27353299220873e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39863,0.0384934494324936,0.00440518800658336,0.0298592809395902,0.047127617925397,2.72294855596615e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,42094,-0.0496266207930713,0.00569537584753481,-0.0607895574542395,-0.0384636841319031,3.30295250220653e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,42120,0.0254066805818532,0.00293181099648798,0.0196603310287368,0.0311530301349697,5.00965582829649e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,42122,0.151124423104892,0.0174934951196588,0.11683717267036,0.185411673539423,6.33703497388033e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39804,-0.049509209401713,0.00577468460784757,-0.0608275912330943,-0.0381908275703318,1.1434905303366e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42186,-0.0206177890165803,0.0024084607745044,-0.0253383721346089,-0.0158972058985516,1.24841991001077e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,42213,0.0329406352587517,0.00388705489784919,0.0253220076589673,0.0405592628585361,2.61411530116905e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42296,0.0231601056032602,0.00275510401210267,0.017760101739539,0.0285601094669814,4.66716869155872e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,40076,0.0420334061410499,0.00500727658805303,0.0322191440284659,0.0518476682536338,5.2600469751169e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,42094,-0.0364809924262614,0.00434917451534738,-0.0450053744763423,-0.0279566103761806,5.4543073801926e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,40080,-0.071324215879778,0.00851181425642268,-0.0880073718223664,-0.0546410599371895,5.97182180265149e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,42217,-0.0510594490779673,0.00619384125454103,-0.0631993779368678,-0.0389195202190669,1.83037310717069e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41876,-0.0569863603395455,0.00696724456960985,-0.0706421596959808,-0.0433305609831102,3.12855896547223e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,42186,-0.0437528433819708,0.00535941438347595,-0.0542572955735836,-0.0332483911903579,3.54599376774623e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,40097,-0.0613564136818046,0.00751714978217162,-0.0760900272548609,-0.0466228001087482,3.65199413394587e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,42223,-0.0385025077996955,0.00472355660912215,-0.047760678753575,-0.0292443368458161,3.93162593977923e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42146,0.0199891535626269,0.00245506249652782,0.0151772310694324,0.0248010760558215,4.24123572537215e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,42213,-0.0305456576744439,0.00376251849992543,-0.0379201939342977,-0.02317112141459,5.14576554231763e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,39863,-0.0274126849432244,0.00340107673456152,-0.034078795342965,-0.0207465745434838,8.44441584004122e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,42296,-0.0414876011518241,0.00515942622029678,-0.0516000765436058,-0.0313751257600424,9.66189211047062e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,42296,-0.0381365340589028,0.00474557297771905,-0.0474378570952321,-0.0288352110225734,1.00534798368583e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,41830,-0.0406913413855259,0.00506538295865628,-0.0506194919844922,-0.0307631907865596,1.0333276044782e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,42296,-0.0367490301688312,0.00457515086886409,-0.0457163258718048,-0.0277817344658576,1.03787563768693e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,42120,0.0482379858275464,0.00604459042621251,0.0363905885921699,0.0600853830629229,1.58163281615325e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,42162,-0.0543868440005494,0.00682415590209687,-0.0677621895686593,-0.0410114984324395,1.72223572114281e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,42223,-0.0202011123898022,0.00254279612360471,-0.0251849927920674,-0.0152172319875369,2.11004241785662e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,42223,-0.101043867771829,0.0127419373389716,-0.126018064956214,-0.0760696705874448,2.36884391302027e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39863,-0.0309177177155204,0.00390795532791523,-0.0385773101582342,-0.0232581252728065,2.79508104369632e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,42223,-0.0232864263129634,0.00295091284940341,-0.0290702154977941,-0.0175026371281328,3.22941006207808e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,42120,0.0218311245851149,0.00276704624125758,0.0164077139522501,0.0272545352179798,3.27225632723499e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,42164,0.0429907464937436,0.0054810905864139,0.0322478089443724,0.0537336840431148,4.72446707723817e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,42223,0.0378141568921465,0.00482115083454133,0.0283647012564455,0.0472636125278475,4.72577811910632e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,40058,0.0155612097555684,0.00198496179312344,0.0116706846410465,0.0194517348700904,4.94440795621063e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,42256,-0.026357747306736,0.00336408046995347,-0.0329513450278448,-0.0197641495856272,5.04757577639339e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,40083,0.0592418285736323,0.00758701197723016,0.0443712850982611,0.0741123720490034,6.32731001244139e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42144,-0.0345600006547159,0.00443679259022665,-0.0432561141315601,-0.0258638871778717,7.243294470539e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,42003,0.0221327160254044,0.00284230337107841,0.0165618014180908,0.0277036306327181,7.39421520222908e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42186,-0.0244663530880404,0.00314327002199947,-0.0306271623311594,-0.0183055438449215,7.57311061396486e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,42214,-0.0434089979951691,0.00557998604782643,-0.0543457706489089,-0.0324722253414293,7.83355071189641e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42186,-0.0176779825826579,0.00228577902046844,-0.022158109462776,-0.0131978557025398,1.11967148040725e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42239,-0.0247205314772441,0.00319821754734851,-0.0309890378700472,-0.0184520250844411,1.15878369767488e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40113,0.01998156537148,0.00258997246287696,0.0149052193442412,0.0250579113987189,1.31549129513078e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,40084,0.0273230107370951,0.00355495598981097,0.0203552969970656,0.0342907244771246,1.65000854852446e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42177,0.0239765526916893,0.00312202540468755,0.0178573828985017,0.0300957224848769,1.70715397951598e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,42103,-0.0300594825734818,0.00392232208123926,-0.0377472338527108,-0.0223717312942529,1.93535077854034e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,42186,0.0313176376155589,0.0040998252315836,0.0232819801616551,0.0393532950694628,2.346247212046e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,42213,0.0169846925620815,0.00222470053491641,0.0126242795136454,0.0213451056105177,2.42288151271212e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,42267,0.0428078283429956,0.005650579893777,0.0317326917511927,0.0538829649347985,3.80799082058071e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42120,0.0182096131453119,0.00242592133167721,0.0134548073352245,0.0229644189553992,6.48180021330196e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42144,-0.0577332515148346,0.007702329683071,-0.0728298176936538,-0.0426366853360155,7.03039353614862e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,42223,-0.0289131682756444,0.00385874502382957,-0.0364763085223504,-0.0213500280289385,7.17121168513276e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41957,-0.0221738066655899,0.00297484289813685,-0.0280044987459382,-0.0163431145852417,9.65519545255175e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,40080,-0.0213225600824136,0.00286254369206215,-0.0269331457188554,-0.0157119744459718,1.01312609130047e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,42004,-0.0314672293248722,0.00422727912209864,-0.0397526964041856,-0.0231817622455589,1.04036587608354e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,41861,-0.0360374982989374,0.00486020640874896,-0.0455635028600854,-0.0265114937377895,1.29544183219478e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,42094,0.0222362402571423,0.00302324891511132,0.0163106723835241,0.0281618081307605,2.02333860720616e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,40102,0.0366952539757545,0.00499459062447847,0.0269058563517767,0.0464846515997323,2.1718793072229e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41861,-0.044225720758347,0.00602829931590206,-0.0560411874175151,-0.032410254099179,2.3286204010018e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,40021,-0.075999560046515,0.0103752471588935,-0.0963350444779462,-0.0556640756150837,2.5573011348618e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41887,0.0300520449292254,0.00410742049678826,0.0220015007555204,0.0381025891029304,2.6977029749137e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39933,-0.0197911838090224,0.00270523905629943,-0.0250934523593693,-0.0144889152586756,2.73963082887543e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42103,-0.0204379368862485,0.00279715563861792,-0.0259203619379396,-0.0149555118345574,2.89900017127267e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,42103,-0.0295722890945352,0.00404936569333026,-0.0375090458534625,-0.0216355323356079,2.98047008375939e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,40054,-0.0522410190797862,0.00717562185280772,-0.0663052379112893,-0.0381768002482831,3.55990897013713e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,39863,-0.0208555002979632,0.0028678359508589,-0.0264764587616467,-0.0152345418342798,3.78456891799093e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,40097,0.0282429042912159,0.00390948832672217,0.0205803071708405,0.0359055014115914,5.37730695335605e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,40113,0.0174503845119043,0.00241760076109096,0.012711887020166,0.0221888820036426,5.62378771901159e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,40021,-0.0627860729309033,0.00871084781991762,-0.0798593346579418,-0.0457128112038647,6.06501959330552e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42186,-0.0271526854010649,0.00377318963661509,-0.0345481370888305,-0.0197572337132994,6.53050505101755e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39604,-0.0236188164340935,0.00328508376808908,-0.0300575806195481,-0.0171800522486389,6.93851573417635e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,40097,-0.0285000023600682,0.00396505664216897,-0.0362715133787194,-0.020728491341417,7.0154205763027e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,41861,-0.0465433296555379,0.00649957957228959,-0.0592825056172255,-0.0338041536938503,8.45294671148186e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,42144,-0.0483349886199746,0.00675539729669765,-0.061575567321502,-0.0350944099184472,8.81644315938457e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,40054,-0.105797233431864,0.0147960822946263,-0.134797554729332,-0.0767969121343968,9.21193907991469e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,42081,-0.0225135241800861,0.00314976483796675,-0.028687063262501,-0.0163399850976713,9.30077675132889e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41954,-0.0352743937800252,0.00493701573071781,-0.0449509446122321,-0.0255978429478183,9.49667581729924e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41876,-0.0670239361798033,0.00942737249566386,-0.0855015862713045,-0.0485462860883022,1.2270217377947e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42103,0.025462271990762,0.00358919838655239,0.0184274431531193,0.0324971008284047,1.36949438947647e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,42296,-0.0375075129567403,0.00531052007745416,-0.0479161323085505,-0.0270988936049302,1.71331164113928e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,41887,-0.032613862334687,0.00462163570229778,-0.0416722683111907,-0.0235554563581834,1.79260701351999e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,40020,-0.0371790585637103,0.00527083286417752,-0.0475098909774982,-0.0268482261499223,1.84812672190154e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42004,-0.0516858572277575,0.00733557064908512,-0.0660635756999643,-0.0373081387555507,1.93663033475618e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42197,0.0318580246041324,0.00453100578486529,0.0229772532657964,0.0407387959424684,2.15124903187521e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,40020,-0.0403300396465049,0.00575586704546659,-0.0516115390556195,-0.0290485402373904,2.58376614497719e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39804,-0.0262906092867585,0.00376366609615885,-0.0336673948352298,-0.0189138237382872,3.01128250676002e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,39847,-0.0265228962898627,0.00379763403971264,-0.0339662590076995,-0.0190795335720259,3.03876512444358e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,42213,-0.0170116393835475,0.0024383107529415,-0.0217907284593128,-0.0122325503077821,3.16554679890364e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,39863,-0.0447712327318551,0.00644419217948001,-0.0574018494036359,-0.0321406160600743,3.93403984954988e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41977,-0.0253806212915678,0.00365852628612899,-0.0325513328123806,-0.018209909770755,4.18652576671982e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42094,0.0291281975529953,0.00420911703166097,0.0208783281709398,0.0373780669350508,4.72108602544999e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42122,-0.0335216423764382,0.00486403435355294,-0.043055149709402,-0.0239881350434744,5.76715736171618e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,40054,-0.0262339289262684,0.00381273564770517,-0.0337068907957706,-0.0187609670567663,6.28805685251682e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,41984,-0.0371843433607548,0.00543780211919125,-0.0478424355143696,-0.0265262512071399,8.38856229896606e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,42176,0.0269335134492963,0.0039570068691418,0.0191777799857784,0.0346892469128143,1.04368832915737e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,39768,-0.0566021555236142,0.00832514549465744,-0.0729194406931428,-0.0402848703540856,1.11077246902178e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,41829,-0.0351260804147908,0.005221077057513,-0.0453593914475162,-0.0248927693820653,1.79740429381038e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39959,0.0289590888361836,0.00431329261048682,0.0205050353196295,0.0374131423527378,1.99008274955157e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,41829,-0.0421360907378623,0.00631538836641709,-0.0545142519360398,-0.0297579295396848,2.6291554902661e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42208,-0.0452261633922458,0.00678151322153708,-0.0585179293064585,-0.0319343974780331,2.67889028737569e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41963,0.0169341313519137,0.00254055601747891,0.011954641557655,0.0219136211461724,2.74566007132229e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,41716,-0.0271623676833139,0.0040798792921233,-0.0351589310958756,-0.0191658042707522,2.89870534768839e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,40113,0.0178985610883304,0.00270560336899975,0.0125955784850909,0.0232015436915699,3.87965626855992e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,40054,-0.0208241023455112,0.00315264283620273,-0.0270032823044686,-0.0146449223865539,4.1530279068018e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,42246,-0.0163002830633096,0.00246867845195791,-0.0211388928291471,-0.0114616732974721,4.18974358061296e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,39706,-0.0520709729016932,0.0078899049079457,-0.0675351865212668,-0.0366067592821196,4.3184621924147e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42162,0.0299234594457334,0.00457049301838628,0.0209652931296963,0.0388816257617705,6.08763192024391e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42094,-0.0529159530535374,0.00809456561361258,-0.068781301656218,-0.0370506044508567,6.50322561525825e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,42004,0.0230811236284547,0.0035430336643474,0.0161367776463338,0.0300254696105755,7.5654831595675e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39863,-0.0250268070143013,0.00384274075633331,-0.0325585788967145,-0.017495035131888,7.7107551302557e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,42144,-0.0421812983429903,0.00650579740713173,-0.0549326612609684,-0.0294299354250121,9.27801212386302e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,42184,0.0279202254179418,0.00431088331892648,0.0194708941128459,0.0363695567230377,9.71381363528973e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,40076,0.00995708140130242,0.00154561265911721,0.00692768058943269,0.0129864822131721,1.22759256720971e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,42186,0.0186614270582436,0.00289733779238298,0.0129826449851729,0.0243402091313142,1.22961399163624e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,42144,0.0247730857413834,0.0038484848808485,0.0172300553749204,0.0323161161078465,1.26071297173076e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,41967,0.0180340397737226,0.00281460677843468,0.0125174104879906,0.0235506690594545,1.53315758361833e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42197,0.0219669032037301,0.0034331084097396,0.0152380107206405,0.0286957956868197,1.622420251174e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,42256,-0.0289792384077853,0.00453558136280013,-0.0378689778788735,-0.020089498936697,1.72290452955802e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39863,-0.0150998682435276,0.0023646391456276,-0.0197345609689577,-0.0104651755180975,1.77715542250025e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,40054,-0.0291625088971049,0.00457004204372473,-0.0381197913028054,-0.0202052264914045,1.82822158340975e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41876,-0.0359857085695631,0.00564276528785961,-0.0470455285337679,-0.0249258886053583,1.86471371276707e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42004,-0.0153989921582803,0.00242368457290592,-0.0201494139211759,-0.0106485703953846,2.17529654393493e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42162,0.031929130106663,0.00504039140063825,0.022049962961412,0.041808297251914,2.45735949487838e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,42296,-0.0354940655973254,0.0056213131199871,-0.0465118393125001,-0.0244762918821507,2.80338764559271e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,42186,-0.025492173711578,0.00404459797485109,-0.0334195857422862,-0.0175647616808699,3.01822544345325e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41952,-0.0232052949388532,0.00368647197230974,-0.0304307800045802,-0.0159798098731261,3.18051955168216e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,40055,0.0305656299055204,0.00486934978243731,0.0210217043319433,0.0401095554790975,3.57995924777843e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42094,-0.0444287415059051,0.0071109108942155,-0.0583661268585675,-0.0304913561532427,4.28906538452903e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,41989,-0.0236466205990089,0.00378658644647418,-0.0310683300340983,-0.0162249111639195,4.37666120548412e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42256,-0.0255414994097226,0.00409531320925833,-0.033568313299869,-0.0175146855195763,4.60492502055227e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41841,0.0312758326658273,0.00501757774420653,0.0214413802871825,0.041110285044472,4.71370924278737e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,39804,-0.0329109207203436,0.00528540045490891,-0.0432703056119651,-0.0225515358287222,4.94197323945985e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,42144,-0.0225818536106908,0.00363748808147919,-0.02971133025039,-0.0154523769709916,5.5270628889555e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42094,-0.037467922693946,0.00604216279356837,-0.04931056176934,-0.025625283618552,5.77896741755388e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,39863,0.0146692306869965,0.00236961364393418,0.0100247879448855,0.0193136734291075,6.21557233963586e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,41829,-0.0403471137973319,0.00653031995526935,-0.0531465409096599,-0.027547686685004,6.67323429211051e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42121,-0.0613734921757395,0.00994279547914504,-0.0808613713148638,-0.0418856130366152,6.91594919170094e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41718,-0.0539257218564616,0.00874473862502644,-0.0710654095615135,-0.0367860341514098,7.18993549783113e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42120,-0.028814449354267,0.0046780655879173,-0.0379834579065849,-0.0196454408019491,7.51495198044549e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,42094,-0.0442188250973096,0.00718912233097894,-0.0583095048660283,-0.0301281453285908,7.93739940425875e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39706,-0.0226158513530714,0.00367703416243258,-0.0298228383114392,-0.0154088643947035,8.00139638708369e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42197,-0.0267658417937099,0.0043686054233962,-0.0353283084235664,-0.0182033751638533,9.22172905594593e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,42004,0.0161293179775139,0.0026345535509808,0.0109655930175916,0.0212930429374363,9.4977299200545e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,42197,0.0302235405308053,0.00494331082099461,0.0205346513216559,0.0399124297399547,9.99292576105997e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42095,-0.0338403152918535,0.00553507348484601,-0.0446890593221517,-0.0229915712615553,1.0009598229731e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,42167,-0.0205640306945573,0.0033638226309913,-0.0271571230513002,-0.0139709383378143,1.00396474946063e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42103,-0.0434273570886137,0.00712374870291491,-0.0573899045463269,-0.0294648096309005,1.11759991799787e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42146,0.0212584629177971,0.00349088295062166,0.0144163323345786,0.0281005935010155,1.16317147427045e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39706,-0.0391530454254912,0.00643394916155201,-0.0517635857821331,-0.0265425050688493,1.20265540276156e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41876,-0.0358822065223118,0.00590508361432525,-0.0474561704063893,-0.0243082426382343,1.26359528698849e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,40054,-0.0272030444829175,0.00448320808912257,-0.0359901323375977,-0.0184159566282372,1.34029965743638e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42101,0.0302997812363439,0.00500405365311873,0.0204918360762312,0.0401077263964566,1.44274496186863e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,40054,-0.0434961561489605,0.00718848828673969,-0.0575855931909703,-0.0294067191069507,1.48875746429654e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,42103,-0.0310001459628862,0.00512993777056916,-0.0410548239932018,-0.0209454679325707,1.55454492545542e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,42296,0.0100717510313986,0.00166690585855693,0.00680461554862701,0.0133388865141702,1.561660654535e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42103,0.0370512636218288,0.00613682006258784,0.0250230962991566,0.0490794309445009,1.60781893795333e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,40097,-0.014256752461606,0.00237362043189932,-0.0189090485081286,-0.00960445641508328,1.95822455494184e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39863,-0.0252485156814813,0.00420918931678658,-0.0334985267423829,-0.0169985046205796,2.05702691147672e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39784,0.0200804909342877,0.00334786035936049,0.0135186846299412,0.0266422972386343,2.06282357134418e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,42120,0.0234576110132604,0.00391792498240909,0.0157784780477386,0.0311367439787823,2.19073893987666e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,40113,0.0167201539094814,0.00279766762120672,0.0112367253719162,0.0222035824470466,2.35159452570045e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,40080,-0.040590575871864,0.00681701767989342,-0.0539519305244551,-0.0272292212192729,2.6925050124032e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42099,-0.050627854292716,0.00851484188096638,-0.0673169443794101,-0.0339387642060219,2.82158874886893e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42094,-0.0208128585507804,0.00350609727530401,-0.0276848092103762,-0.0139409078911845,2.9921767580624e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",40054,-0.0373706795222715,0.0062962642339632,-0.0497113574208393,-0.0250300016237036,3.02138745919384e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,39881,-0.032859207959928,0.00553971392202229,-0.0437170472470917,-0.0220013686727643,3.09347509755138e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,42081,-0.0183888605757647,0.00310325520029395,-0.0244712407683409,-0.0123064803831886,3.18974041033382e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42168,0.0319861303297643,0.00541155431109593,0.0213794838800163,0.0425927767795124,3.49190978746027e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,42197,-0.0336709535642826,0.00571540207046647,-0.0448731416223969,-0.0224687655061683,3.92728482035131e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42094,-0.0260420795258019,0.00445283054623852,-0.0347696273964294,-0.0173145316551744,5.08250151355732e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,42296,0.0178778715857591,0.00306022159557344,0.0118798372584352,0.023875905913083,5.27968758310691e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,42213,-0.0269909414957346,0.00462905429596116,-0.0360638879158184,-0.0179179950756507,5.64816960821715e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42120,0.016122873838513,0.0027785833559384,0.0106768504608738,0.0215688972161523,6.68443665189625e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39881,-0.0265608797724424,0.00459055073468446,-0.035558359212424,-0.0175634003324609,7.41118940239536e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,-0.0582580471694004,0.0100750101971988,-0.0780050671559101,-0.0385110271828908,7.5330981292737e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,42120,-0.0183458728044996,0.00317492601388785,-0.0245687277917197,-0.0121230178172794,7.7170792958426e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,42122,-0.0184362647804304,0.003191507022759,-0.024691618545038,-0.0121809110158227,7.79509712052244e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,42223,-0.0254153895708048,0.00441545974256634,-0.0340696906662348,-0.0167610884753748,8.80706409750208e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42181,0.0190993556453585,0.00332342431619913,0.0125854439856082,0.0256132673051088,9.29415915577745e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39719,-0.0479339705558536,0.00834476167062476,-0.0642897034302781,-0.031578237681429,9.4918257617078e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,40113,-0.0178942565487702,0.00311567303029519,-0.0240009756881488,-0.0117875374093916,9.53261439311769e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,39804,-0.0299208996611655,0.00521417099530098,-0.0401406748119554,-0.0197011245103756,9.8204550361108e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39804,0.035283682285397,0.00614895887283225,0.0232317228946458,0.0473356416761482,9.83349381598895e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,42184,-0.0453015361642074,0.00790373777455971,-0.0607928622023445,-0.0298102101260704,1.01663085413831e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42093,0.0193032327897213,0.00336980531380619,0.0126984143746612,0.0259080512047815,1.03711769436459e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,42004,0.0198255345189909,0.00347219050824692,0.0130200411228269,0.0266310279151548,1.15616610460383e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,42223,0.0200748768914611,0.00351845361722846,0.0131787078016933,0.0269710459812289,1.18459834731084e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42103,-0.0375323253649597,0.00658146161690721,-0.0504319901340979,-0.0246326605958216,1.20486120051401e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,42256,-0.0279050374858746,0.00490158478750416,-0.0375121436693828,-0.0182979313023664,1.27465160512535e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,42296,-0.0363114289603285,0.006382336130469,-0.0488208077760478,-0.0238020501446093,1.3024316147461e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,42128,0.0538680383468909,0.00948893980061826,0.0352697163376791,0.0724663603561027,1.40082490146146e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41887,-0.0344296603555435,0.00608320329605433,-0.04635273881581,-0.022506581895277,1.5483884299598e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,41961,-0.0220512442751292,0.00392589562505401,-0.029745999700235,-0.0143564888500233,1.98510404325484e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,40054,-0.0312002649721766,0.00555520829093601,-0.0420884732224112,-0.0203120567219421,1.99773058276204e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42126,0.0196170735206415,0.00350429763847226,0.0127486501492359,0.0264854968920471,2.21246573609497e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42156,-0.0331165049537727,0.005951329657212,-0.0447811110819082,-0.0214518988256371,2.68034262180916e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42053,-0.0254575492305778,0.0045863479642854,-0.0344467912405772,-0.0164683072205785,2.90122985869406e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40054,-0.036091243766579,0.00651195255737028,-0.0488546707790247,-0.0233278167541332,3.05479289868293e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40080,-0.0416120789304128,0.00751912405937654,-0.0563495620867909,-0.0268745957740348,3.199530384791e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,42296,-0.0332152792798639,0.00600299858687916,-0.0449811565101471,-0.0214494020495808,3.20630964751689e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,42125,-0.0249115047468462,0.00450554263827378,-0.0337423683178629,-0.0160806411758296,3.28157149878128e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,40021,0.06385278891925,0.0115634237288925,0.0411884784106208,0.0865170994278792,3.4297136049266e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,42296,-0.034180743605349,0.00620250904913042,-0.0463376613416446,-0.0220238258690533,3.63968259797328e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41861,-0.0319604358063173,0.00581209899865816,-0.0433521498436873,-0.0205687217689473,3.89465832310547e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,42162,0.0274636686200956,0.00501157563729599,0.0176409803709954,0.0372863568691957,4.33153532723108e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42296,0.0190544414968273,0.00348210411257035,0.0122295174361894,0.0258793655574651,4.52891798325832e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,41815,0.0317115727353326,0.00580603720408563,0.0203317398153247,0.0430914056553404,4.80184930915144e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,42213,0.0166242310512599,0.00304710042059856,0.0106519142268867,0.022596547875633,4.96567802637601e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,39957,0.0605886196895532,0.0111072323482379,0.0388184442870069,0.0823587950920995,5.00905038554237e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40054,0.0507040352958794,0.00930868041386685,0.0324590216847004,0.0689490489070584,5.23545600315411e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,42186,-0.0148153962161194,0.00272044612604843,-0.0201474706231743,-0.00948332180906444,5.24687546492871e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,40080,-0.0165939252941953,0.003048822396401,-0.0225696171911412,-0.0106182333972493,5.36073702699433e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42071,-0.0391654646110938,0.00721124926193937,-0.053299513164495,-0.0250314160576927,5.70048719949529e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,42120,-0.0363516580947665,0.00671322811512133,-0.0495095852004043,-0.0231937309891287,6.24090054278367e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,42094,-0.076716805663212,0.0141770594960913,-0.104503842275551,-0.0489297690508732,6.36747435730409e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,40080,-0.0201308816956356,0.00373543711433507,-0.0274523384397323,-0.0128094249515389,7.22633620518454e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40080,-0.0402766444042009,0.00747905339982251,-0.054935589067853,-0.0256176997405488,7.38453099170184e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42122,-0.0446736405532966,0.00831487202599518,-0.0609707897242471,-0.028376491382346,7.88939408539105e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,39804,-0.0304347296579687,0.00567773925673519,-0.0415630986011697,-0.0193063607147678,8.47976323510932e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,40021,-0.0603632306992301,0.0112966583005284,-0.0825046809682658,-0.0382217804301944,9.30399987695049e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41861,-0.0444157653198716,0.00831877643077613,-0.0607205671241929,-0.0281109635155504,9.49602867718802e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,41829,-0.0198365610623694,0.00371666455432035,-0.0271212235888373,-0.0125518985359016,9.60278981581599e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,40092,0.0197645298039058,0.00372905938395933,0.0124555734113455,0.0270734861964661,1.17974931071021e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42096,0.0327344925029375,0.00618241119916866,0.020616966552567,0.0448520184533081,1.21116822379001e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,42120,-0.0240724696778525,0.00454829081946036,-0.0329871196839948,-0.0151578196717102,1.225342519408e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39784,-0.0286955755884425,0.00543226696749309,-0.039342818844729,-0.0180483323321561,1.30010172022485e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,42223,0.00885311765717711,0.00168045586273206,0.00555942416622228,0.0121468111481319,1.3989974679806e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42223,-0.0185527678841305,0.0035263896540013,-0.025464491605973,-0.0116410441622879,1.45448085819313e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,42256,-0.014301751886462,0.00272770084403541,-0.0196480455407714,-0.00895545823215263,1.60318551655085e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39784,0.0236093965077549,0.00450521037528601,0.0147791841721943,0.0324396088433155,1.63253192595502e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42184,0.0111119090094844,0.00212233027180064,0.00695214167675517,0.0152716763422137,1.66914616188078e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39804,-0.0125243756069934,0.00240605427354446,-0.0172402419831405,-0.00780850923084622,1.97242877490433e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41965,0.0163325623461552,0.00313846801613189,0.0101811650345367,0.0224839596577737,1.98075685096669e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,42144,0.0165279714651567,0.00317656661956607,0.0103019008908072,0.0227540420395062,1.98992392993592e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41829,-0.0152872677984525,0.00294114273225863,-0.0210519075536794,-0.00952262804322556,2.04882055875288e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,42004,-0.0283169708389386,0.00545445286313656,-0.0390076984506862,-0.0176262432271909,2.11762782904868e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,42045,-0.0379371809918291,0.00733104042459616,-0.0523060202240375,-0.0235683417596206,2.31506723122433e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41757,-0.0104820501992682,0.00202599875074591,-0.0144530077507302,-0.00651109264780621,2.32952143729792e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41887,-0.0365868002531489,0.00707397915063626,-0.050451799388396,-0.0227218011179018,2.35095903671648e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42186,0.014603844352932,0.00282533482446325,0.00906618809698401,0.02014150060888,2.38982971682545e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42144,-0.0162123075363381,0.00313845398833519,-0.0223636773534751,-0.0100609377192011,2.43099928209134e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,42256,-0.0193264123244888,0.00374908348361783,-0.0266746159523798,-0.0119782086965979,2.57376469326202e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,42162,-0.0306490550114455,0.00594578303028656,-0.0423027897508072,-0.0189953202720839,2.57698121456125e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42103,-0.0268931191017024,0.00522067403287416,-0.0371256402061357,-0.016660597997269,2.62536653517263e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,39804,-0.020982352102855,0.0040783456467678,-0.0289759095705199,-0.0129887946351901,2.72562453596647e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",40021,0.0458777692787405,0.00892093988007587,0.0283927271137918,0.0633628114436892,2.75542709468668e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42103,-0.0126965549111209,0.00246971294775693,-0.0175371922887245,-0.00785591753351729,2.77419128426119e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40020,-0.0199058735638646,0.00387495056134454,-0.0275007766640999,-0.0123109704636293,2.83919284664467e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,40097,-0.028718411130347,0.00559272152374724,-0.0396801453168916,-0.0177566769438024,2.87070427112684e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,42082,-0.0363274062652894,0.00708622674029678,-0.0502164106762711,-0.0224384018543077,2.9948468421153e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,39940,-0.0282371622821641,0.0055082328351092,-0.0390332986389782,-0.0174410259253501,3.00541995158823e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,41985,-0.0330512238747314,0.00644926306550529,-0.0456917794831218,-0.0204106682663411,3.0218614232237e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,40021,-0.0422076561720335,0.00826689830985726,-0.0584107768593537,-0.0260045354847133,3.3531112204327e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,40113,0.0160708314553965,0.00315347001364249,0.00989003022865722,0.0222516326821358,3.52266653810374e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42032,0.0300237316470275,0.00590364242246031,0.0184525924990053,0.0415948707950497,3.71576758506789e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,42144,0.0183182292336878,0.00360323449352996,0.0112558896263691,0.0253805688410065,3.75063007204807e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42223,0.030401368809676,0.00598471452025778,0.0186713283499707,0.0421314092693812,3.82984931107018e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,42076,-0.0375098700541826,0.00739208868764556,-0.0519983638819679,-0.0230213762263973,3.94288027552793e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42256,-0.0179707318641507,0.00355084195962968,-0.0249303821050248,-0.0110110816232765,4.22783406147027e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41861,-0.0299240272680078,0.00591548343466016,-0.0415183747999417,-0.0183296797360739,4.28271634311704e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40021,0.0524155559805699,0.0103636802375085,0.0321027427150532,0.0727283692460867,4.3147490493851e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41813,-0.0372136024523047,0.00737297266651367,-0.0516646288786715,-0.0227625760259379,4.54340049933291e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,42085,-0.0175006879817206,0.00347103860961856,-0.0243039236565729,-0.0106974523068682,4.67149453309132e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42091,0.0175186406537397,0.00347847632098106,0.0107008270646168,0.0243364542428626,4.81036837375163e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,39863,-0.0137886010552482,0.00274383894250474,-0.0191665253825574,-0.00841067672793888,5.10808842362774e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39784,-0.0176420703662677,0.00351177628440389,-0.0245251518836993,-0.010758988848836,5.15154521914537e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40054,-0.0419220630583521,0.00834800468833572,-0.0582841522474901,-0.0255599738692141,5.20008850797151e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41971,0.0315184892093391,0.00627846026945748,0.0192127070812025,0.0438242713374758,5.2340683113437e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42103,0.0270430570466776,0.00538973631039186,0.0164791738783095,0.0376069402150456,5.30419108793339e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42094,-0.0280845879173644,0.00560413320503808,-0.0390686889992391,-0.0171004868354898,5.47497923033171e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,39863,0.0183030643702719,0.00365675720635482,0.0111358202458164,0.0254703084947273,5.66738044437635e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,42103,0.0174050561570416,0.00347853716668645,0.0105871233103362,0.0242229890037471,5.70230824249379e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41876,-0.0171486572776966,0.0034286790128183,-0.0238688681428204,-0.0104284464125727,5.76366290348347e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,39804,-0.0154169980566476,0.00308235693452023,-0.0214584176483073,-0.00937557846498797,5.77393616613023e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39872,-0.0223534760218019,0.00447643490948331,-0.0311272884443892,-0.0135796635992146,6.02043388051017e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41829,-0.0291485605627278,0.00584785417909771,-0.0406103547537593,-0.0176867663716963,6.29493122002921e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,42103,-0.0286401389323679,0.00574860301776211,-0.0399074008471817,-0.0173728770175542,6.37107797017542e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,40080,-0.0163590470996433,0.00328614919290152,-0.0227998995177303,-0.00991819468155633,6.51676894337896e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,40113,-0.0180632289725465,0.0036426627574766,-0.0252028479772006,-0.0109236099678923,7.19976529604819e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,40097,0.0106448432415198,0.0021540124467069,0.00642297884597424,0.0148667076370653,7.85282979579997e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39958,-0.0134237587090539,0.00271868530248229,-0.0187523819019191,-0.00809513551618856,8.02802348368076e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,40113,0.0112026747788266,0.00227102784230825,0.00675146020790247,0.0156538893497508,8.22263912366875e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,42296,0.0121765886347297,0.0024692830721206,0.00733679381337336,0.0170163834560861,8.27173822278171e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,42172,-0.00911796462000855,0.00184958173413068,-0.0127431448189047,-0.00549278442111242,8.3355060945426e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,39804,-0.0112962809934702,0.00229186020558128,-0.0157883269964095,-0.00680423499053089,8.39574657540023e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,42094,-0.0354514616246886,0.00719688509294196,-0.0495573564068548,-0.0213455668425223,8.49943489197005e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,40097,0.0204325304230529,0.0041493249900862,0.0122998534424839,0.0285652074036218,8.59032612780917e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,42223,-0.0324796092304395,0.0066032687437917,-0.0454220159682712,-0.0195372024926077,8.8176566838761e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39784,-0.0182295570168252,0.00370745808275048,-0.0254961748590162,-0.0109629391746343,8.92015808246243e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,40080,-0.030091834770983,0.00612591945103048,-0.0420986368950027,-0.0180850326469632,9.13630813666418e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,42144,0.0191217753220632,0.00390436931969646,0.0114692114554582,0.0267743391886683,9.82195758980968e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39768,-0.0166034060590101,0.00339823180865191,-0.0232639404039678,-0.00994287171405231,1.04470095012884e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,42094,0.0231135708752188,0.00474170575334735,0.013819827598658,0.0324073141517796,1.10368065112575e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,42094,0.0384871968955245,0.00790774241794711,0.0229880217563482,0.0539863720347009,1.14630086887785e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,42144,-0.013518553865156,0.00277917787864348,-0.0189657425072972,-0.0080713652230148,1.16256039545015e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42186,0.0187624075442169,0.00385752309527353,0.0112016622774808,0.026323152810953,1.16474323315228e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,39466,-0.0612136800781607,0.0126085005566259,-0.0859263411691474,-0.0365010189871739,1.22189655645863e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42144,0.0134695999475262,0.00277476506949286,0.00803106041132023,0.0189081394837323,1.22209625180085e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,42223,-0.0241224299162695,0.00497307711576525,-0.0338696610631694,-0.0143751987693696,1.2450911613151e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42296,0.0144924437164024,0.0029932369443294,0.00862569930551679,0.020359188127288,1.30183500124368e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42186,-0.0173715330629089,0.0035879609929457,-0.0244039366090824,-0.0103391295167353,1.30269612892212e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",42223,0.0361505140891063,0.00747846004559414,0.0214927323997418,0.0508082957784708,1.35376455609074e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,40041,-0.0160019743956627,0.00331007074435405,-0.0224897130545966,-0.00951423573672878,1.35428094401033e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,40021,-0.0291236445198145,0.00602742623096185,-0.0409373999324998,-0.0173098891071293,1.37123346202199e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42004,-0.0193366112258163,0.00401249239268704,-0.0272010963154829,-0.0114721261361497,1.45859597007354e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42296,-0.019347824971894,0.00402185174098437,-0.0272306543842234,-0.0114649955595646,1.5209608434538e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,40054,-0.0196884175024984,0.00409665317267431,-0.0277178577209401,-0.0116589772840568,1.56061504146867e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40054,-0.0210256690133829,0.00437656802406746,-0.0296037423405551,-0.0124475956862107,1.57493045487716e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,42193,-0.0146002273116219,0.00304034934624419,-0.0205593120302606,-0.00864114259298334,1.58717570580138e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42144,-0.0135546165808294,0.00282581380405873,-0.0190932116367846,-0.00801602152487433,1.63088002401773e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,42103,-0.0442908495567095,0.00926844145860644,-0.0624569948155781,-0.0261247042978409,1.7840000277863e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,42103,0.0152633323620347,0.00319600089690099,0.00899917060410874,0.0215274941199606,1.80997745408416e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41984,-0.022803684154173,0.00477886358869801,-0.0321702567880211,-0.0134371115203249,1.84624418903747e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41861,-0.0396620829170546,0.00832020469291464,-0.0559696841151673,-0.0233544817189419,1.89106579731307e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,42211,0.0134931728306211,0.00283146110970423,0.00794350905560077,0.0190428366056414,1.90473832149296e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,42145,-0.0317696032643727,0.00667176333210268,-0.044846259395294,-0.0186929471334515,1.93952062168966e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,42103,0.0289625811070313,0.00610235883140121,0.0170019577974849,0.0409232044165777,2.09571497126996e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42097,0.0121079851279957,0.00255374244885804,0.00710264992823395,0.0171133203277575,2.14652478595122e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,42120,0.0168904426303383,0.00356330418166506,0.00990636643427475,0.0238745188264018,2.15883273496765e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,42213,0.0386683483184523,0.00815896341610714,0.0226767800228823,0.0546599166140223,2.16651769182528e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41987,-0.0722577063793887,0.0152669007785271,-0.102180831905302,-0.0423345808534755,2.23633914637198e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39863,-0.0156619455172466,0.00331506366046619,-0.0221594702917604,-0.00916442074273292,2.3365248768717e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,42103,0.0209352647936493,0.00444559382922082,0.0122219008883765,0.0296486286989221,2.51259591883961e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,41986,-0.0222580200726507,0.00473979825718337,-0.0315480246567301,-0.0129680154885713,2.6808312825474e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,39863,0.0248472544370243,0.00529686505149321,0.0144653989360976,0.035229109937951,2.75335976488532e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,40021,-0.0234059227313212,0.00499092772234935,-0.0331881410671259,-0.0136237043955165,2.76959327547765e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39772,-0.0128517933497225,0.00274050124527506,-0.0182231757904616,-0.00748041090898341,2.77195421232637e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,40102,-0.0311531126190266,0.00666024694385797,-0.0442071966289882,-0.018099028609065,2.93923460055022e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,40054,-0.0181264426651108,0.00387693038593608,-0.0257252262215456,-0.0105276591086761,2.96824944607445e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40080,-0.0139809021462747,0.00300105806315284,-0.0198629759500543,-0.00809882834249515,3.22050118951191e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,42223,-0.0188169407965261,0.00403989708668869,-0.0267351390864359,-0.0108987425066163,3.2280227552897e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42094,-0.0209269795755068,0.00449701118112403,-0.0297411214905099,-0.0121128376605037,3.29546286776283e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,40102,0.0275279426604988,0.0059176791661712,0.0159292914948032,0.0391265938261943,3.32897464593511e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41861,-0.0303845157272105,0.00653560185871494,-0.0431942953702918,-0.0175747360841292,3.36790892714524e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,39804,-0.0144014811153414,0.00309809946650056,-0.0204737560696825,-0.00832920616100028,3.38407909655116e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39804,0.0431475209557407,0.00928309497420603,0.0249526548062969,0.0613423871051845,3.39263029526252e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,41829,-0.0165853264463883,0.00357768980569726,-0.023597598465555,-0.00957305442722172,3.59181880661484e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,39911,-0.029465471598552,0.00635798404206451,-0.0419271203209984,-0.0170038228761055,3.6218982348504e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,42103,-0.0344570535774833,0.00744664113391122,-0.0490524701999493,-0.0198616369550173,3.74259605261929e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,40102,-0.0343051225343359,0.00741402257199457,-0.0488366067754453,-0.0197736382932266,3.7516746936465e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42213,0.0220173403851671,0.0047771271201637,0.0126541712296462,0.0313805095406879,4.08635066462056e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,42094,-0.0251785674374547,0.00546797036574862,-0.035895789354322,-0.0144613455205874,4.16933258297046e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,42255,0.0168649797313872,0.0036660826835128,0.00967945767170216,0.0240505017910723,4.25905748647107e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,42144,-0.0221483554694058,0.00482507388776597,-0.0316055002894271,-0.0126912106493845,4.46852256680812e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,40097,-0.0218597960068738,0.00477006643305876,-0.0312091262156689,-0.0125104657980786,4.64102692428864e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39804,0.0322606043098974,0.00704117916416972,0.0184598931481248,0.0460613154716701,4.66460847843163e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41829,-0.0255965795886705,0.00559091329984658,-0.0365547696563698,-0.0146383895209712,4.73364439369777e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,42208,-0.00979852925012779,0.00214336134428758,-0.0139995174849315,-0.00559754101532414,4.88539952271181e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39804,-0.017125641463395,0.00376184282257212,-0.0244988533956364,-0.0097524295311537,5.36120965458548e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42094,-0.0247166442286272,0.00543135628610943,-0.0353621025494017,-0.0140711859078527,5.3947928982111e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,40113,0.0106060913526016,0.00233388705156299,0.00603167273153813,0.015180509973665,5.56863603623356e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42144,-0.0135174593139428,0.00297890901313443,-0.0193561209796863,-0.00767879764819937,5.73769324116763e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,40021,-0.0455742543941332,0.0100472638040034,-0.0652668914499798,-0.0258816173382866,5.79513216048767e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,39863,-0.0178578578068613,0.00394065077437999,-0.0255815333246461,-0.0101341822890765,5.91463435028237e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42094,-0.0098343153992303,0.00217196968078627,-0.0140913759735714,-0.00557725482488921,6.01254744845218e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,39768,-0.0208865654726493,0.00461673922251454,-0.0299353743487778,-0.0118377565965209,6.13157333120965e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,42103,-0.0255759837158364,0.00566863011677187,-0.0366864987447092,-0.0144654686869635,6.48334223034467e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,40080,-0.0209491179666937,0.00464597460697497,-0.0300552281963647,-0.0118430077370228,6.5786793827104e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,40054,0.0221057109987835,0.00490356806689829,0.0124947175876629,0.0317167044099042,6.60995937486038e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,42213,0.013614327869148,0.00303463817433736,0.0076664370474468,0.0195622186908493,7.30880144679017e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39881,-0.0257112185573651,0.00574726110965774,-0.0369758503322942,-0.0144465867824359,7.76909210903984e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42071,-0.0310449950202732,0.00694340343459095,-0.0446540657520715,-0.017435924288475,7.84653978478995e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41876,-0.0173401195387388,0.00389799187576479,-0.0249801836152377,-0.00970005546223976,8.72183475150804e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42149,-0.0224184475966649,0.00504411588623475,-0.032304914733685,-0.0125319804596448,8.88383937243241e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,39995,0.0153539926564844,0.0034546159693771,0.00858294535650526,0.0221250399564635,8.89803300799684e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,40097,-0.0186315189855604,0.00421232473370781,-0.0268876754636277,-0.0103753625074931,9.82392755101869e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42111,0.0259454128975894,0.0058668095349895,0.0144464662090099,0.0374443595861688,9.8405499958969e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42256,-0.0188329078445548,0.00426235566333611,-0.0271871249446936,-0.010478690744416,1.00222424463775e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42296,0.0148656790615574,0.00336620836879186,0.00826791065872536,0.0214634474643895,1.01279692118774e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42094,-0.0125102191929379,0.00283490646599395,-0.0180666358662861,-0.00695380251958977,1.02812716960592e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40021,-0.0139179796394735,0.00315391520941997,-0.0200996534499366,-0.00773630582901037,1.029717675892e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,40080,0.0126727587826097,0.00287664519973996,0.00703453419111939,0.0183109833741,1.06600621229849e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41829,-0.0234284772791895,0.00533042467520801,-0.0338761096425972,-0.0129808449157818,1.11555078497095e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42094,-0.0453527546280477,0.0103208350725952,-0.0655815913703343,-0.025123917885761,1.12022169776267e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,40020,-0.0160853551030417,0.00366376715818317,-0.0232663387330807,-0.00890437147300263,1.14222717221409e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,40054,-0.0144422646220198,0.00329925626685749,-0.0209088069050604,-0.0079757223389791,1.21209678199617e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39706,-0.030329579612658,0.00693170371138245,-0.0439157188869676,-0.0167434403383484,1.22330337332923e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41829,-0.0228664492291954,0.00523440791702626,-0.0331258887465669,-0.012607009711824,1.2610683084416e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,42120,-0.0247752884235669,0.00567396860046329,-0.0358962668804749,-0.0136543099666588,1.27245008232294e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,40102,0.0233254980524423,0.00534192534030163,0.0128553243854511,0.0337956717194335,1.27419577644986e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,39863,0.0242749979512477,0.00556195387450798,0.0133735683572121,0.0351764275452834,1.28628893411774e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42144,-0.028061860906537,0.00646033987467523,-0.0407241270609005,-0.0153995947521735,1.41160652466227e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,42262,-0.0222832564049312,0.00513700962184638,-0.0323517952637501,-0.0122147175461123,1.45003738914204e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,40020,-0.0292906841443684,0.00675906149232386,-0.0425384446693232,-0.0160429236194136,1.48052885668438e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39863,-0.00951332640128319,0.00219985002567041,-0.0138250324515972,-0.00520162035096918,1.54243463121112e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,42213,0.0134907727713502,0.00312134747240105,0.00737293172544417,0.0196086138172563,1.55699458288202e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,42103,0.0194947781250774,0.00453394334785596,0.0106082491632797,0.0283813070868751,1.72253987543795e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42126,-0.0415139557947686,0.00965637349728955,-0.0604404478494562,-0.0225874637400811,1.72729853700877e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41966,0.0193613984389019,0.00452460808851149,0.0104931665854194,0.0282296302923844,1.88990000094735e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,42144,0.0309485305900816,0.00724585349404381,0.0167466577417557,0.0451504034384074,1.95806145742524e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39768,-0.0282184946324367,0.00661381696383484,-0.041181575881553,-0.0152554133833204,2.00205003807765e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,42094,-0.0406630696152111,0.00956644679654217,-0.0594133053364337,-0.0219128338939884,2.14704650033525e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,42129,0.0194905538654931,0.00458783887842158,0.0104983896637868,0.0284827180671994,2.16898179722272e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41635,-0.0163635789307233,0.00385498692944613,-0.0239193533124377,-0.00880780454900888,2.20393220999613e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,40054,0.0135361576083727,0.00319238200940973,0.00727908886992957,0.0197932263468157,2.25226160673517e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39804,-0.0133345592977669,0.00314906902571232,-0.019506734588163,-0.00716238400737075,2.31048497494723e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39863,-0.0173618986109999,0.00410662820303488,-0.0254108898889482,-0.0093129073330515,2.37980780207981e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42144,0.0342330348911912,0.00811194832463563,0.0183336161749053,0.050132453607477,2.45884627683348e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,42072,-0.0157418304036913,0.00373078877276464,-0.02305417639831,-0.00842948440907264,2.46589785017064e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39804,0.0326875624914393,0.00775201547919357,0.0174936121522199,0.0478815128306586,2.50011651855666e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,40054,-0.0245397666635272,0.00582852613954083,-0.0359636778970272,-0.0131158554300272,2.57101832246921e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,42121,0.0283396219788212,0.0067392198070108,0.01513075115708,0.0415484928005623,2.62633214539611e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41861,0.0164953099771678,0.00392487965445586,0.00880254585443429,0.0241880740999013,2.65493700429213e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42177,0.0104264820572756,0.00248267098005721,0.00556044693636346,0.0152925171781877,2.69048052824643e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42296,-0.0135445882136733,0.00322793416703463,-0.0198713391810612,-0.00721783724628542,2.73394585976148e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41861,-0.0218337247508894,0.00521220834376486,-0.0320496531046685,-0.0116177963971103,2.82135608500267e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42004,-0.0251034961824717,0.00599484140564721,-0.0368533853375402,-0.0133536070274031,2.83910043409632e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,40080,0.0411112342244323,0.00983068289485755,0.0218430957505115,0.0603793726983531,2.91308479644869e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,40097,-0.0124981896109137,0.00299113143226737,-0.0183608072181577,-0.00663557200366964,2.9583584112611e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,39804,-0.0253638800774741,0.00607616395736231,-0.0372731614339042,-0.013454598721044,3.0125730827524e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,39706,-0.0168099240473685,0.00402871245736333,-0.0247062004638006,-0.00891364763093638,3.03658953658208e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42144,-0.0159975505051395,0.00383762037350179,-0.023519286437203,-0.00847581457307595,3.08452955733532e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,40021,0.0401131397721127,0.00962660030617381,0.021245003172012,0.0589812763722133,3.11160459031618e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,42186,0.0119743962388535,0.00287892725364496,0.00633169882170937,0.0176170936559976,3.21239815202337e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42296,-0.0218071188496085,0.00524710876513271,-0.0320914520292686,-0.0115227856699484,3.2588890770006e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39577,-0.0207520774750089,0.0049975643343604,-0.0305473035703553,-0.0109568513796625,3.31581736911924e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,42144,0.0360955724402736,0.00873169878039467,0.0189814428307,0.0532097020498471,3.58976269589361e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42256,0.0107622403287208,0.00260574824483141,0.00565497376885123,0.0158695068885903,3.64716320082299e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,41887,-0.0197663915927177,0.00480330553038773,-0.0291808704322776,-0.0103519127531577,3.89347596928809e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42083,0.0262490289563297,0.00638611456480983,0.0137322444093025,0.038765813503357,3.97543239383654e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42094,-0.0361015745317747,0.00879211316145635,-0.0533341163282291,-0.0188690327353202,4.04819893467066e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,41984,-0.014335499977883,0.00349216046012929,-0.0211801344797364,-0.00749086547602961,4.06734412078414e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,40021,-0.0185197742186497,0.00451254198037334,-0.0273643565001815,-0.00967519193711797,4.08926576656561e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41861,-0.030272448860408,0.00738059152420026,-0.0447384082478406,-0.0158064894729755,4.1281592767981e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,39706,-0.0203738914904948,0.00497308258587353,-0.0301211333588069,-0.0106266496221827,4.21982096857299e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,42087,-0.0346635129563038,0.00847735132531708,-0.0512791215539253,-0.0180479043586824,4.35949693404672e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,40001,-0.0177939560649777,0.00435307703657794,-0.0263259870566705,-0.00926192507328497,4.38873922093744e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,40102,0.0112391287842315,0.00275091113813446,0.00584734295348795,0.0166309146149751,4.42771416163335e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,40113,0.0126303800470208,0.00309173250319313,0.00657058434076225,0.0186901757532793,4.43513630205531e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,42120,-0.0241741664236857,0.00592107789295682,-0.0357794790938811,-0.0125688537534903,4.47774792403685e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,40097,0.0106455861308164,0.00260814458466349,0.005533622744876,0.0157575495167569,4.50320653064739e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42103,-0.0401625184103999,0.00984372432398356,-0.0594562180854077,-0.0208688187353921,4.53039863100907e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,40020,-0.0279585309826472,0.00685515268165624,-0.0413946302386935,-0.014522431726601,4.56577655418189e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,42004,-0.0287436206735083,0.00705111894442267,-0.0425638138045768,-0.0149234275424399,4.6002149586507e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,40080,0.0113796748197631,0.00279196609799287,0.00590742126769712,0.0168519283718292,4.61694209651079e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,39849,-0.0243567848286427,0.0059784504079943,-0.0360745476283116,-0.0126390220289739,4.65280209632339e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42103,-0.043959080215151,0.0107928780541977,-0.0651131212013785,-0.0228050392289234,4.66943918796305e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,40020,-0.0242358189047246,0.00595654509590147,-0.0359106472926915,-0.0125609905167577,4.75971094312794e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42004,-0.0120725548911503,0.00296751386180757,-0.0178888820602932,-0.00625622772200747,4.76536572000849e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42126,-0.0310535717070396,0.00764719684756808,-0.046042077528273,-0.0160650658858061,4.91976414853914e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,40063,-0.0193558336872468,0.0047716410019709,-0.0287082500511097,-0.0100034173233838,5.01763587155123e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42213,-0.0147100943918283,0.00363035602276366,-0.0218255921964451,-0.00759459658721154,5.10830244650795e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,41879,-0.0248753144899802,0.00614656617763297,-0.0369225841981408,-0.0128280447818196,5.21801325721838e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,42146,-0.0218460416633928,0.00540155878376591,-0.032433096879574,-0.0112589864472116,5.27622277223705e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39754,-0.0161570389961585,0.00400169425426999,-0.0240003597345277,-0.00831371825778934,5.43940462319233e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41861,-0.0242793186642592,0.00601415683225302,-0.0360670660554752,-0.0124915712730433,5.44512008646827e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41770,0.0166352612493783,0.00412709660539617,0.00854615190280182,0.0247243705959548,5.59286977622081e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41880,-0.0163901966376406,0.00406913364896825,-0.0243656985896183,-0.0084146946856628,5.65972510159315e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42004,-0.0299443539115891,0.00744670002590557,-0.044539885962364,-0.0153488218608142,5.82448461332595e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42144,-0.030038386176462,0.00747114594824833,-0.0446818322350288,-0.0153949401178953,5.8382517960038e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42103,-0.0236587052994683,0.00590572274944966,-0.0352339218883897,-0.012083488710547,6.20850637385053e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41824,-0.0143920155896934,0.00359371078724334,-0.0214356887326903,-0.00734834244669643,6.24310128973831e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,42146,0.00875398640404673,0.00218605405351225,0.00446932045916271,0.0130386523489307,6.2503740272107e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,42256,0.0316493784244847,0.00791292633294831,0.016140042811906,0.0471587140370634,6.37706130766517e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,40085,-0.0226379889976218,0.00566869590189012,-0.0337486329653264,-0.0115273450299171,6.55303318843565e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39899,0.0054832147222035,0.00137315564423394,0.00279182965950498,0.00817459978490203,6.56373730305837e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42213,0.0192454327990844,0.00482215571939923,0.00979400758906187,0.0286968580091068,6.61438441450014e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42103,-0.034782755273469,0.00872023934049166,-0.0518744243808326,-0.0176910861661054,6.67920017794379e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,41876,0.0158542225549094,0.00397512161301109,0.00806298419340771,0.0236454609164112,6.69046523387047e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,42256,-0.014154434749599,0.00355119042544698,-0.0211147679834751,-0.00719410151572293,6.76107589423816e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,40080,-0.0108846864726463,0.0027307095231379,-0.0162368771379966,-0.00553249580729607,6.7626941025264e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,42094,-0.0223378199850374,0.00560661192491952,-0.0333267793578796,-0.0113488606121951,6.80821981132303e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,42256,-0.0141374082090935,0.00355097666048504,-0.0210973224636442,-0.00717749395454285,6.89181611795565e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,40113,0.00841216859516983,0.0021175451524094,0.0042617800964474,0.0125625570938923,7.15478779132692e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41829,-0.023336872936748,0.00588210792149716,-0.0348658044628824,-0.0118079414106135,7.30519782746779e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39768,-0.0273866059075623,0.00691061044870487,-0.0409314023870238,-0.0138418094281007,7.45068192201584e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,40020,-0.0162622239458335,0.00411331790374362,-0.024324327037171,-0.00820012085449606,7.74888518068408e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,42120,0.0127511753002319,0.00322871458270528,0.0064228947181295,0.0190794558823342,7.87946137758284e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,39784,-0.0187467295604572,0.00474759272830675,-0.0280520113079385,-0.009441447812976,7.90917620068214e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,42004,-0.0353148029004724,0.00894911563399231,-0.0528550695430973,-0.0177745362578475,7.98324580183614e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,42186,0.0113484715108506,0.00287602941237468,0.00571145386259623,0.016985489159105,7.99252059289946e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',40054,-0.0172682449375647,0.00438496037999322,-0.0258627672823514,-0.00867372259277803,8.26557719199363e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42211,-0.0188639234179672,0.00479548117542211,-0.0282630665217945,-0.00946478031413987,8.40867471904596e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,40054,-0.0164505210326621,0.00419130232520216,-0.0246654735900584,-0.00823556847526589,8.72943770590991e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41861,-0.0210317409354221,0.00536039278284186,-0.0315381107897922,-0.0105253710810521,8.7716409755394e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42094,-0.0387821765697872,0.00989128124175447,-0.0581690878036259,-0.0193952653359484,8.86955877039127e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,39784,0.023104258957406,0.00589367770562621,0.0115526506543786,0.0346558672604334,8.9041403179575e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,42186,-0.0144287089241479,0.00368570258725188,-0.0216526859951616,-0.00720473185313422,9.09492940900863e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,41774,-0.0413061433051714,0.0105623217622595,-0.0620082939592001,-0.0206039926511427,9.25098292365153e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,42006,-0.0279104753252684,0.00715603882986168,-0.0419363114317973,-0.0138846392187395,9.65765008036135e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,40054,-0.0245019672926426,0.00630538754637036,-0.0368605268835285,-0.0121434077017567,0.000102566467348562
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42094,0.0093713539604005,0.00241849528530642,0.00463110320119991,0.0141116047196011,0.000107209540145221
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,40080,0.0250642067172456,0.0064919029184593,0.0123400769970654,0.0377883364374259,0.000113650887570028
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42126,-0.0115915705218053,0.00300310751105079,-0.0174776612434649,-0.00570547980014579,0.000114004326875696
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39706,0.022138407716589,0.00575959084613262,0.0108496096581691,0.033427205775009,0.000121883904486018
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,42184,0.0130195531116121,0.00338807966546792,0.006378916967295,0.0196601892559293,0.000122241094399314
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,40021,-0.0121005172685774,0.00315563002662748,-0.0182855521207673,-0.00591548241638755,0.000126491662152952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,41840,0.0337305973192877,0.00880673901381183,0.0164693888522165,0.0509918057863589,0.000128715399336879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,40097,0.0194092311426434,0.00507132072287029,0.00946944252581766,0.0293490197594692,0.000130304967290109
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39706,-0.029949111482826,0.00783967522584451,-0.0453148749254812,-0.0145833480401708,0.000134112069655832
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,40054,0.0229909283395491,0.00602114713018299,0.0111894799643905,0.0347923767147078,0.000135086913329515
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42094,-0.0406185168302589,0.0106542917357584,-0.0615009286323454,-0.0197361050281724,0.000138259213022151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,41876,-0.0222160724986135,0.00583762930522915,-0.0336578259368626,-0.0107743190603643,0.000142087455737645
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,40113,0.0195862068161693,0.00516874109349279,0.00945547427292341,0.0297169393594152,0.000151849173735537
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42197,0.0117323718279123,0.00309777066151519,0.00566074133134249,0.017804002324482,0.000152942081015506
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39706,-0.0141474124896388,0.00374401920798948,-0.0214856901372982,-0.00680913484197942,0.000158539101655683
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,42273,-0.0230094754228608,0.00608984067737916,-0.034945563150524,-0.0110733876951977,0.000158578947048058
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41829,-0.0147676224096423,0.00391440427755822,-0.0224398547936564,-0.00709539002562816,0.000162269431164971
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,41985,0.0192537225110869,0.00511555620408696,0.00922723235107642,0.0292802126710973,0.000168126200505188
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,42144,0.0306551996964711,0.00815133301008744,0.0146785869966998,0.0466318123962425,0.000170144233068796
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39784,0.0100649377270756,0.00267653709495839,0.00481892502095716,0.0153109504331941,0.000170532770793515
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42122,-0.0437512616709313,0.0116488245923792,-0.0665829578719944,-0.0209195654698682,0.000173510773767798
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42213,-0.0254883768807351,0.00678980641660603,-0.038796397457283,-0.0121803563041873,0.000174848897155485
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,40021,0.0430508615338449,0.0114991356313199,0.020512555696458,0.0655891673712318,0.000182171445075364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42004,0.0199152584431754,0.00532865486654901,0.00947109490473936,0.0303594219816115,0.00018674910309784
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42004,-0.0166266137919166,0.00445029760833132,-0.025349197104246,-0.00790403047958727,0.000187731730294523
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,42094,0.0272843394591942,0.00731145934580952,0.0129538791414076,0.0416147997769809,0.000190990964660066
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,41852,-0.0151772445810623,0.00406912292474745,-0.0231527255135673,-0.00720176364855729,0.000192425344590879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41861,-0.0188578662687069,0.00506404647928991,-0.0287833973681151,-0.00893233516929864,0.000197040407960514
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,39804,-0.0273265636200815,0.00737017691210089,-0.0417721103677993,-0.0128810168723638,0.000210197947727008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,40093,0.00750623972633855,0.00202659110818493,0.00353412115429608,0.011478358298381,0.000213380050011944
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39863,-0.0202964740656331,0.00548470732564695,-0.0310465004239012,-0.00954644770736511,0.000216208512379782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,40002,0.0325266317911099,0.00879169867854377,0.0152949023811641,0.0497583612010557,0.000216926822676897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,41985,-0.0143654191629501,0.00388334407361669,-0.0219767735472388,-0.00675406477866139,0.000217152394077178
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41861,-0.0213938557703754,0.00581494688820109,-0.0327911516712495,-0.00999655986950124,0.000235014983135399
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39863,-0.0294256109427809,0.00799939954169491,-0.0451044340445029,-0.0137467878410588,0.00023578433132069
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,42144,0.00983679434681834,0.0026836436335297,0.00457685282510014,0.0150967358685365,0.000247879091632178
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41861,-0.0189942755274635,0.00519098535374403,-0.0291686068208018,-0.00881994423412519,0.000254141383730578
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42103,0.0216221920781253,0.00591158937923175,0.0100354768948311,0.0332089072614195,0.00025560684650879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,42122,-0.0118312214986964,0.00323803749879022,-0.0181777749963252,-0.00548466800106755,0.0002593848237673
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,42103,-0.0258337344911494,0.00707059135738243,-0.0396920935516189,-0.0119753754306798,0.000259524468052937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,42274,0.0176857811141079,0.00484175382138519,0.00819594362419296,0.0271756186040229,0.000260446609649624
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41861,-0.0245967988186958,0.00673433960446553,-0.0377961044434483,-0.0113974931939434,0.00026080356336987
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,40020,-0.0150483188901506,0.00412198871512914,-0.0231274167718037,-0.00696922100849748,0.000262715189851142
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,39833,-0.0122644015433357,0.00336314791789926,-0.0188561714624182,-0.00567263162425311,0.000266894698031234
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,39719,-0.0148652322111908,0.00408799123291892,-0.0228776950277119,-0.00685276939466972,0.000277884264626027
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,42004,-0.0135110319638317,0.00373632275102106,-0.0208342245558329,-0.00618783937183041,0.000300187697648671
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,40093,0.00931289275075201,0.00259404746172643,0.0042285597257682,0.0143972257757358,0.000332002168002216
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,42161,0.014038870729771,0.00391655118875781,0.00636243039980572,0.0217153110597363,0.000338966673327388
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,41998,0.0376023502092849,0.0105078116192055,0.0170070394356422,0.0581976609829277,0.000346830139195189
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,42103,0.0202193703230618,0.00565999599060724,0.00912577818147159,0.0313129624646519,0.000355108122319985
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42296,0.00581462978380575,0.00163042728057378,0.00261899231388114,0.00901026725373036,0.000363316061165998
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41861,-0.0199331835108296,0.00558949334385647,-0.0308885904647883,-0.00897777655687089,0.000363547072600329
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,42094,-0.0411717139969959,0.0115603713271739,-0.0638300417982568,-0.018513386195735,0.000370137226440972
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,42085,-0.0190581600640582,0.00536380536686007,-0.0295712185831039,-0.00854510154501246,0.000382073752808714
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39863,0.0226198847457047,0.00637585539841165,0.0101232081648179,0.0351165613265915,0.000390218227040545
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42296,-0.009989301217767,0.0028165609876944,-0.015509760753648,-0.00446884168188598,0.000391553746726253
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,42004,0.0125180830112438,0.003529781795094,0.00559971069285952,0.019436455329628,0.00039189997063982
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42296,0.00824971907919443,0.00232853886433463,0.00368578290509855,0.0128136552532903,0.000397168682467095
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,39863,-0.0256809956617782,0.00724924941062315,-0.0398895245065995,-0.0114724668169568,0.000397935819650488
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,42120,0.010706970076268,0.00302582295073467,0.00477635709282805,0.016637583059708,0.000403771026637538
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,41999,-0.018746809245033,0.00529799991636085,-0.0291308890811002,-0.00836272940896569,0.000403879791665739
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,42094,-0.0116147568996766,0.00328816424206427,-0.0180595588141226,-0.00516995498523068,0.000413412877866218
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,40054,0.013550051457475,0.00383824293497074,0.00602709530493232,0.0210730076100176,0.00041684769596156
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42004,-0.0171261901316217,0.00486374890069144,-0.0266591379769769,-0.00759324228626644,0.000431106124911219
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,42120,-0.00832167325913883,0.00236478576550824,-0.012956653359535,-0.00368669315874268,0.00043467103712604
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41984,-0.0318789484324348,0.00907427676001889,-0.0496645308820718,-0.0140933659827977,0.000444420032299103
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41928,-0.0173264503202307,0.00493451392435878,-0.026998097611974,-0.00765480302848754,0.000447500967560845
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,42296,0.00997549581522492,0.00284878877479955,0.00439186981661781,0.015559121813832,0.000463904720382998
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,40080,-0.00954765019723714,0.0027342703757368,-0.0149068201336813,-0.00418848026079301,0.000481597622419634
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42004,-0.0190106201501602,0.00545708178831724,-0.0297065004552619,-0.00831473984505839,0.000496258500250572
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,40102,0.0255980745479759,0.00735303562151397,0.0111861247298085,0.0400100243661432,0.000500951206892224
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42094,-0.0211650732965415,0.0060819760608923,-0.0330857463758904,-0.00924440021719263,0.00050313305095874
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41861,-0.0241140254498813,0.00693112469470314,-0.0376990298514994,-0.0105290210482631,0.00050480559264754
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40080,-0.0100644512124228,0.00289692387748835,-0.0157424220123,-0.00438648041254564,0.000514400413074965
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39944,0.0232187711650799,0.00669216957929238,0.0101021187896668,0.0363354235404929,0.000523388498999989
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40021,-0.0107200038762887,0.00309442040451234,-0.0167850678691328,-0.00465493988344446,0.000533669163991759
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,42223,-0.0215163773103851,0.00621307828070863,-0.033694010740574,-0.0093387438801962,0.000535748063576962
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39650,-0.0186751603366008,0.00541064541002245,-0.0292800253402448,-0.00807029533295679,0.000559562268578685
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39665,-0.0146892058838317,0.00425901752380364,-0.0230368802304869,-0.0063415315371766,0.000564953584962329
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,41829,0.026333763439315,0.00764011774799377,0.0113591326532472,0.0413083942253828,0.000569168163636418
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,42120,0.0101810930517852,0.00295446584997457,0.00439033998583507,0.0159718461177354,0.000570756125944821
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42184,-0.00975649253149202,0.00283283422195016,-0.0153088476065143,-0.00420413745646971,0.000574826075056214
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42184,-0.0138886739290014,0.00403278531809229,-0.0217929331524623,-0.00598441470554049,0.000575110439260092
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,40054,-0.0112728599530928,0.00328025709115459,-0.0177021638517558,-0.00484355605442983,0.000591318838557911
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,42172,0.00880351222263058,0.00256569628885622,0.0037747474964724,0.0138322769487888,0.000602707203318293
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,40054,-0.0219854977379132,0.00640813951849437,-0.0345454511941622,-0.00942554428166426,0.000603887010111452
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,42256,-0.0267575366809191,0.00780009872933015,-0.0420457301904062,-0.011469343171432,0.000604533757907889
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,42184,-0.0127378391876688,0.00372729491898247,-0.0200433372288745,-0.00543234114646319,0.000634048329079179
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42004,0.0139692473152933,0.00409520241604182,0.0059426505798513,0.0219958440507352,0.000648952146436113
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,40054,-0.024363553719074,0.00714258771567914,-0.0383630256418051,-0.0103640817963429,0.000649546383517598
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42223,0.0214355073838921,0.00628509121407232,0.00911672860431035,0.0337542861634738,0.000650329010373514
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42103,0.0115302849031801,0.00338236296646447,0.00490085348890972,0.0181597163174504,0.000654143100558048
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,41876,-0.0185971412023631,0.00545713933268157,-0.029293134294419,-0.00790114811030725,0.000656791181172846
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,42004,-0.0139545751733933,0.00410336353241226,-0.0219971676969213,-0.00591198264986527,0.000674027430405014
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,42256,-0.0143507936937525,0.00422165177851496,-0.0226252311796419,-0.0060763562078632,0.000677527571525705
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,40054,-0.0229555230728548,0.00675730975741041,-0.0361998501973792,-0.00971119594833043,0.000683385952476059
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,41876,-0.020107061764947,0.00592389696041684,-0.031717899807364,-0.00849622372252997,0.000690329134525977
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,40020,-0.00728900267921572,0.00214801392576,-0.0114991099737053,-0.00307889538472612,0.000692861742481841
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,42093,0.0133931881484004,0.00395184982474131,0.00564756249190741,0.0211388138048933,0.000703340570211588
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,42186,0.0252379846912181,0.00744750473004812,0.0106408754203238,0.0398350939621124,0.000704118899380103
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42094,-0.0205088596817268,0.00605519084430742,-0.0323770337365694,-0.00864068562688428,0.000708754866512444
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42162,-0.0355649212787839,0.0105044536095467,-0.0561536503534955,-0.0149761922040724,0.000712077640146325
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,39862,0.0106415260797172,0.00314693636647187,0.00447353080143234,0.0168095213580021,0.000723366386798375
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,42156,-0.0208893431034411,0.00617874824022799,-0.0329996896542879,-0.00877899655259421,0.000724786442384838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40054,-0.0293697921399209,0.00869710554102916,-0.0464161190003381,-0.0123234652795038,0.000735484663234574
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41876,0.0318327793288992,0.00942959073301089,0.0133507814921979,0.0503147771656006,0.000738118402906859
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,40020,-0.0210558620416774,0.00624256036405364,-0.0332912803552225,-0.00882044372813226,0.00074627322033584
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,40092,0.00763291660207274,0.00226495590038183,0.00319360303732436,0.0120722301668211,0.000754272105033127
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42094,-0.0136089625978644,0.00403912497444194,-0.0215256475477707,-0.00569227764795825,0.000755842418661813
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,39863,-0.0156126638389918,0.00463430751436125,-0.0246959065671398,-0.00652942111084376,0.000757274122543131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,40097,-0.0391067366975983,0.0116188436498864,-0.0618796702513755,-0.016333803143821,0.000765847652524111
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42227,-0.0289435052998556,0.00860461729031496,-0.0458085551888729,-0.0120784554108383,0.000771216769460717
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39804,-0.0178374943326862,0.00531261276839249,-0.0282502153587354,-0.00742477330663688,0.000789059590740205
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42103,-0.0354620126350475,0.0105650147743828,-0.0561694415928377,-0.0147545836772573,0.000791488919386333
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,40020,-0.00988708810796385,0.00294598617626447,-0.0156612210134422,-0.00411295520248549,0.000793157191568877
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39816,0.0118929501813905,0.00354978231055339,0.00493537685270586,0.0188505235100752,0.000809958970557964
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41861,-0.0128937876422551,0.00384954458766064,-0.02043889503407,-0.00534868025044029,0.000812137522777045
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42146,0.0122338600354528,0.00365358325785611,0.00507283685005479,0.0193948832208507,0.00081495072780585
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39706,-0.0230924811191405,0.00689663916274844,-0.0366098938781274,-0.00957506836015351,0.000815747596516888
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,40010,0.00932579261071268,0.00278986369157825,0.00385765977521931,0.0147939254462061,0.000832366481095647
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42076,-0.00868353881333598,0.00260884649450425,-0.0137968779425643,-0.00357019968410765,0.000875606022619001
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",40080,-0.0243312700938054,0.00731281276871152,-0.03866438312048,-0.00999815706713079,0.000880106067045143
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42296,0.00785320320377325,0.00236558423660643,0.00321665810002466,0.0124897483075218,0.000903365156850205
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41876,0.00728658831782812,0.00219588213716546,0.00298265932898382,0.0115905173066724,0.000908232383301733
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,41887,-0.01818913176515,0.00548410333141861,-0.0289379742947304,-0.0074402892355695,0.000913427708100643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,40020,0.0115118740021064,0.00347150400833015,0.00470772614577926,0.0183160218584334,0.000915816871719176
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39758,-0.00930760361104429,0.0028083040262385,-0.0148118795024717,-0.00380332771961684,0.000921771977767075
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39784,-0.0117882373433056,0.00355965806435519,-0.0187651671494418,-0.00481130753716943,0.000930676875635983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42116,0.00757719381102529,0.00228839718596098,0.00309193532654177,0.0120624522955088,0.000931728086992268
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42186,-0.00955102380394473,0.0028879054629804,-0.0152113185113863,-0.00389072909650315,0.000944726976390075
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,42213,-0.00967086210917474,0.00292416206906699,-0.015402219764546,-0.00393950445380344,0.000944803880295402
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,40020,-0.0154416821420909,0.00467790512897533,-0.0246103761948825,-0.00627298808929924,0.00096658663877138
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,41662,0.0109364165422972,0.00331376540278808,0.00444143635283254,0.0174313967317618,0.000968529576452105
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,42057,-0.0188838650485783,0.00572396418290612,-0.0301028348470743,-0.00766489525008235,0.000972628104195373
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,40054,0.0153112171035965,0.00464271048260586,0.00621150455768898,0.024410929649504,0.000977222370734768
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,40021,0.0171845436053187,0.00521439356569891,0.00696433221654882,0.0274047549940885,0.000985283376910826
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,42153,0.00935480685877532,0.00284160650800904,0.0037852581030776,0.014924355614473,0.00099714030734631
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39863,0.00931435918990853,0.00283029167400909,0.00376698750885072,0.0148617308709663,0.00100172427445325
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,41854,-0.0170282863339206,0.00517630967882793,-0.0271738533044234,-0.00688271936341789,0.0010058334346623
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42103,-0.0126903087544866,0.00386891398389439,-0.0202733801629196,-0.00510723734605364,0.00104056320057712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,40102,0.00911247024251328,0.00277920113296671,0.00366523602189853,0.014559704463128,0.00104572570474005
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,42094,0.0282128841610306,0.00862211705059555,0.0113135347418633,0.0451122335801979,0.00107012376689004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,42103,0.0169813874718527,0.00520413390748759,0.00678128501317698,0.0271814899305283,0.00110503688548674
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,42051,0.0166569183230019,0.0051174596266601,0.00662669745474812,0.0266871391912557,0.00113717863550037
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42280,-0.00951078439041565,0.00292882271895646,-0.0152512769195703,-0.003770291861261,0.00116796369243522
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,40054,0.0252214109384993,0.00776893565226013,0.00999429706006941,0.0404485248169291,0.00117210971048067
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39804,-0.0107737709146526,0.00332148974907711,-0.0172838908228438,-0.00426365100646149,0.00118371184864392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42146,-0.00854167689779294,0.00263921566122972,-0.0137145395938032,-0.00336881420178268,0.00121332643824728
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,42213,-0.0102616339088843,0.00317111653399078,-0.0164770223155062,-0.00404624550226235,0.00121533630652367
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39784,-0.0165337784585884,0.00510924492154511,-0.0265478985048169,-0.00651965841236002,0.0012156806018194
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41829,-0.0149671462635399,0.00462592520212975,-0.0240339596597142,-0.00590033286736555,0.00121745606542747
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42162,0.0291809600069233,0.0090198857794392,0.0115019838792225,0.0468599361346241,0.00121870507787319
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,42144,0.0249610232766731,0.00772380782392473,0.00982235994178068,0.0400996866115656,0.0012336419640891
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,42248,-0.0173928425089057,0.00538494171243723,-0.0279473282652827,-0.00683835675252871,0.00124138474067135
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42103,-0.0201705787059008,0.00625420737846852,-0.0324288251676991,-0.00791233224410253,0.00126232666286253
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,42144,-0.0123223873548036,0.00382457722731485,-0.0198185587203407,-0.00482621598926653,0.00127660497497032
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,42184,0.0137719706418469,0.00427724851847316,0.00538856354563947,0.0221553777380543,0.00128586468914167
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40021,-0.0169346373468937,0.00526542096508157,-0.0272548624384536,-0.00661441225533382,0.00130282765322987
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42004,0.0189273030144113,0.00588660653432349,0.00738955420713721,0.0304650518216853,0.00130623992902795
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,42091,0.0205376657285463,0.00639195629809981,0.00800943138427064,0.0330659000728219,0.00131656836125963
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,42256,-0.0130800087732191,0.00407209954885394,-0.0210613238889728,-0.00509869365746534,0.00132085852862294
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39804,-0.0273617989236163,0.00852564752717314,-0.0440720680768756,-0.0106515297703569,0.00133430546027818
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42120,0.0172499290272329,0.00537621139788352,0.0067125546873812,0.0277873033670846,0.00133724087041647
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,42284,0.0149430092068236,0.00466138813356676,0.00580668846503277,0.0240793299486145,0.00135058115551818
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39706,-0.0123375226389708,0.00384923887802008,-0.0198820308398902,-0.00479301443805144,0.00135379045537105
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42094,0.0136469509925209,0.00426028833624249,0.00529678585348563,0.0219971161315562,0.0013619583381735
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42240,0.0139701744492913,0.00436549741149058,0.00541379952276976,0.0225265493758128,0.00137692726423079
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,40054,-0.0181410487429821,0.00568061620644339,-0.0292750565076111,-0.00700704097835303,0.00140960375712008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,41829,0.0109032359208386,0.00341685969283909,0.00420619092287394,0.0176002809188032,0.00142122728534385
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42094,-0.0401056436835522,0.0125800250404826,-0.0647624927628981,-0.0154487946042064,0.00143581820867366
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39706,0.0232548848398249,0.00730188402869723,0.00894319214357832,0.0375665775360715,0.00145287548229151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,39768,-0.0162215772689186,0.00510340627673628,-0.0262242535713217,-0.00621890096651548,0.00148425509489912
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39804,-0.0188916310451067,0.005954194455862,-0.0305618521785962,-0.00722140991161718,0.00151392795371733
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41861,-0.0195790504539098,0.00617237004765781,-0.0316768957473192,-0.00748120516050054,0.00151729501852784
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39902,-0.018386720006976,0.00580142835036979,-0.0297575195737008,-0.00701592044025122,0.00153213632175099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,39706,0.0196289991936729,0.00620753161119484,0.00746223723573105,0.0317957611516148,0.00157066860376443
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,42067,-0.02684437136554,0.00849129632936053,-0.0434873121710867,-0.0102014305599934,0.00157377681047135
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39706,0.0125359733098891,0.00396912870165917,0.00475648105463713,0.0203154655651411,0.00159103632428913
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42184,0.0274400388853579,0.0086997692893176,0.0103884910782954,0.0444915866924204,0.00161354653071077
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39863,-0.0121181082516868,0.00384715317068283,-0.0196585284662251,-0.00457768803714844,0.00163783116681088
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42144,-0.0128253375916757,0.00408293501556952,-0.0208278902221919,-0.00482278496115939,0.00168632828629928
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,42099,0.0277918430804706,0.0088593431473925,0.0104275305115813,0.0451561556493599,0.00171064398397101
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42091,-0.0217367419083879,0.00693072802361675,-0.0353209688346767,-0.00815251498209903,0.00171487167318926
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42126,-0.00876312755516424,0.00279496893638617,-0.0142412666704811,-0.00328498843984735,0.00172049992742111
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,41829,0.0144970481792282,0.00463022064121707,0.00542181572244275,0.0235722806360137,0.00174631586130392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39804,-0.0171526855522579,0.00548033624215975,-0.027894144586891,-0.00641122651762474,0.00175363948928167
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,42223,-0.0127606171619805,0.00407733641998052,-0.0207521965451423,-0.0047690377788187,0.00175403850950623
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40080,0.0106260835716382,0.00339949980272768,0.00396306395829192,0.0172891031849844,0.00177801576795772
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,42103,0.0151795418167162,0.00485778736307979,0.00565827858507986,0.0247008050483526,0.00178329223163463
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,42223,-0.0104155773638565,0.00333550461252582,-0.0169531664044071,-0.00387798832330591,0.0017962982842784
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,40054,0.0242096390756586,0.00775702533568132,0.00900586941772317,0.0394134087335939,0.00180713608588689
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,40020,-0.0149551921660097,0.0048066507157871,-0.0243762275689524,-0.00553415676306696,0.00186715870345007
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,40021,-0.0241751748806943,0.00777682984146309,-0.0394177613699619,-0.00893258839142664,0.0018845332098294
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,42103,0.0201268131814413,0.00648532547031985,0.00741557525961437,0.0328380511032682,0.00191698841468464
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,42248,-0.00690690098615976,0.00223087089721123,-0.0112794079446938,-0.00253439402762576,0.00196528762039654
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42184,0.0369930997591211,0.0120080822686385,0.0134572585125897,0.0605289410056526,0.0020695774551125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42094,0.0176204512652237,0.00572062783328569,0.00640802071198379,0.0288328818184637,0.00207324281532084
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,42120,0.0232284654278831,0.0075581545825911,0.00841448244600453,0.0380424484097617,0.0021214733029545
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,42123,-0.0135449876072486,0.00441513811390145,-0.0221986583104954,-0.00489131690400172,0.0021604966026132
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,40054,-0.0197659995568635,0.00644452594019368,-0.0323972703996431,-0.00713472871408392,0.00216678911995404
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,41651,-0.0287069731778106,0.00936060382122198,-0.0470537566674057,-0.0103601896882155,0.00216837178200519
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41948,0.0119652235424421,0.00390596248100468,0.00430953707967295,0.0196209100052113,0.00219350263784405
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,42178,-0.0185763716247787,0.00608049822687067,-0.0304941481494452,-0.0066585951001122,0.00225461339242237
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39881,-0.0164578643802046,0.00539501052133548,-0.0270320850020222,-0.0058836437583871,0.00228966202161106
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42103,0.02538325219855,0.00833601643068743,0.0090446599944026,0.0417218444026973,0.00233141567264995
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41861,-0.0136759289971528,0.00449509707144881,-0.0224863192571925,-0.00486553873711317,0.00235172351447573
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40054,-0.0129544517246871,0.00426021991245953,-0.0213044827531077,-0.00460442069626639,0.00236517509910592
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,40080,0.0160690074995626,0.0052988709393261,0.00568322045848341,0.0264547945406417,0.00243080532801902
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40054,0.0223133110652191,0.0073691944188662,0.00786969000424131,0.0367569321261968,0.00246823383519341
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,40097,0.0162675014024615,0.00537305241275273,0.00573631867346615,0.0267986841314569,0.00247072852953354
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41829,0.01750861566895,0.00578357509472145,0.00617280848329599,0.0288444228546041,0.00247246420452369
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42211,0.00626175560397246,0.00206977759485318,0.00220499151806023,0.0103185196898847,0.00248848536283908
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41829,-0.0205697617430506,0.00681682825765205,-0.0339307451280486,-0.00720877835805259,0.00255378828509525
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,40080,-0.016537590485019,0.00548045199452548,-0.027279276394289,-0.00579590457574907,0.00255408091586622
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,42256,-0.0151556767278545,0.00503041587603369,-0.0250152918448805,-0.00529606161082845,0.00259338551249628
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,42091,0.00892795133234215,0.00296608850390745,0.00311441786468355,0.0147414848000007,0.0026174558641311
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42004,0.0112162309723383,0.0037271673258676,0.00391098301363785,0.0185214789310388,0.00262344365105065
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,40113,0.00456445985792535,0.00151746778885838,0.00159022299176293,0.00753869672408777,0.00263619865923887
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41927,0.0128600139364855,0.00428275544238953,0.00446581326940206,0.021254214603569,0.00268077675836843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41887,-0.0132269813233712,0.00440576930380559,-0.0218622891588301,-0.00459167348791225,0.0026856150156377
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,40113,0.00643340718117451,0.00214460834257466,0.00222997482972817,0.0106368395326208,0.00270761789936335
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39955,-0.0181236527377684,0.00605013639978972,-0.0299819200813563,-0.0062653853941806,0.00274549449548409
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41861,0.0145486847224002,0.00486459313858821,0.0050140821707673,0.0240832872740331,0.00278846640843567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,40054,0.034361820710018,0.0114970353078027,0.0118276315067248,0.0568960099133112,0.00280743577189561
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39784,-0.0112064375725531,0.00375108946195964,-0.018558572917994,-0.0038543022271122,0.00281899589355911
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,42022,0.0102985514926131,0.0034526195586095,0.00353141715773848,0.0170656858274877,0.00286140642252644
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,42255,-0.00844596361565979,0.00283253780763272,-0.0139977377186199,-0.00289418951269965,0.00287120062915945
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,40113,0.00583615726167595,0.0019572232351949,0.00199999972069394,0.00967231480265795,0.00287139329850954
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,42120,0.0117573696452722,0.00394924784602903,0.00401684386705528,0.0194978954234891,0.00291513012172688
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,42094,-0.0233848628136457,0.00785771906323174,-0.0387859921775799,-0.00798373344971147,0.00292541173223309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42223,-0.0104319204129582,0.00350630114841811,-0.0173042706638577,-0.00355957016205871,0.00293341988363842
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,42021,0.0160453914911208,0.00539490513941058,0.00547137741787606,0.0266194055643655,0.0029432427785737
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,41968,0.0203631928298654,0.00685268734491965,0.00693192563382284,0.0337944600259079,0.00296839886000392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39804,0.0168388741462464,0.00567028031510928,0.00572512472863221,0.0279526235638606,0.00298784704731314
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42213,0.0216995856932967,0.00731686583221326,0.00735852866215867,0.0360406427244347,0.00302548714002634
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,39706,0.0180521540263784,0.00610941564503784,0.00607769936210422,0.0300266086906526,0.00313556863988615
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42161,0.0280455396339244,0.00950172195146575,0.00942216460905157,0.0466689146587973,0.00316670451702838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,42099,-0.027665418085523,0.00937435016591269,-0.0460391444107119,-0.00929169176033416,0.00317129038745836
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42186,0.00758513194996284,0.00257235907172778,0.0025433081693764,0.0126269557305493,0.00319675070763732
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,39719,0.0143907927015416,0.00488506261454147,0.00481606997704036,0.0239655154260429,0.00322746077192031
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41861,-0.0189129943053173,0.00642322137448715,-0.0315025081993121,-0.00632348041132248,0.00324094159300726
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39646,0.0150279979986623,0.00510400748859219,0.00502414332102157,0.0250318526763029,0.00324343552110415
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42094,-0.0164007589620112,0.00557145284115623,-0.0273208065306774,-0.00548071139334495,0.00324878431750311
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,40102,-0.00806290597231649,0.00273979208028254,-0.0134328984496703,-0.0026929134949627,0.0032584895506506
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,40020,-0.0134478692328814,0.00458794114845904,-0.0224402338838611,-0.00445550458190165,0.00338433537559033
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,40021,-0.0167137264389561,0.00570259539094557,-0.0278908134052094,-0.00553663947270281,0.00338690025556328
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,42223,0.018306377793891,0.00624814112774368,0.00606002118351335,0.0305527344042686,0.00339668187682997
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,39706,0.0103952484684044,0.00355277895279671,0.0034318017209228,0.0173586952158859,0.0034414252252931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,40102,0.0066701199522587,0.00228238377325151,0.00219664775668573,0.0111435921478317,0.00348018294141962
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41829,-0.0125609633436843,0.00429954771717475,-0.0209880768693468,-0.0041338498180218,0.00349009985207869
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,41876,0.0233115869016213,0.00798444341064573,0.00766207781675562,0.0389610959864869,0.00351068570387675
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40054,0.0121927252119206,0.00417793212695903,0.00400397824308086,0.0203814721807603,0.00352595675624453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,42144,-0.0175468585024251,0.0060162791486783,-0.0293387656338345,-0.00575495137101558,0.0035451850397658
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42144,-0.0202805977695212,0.00695799869341685,-0.0339182752086182,-0.00664292033042414,0.00356620812621317
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41829,0.0103362835349241,0.00355211937851021,0.0033741295530441,0.0172984375168041,0.00362184584925497
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,40097,0.0246921936956991,0.00848565582989627,0.00806030826910246,0.0413240791222958,0.00362305019327662
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,40113,-0.00632178044273183,0.00217262659069694,-0.0105801285604978,-0.00206343232496582,0.00362458751105725
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,42256,-0.0272910610843101,0.009389981292044,-0.0456954244167163,-0.00888669775190381,0.00366225693643013
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41876,0.014594585062632,0.00503075921644252,0.00473429699840462,0.0244548731268593,0.00372530073366365
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,40054,-0.0140364442103434,0.00484277926937381,-0.0235282915783161,-0.00454459684237072,0.00375789642651684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41861,-0.00838543002113745,0.00289717881457593,-0.0140639004977063,-0.00270695954456863,0.00380601055579568
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,42103,0.0196771163138077,0.00680190859730632,0.00634537546308736,0.0330088571645281,0.00382363308891043
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39706,0.0119081706416386,0.00411950575070637,0.00383393937025414,0.0199824019130231,0.00385197072038965
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42120,0.010478920188028,0.00362693052137695,0.00337013636612916,0.0175877040099268,0.0038686773114896
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,42296,0.00927004080220894,0.00320947926877578,0.00297946143540842,0.0155606201690095,0.00387925477478625
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,41542,-0.0083275710698853,0.00288473807735538,-0.0139816577015018,-0.00267348443826877,0.0038989553086107
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,42219,-0.0172600288984143,0.00598589928656569,-0.0289923915000831,-0.00552766629674557,0.00393991724119845
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39784,-0.0131410338764063,0.00456630463872402,-0.0220909909683054,-0.00419107678450725,0.00401225697640429
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41887,0.0109190131160773,0.0038006928133682,0.0034696552018756,0.0183683710302789,0.0040739626226124
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40021,0.0258572896485118,0.00902157394263012,0.00817500472095681,0.0435395745760669,0.00416282786308578
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,39863,0.0311791767138668,0.0108848232205483,0.00984492320159219,0.0525134302261414,0.00418531843045417
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42094,-0.0195401500897276,0.00683088694443463,-0.0329286885008195,-0.00615161167863574,0.00423575071107543
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42161,0.0104019775445495,0.00363980170404601,0.00326796620461929,0.0175359888844796,0.00427212141722209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,40054,0.0198421048294618,0.00695296771986702,0.00621428809852239,0.0334699215604011,0.00432868132926164
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,41854,0.017191029679754,0.00603050312195271,0.0053712435607267,0.0290108157987813,0.00436964721456762
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,41876,0.018071663394233,0.00634214360512742,0.0056410619281832,0.0305022648602827,0.00438645189953166
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,42256,-0.011813572683559,0.00414769204897354,-0.0199430490995471,-0.00368409626757084,0.0044032067002371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39665,-0.0152291187682306,0.00535860171321116,-0.0257319781261244,-0.00472625941033669,0.0044918859489244
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,40054,-0.00745607354186497,0.00262513327573261,-0.0126013347623009,-0.00231081232142905,0.0045159920351765
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42103,-0.0228164203825123,0.00804704945172603,-0.0385886373078953,-0.00704420345712924,0.00458427608853763
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,39706,-0.0156806069577789,0.00553249811667349,-0.0265243032664589,-0.00483691064909884,0.00460177168461431
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41861,-0.0092073338307954,0.00325008332654921,-0.0155774971508319,-0.00283717051075894,0.00461929798054624
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,42144,0.01490630879073,0.00527028954125013,0.00457654128987969,0.0252360762915802,0.00468581049940312
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,40092,0.00423729704872567,0.00149850268818479,0.00130023177988348,0.00717436231756787,0.00469710690531967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41887,-0.0173120018240841,0.00612862932020468,-0.0293241152916853,-0.00529988835648293,0.00473875497156426
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,42103,-0.026237310316404,0.00928879938467854,-0.0444433571103739,-0.00803126352243403,0.00474095871348623
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,41861,-0.0116716058124834,0.00413621800511582,-0.0197785931025104,-0.0035646185224564,0.00478283675466347
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,42184,0.0185473600161564,0.00658398751128161,0.00564274449404448,0.0314519755382684,0.00485415371631336
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42103,0.0138103161423361,0.00491894914339181,0.0041691758212881,0.023451456463384,0.00499910112486934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,40054,-0.0192850679040972,0.00686993555930879,-0.0327501416003424,-0.00581999420785194,0.0050068140729856
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,41984,0.00942762454430351,0.00336040846204321,0.00284122395869881,0.0160140251299082,0.00503145061047175
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39719,0.0135196108475297,0.00482075711713904,0.00407092689793723,0.0229682947971223,0.00504936209946825
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42120,0.0128747291994799,0.00459388305561586,0.0038707184104728,0.021878739988487,0.00507709500574732
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,42256,0.00251985929658177,0.000899352581822548,0.00075712823620958,0.00428259035695397,0.00508838166721361
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,42081,0.00819304913772229,0.00292425978644047,0.00246149995629898,0.0139245983191456,0.0050901815202022
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40020,-0.0136510026789903,0.00487824198599598,-0.0232123569715424,-0.00408964838643814,0.00514560582524573
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42197,0.0103336672657228,0.00369586238798029,0.00308977698528141,0.0175775575461642,0.00518137492026803
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42088,-0.00700303556221633,0.00250500494286093,-0.0119128452502238,-0.0020932258742089,0.00518772793864884
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39719,0.0169718714340328,0.00608059390889554,0.00505390737259752,0.028889835495468,0.00526151583685477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,39784,0.0141751697763689,0.00508097580423315,0.00421645720007196,0.0241338823526659,0.00528264156934799
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39719,0.0175877015314242,0.00631757732027321,0.00520524998368872,0.0299701530791597,0.00538002457253103
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41861,-0.00944496569044387,0.00339306456380818,-0.0160953722355079,-0.00279455914537983,0.00538374431731044
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,42208,-0.010278101350397,0.003694036301054,-0.0175184125004628,-0.00303779020033114,0.0054044557898998
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,40080,-0.00981629974803727,0.00352809189841914,-0.0167313598689388,-0.00290123962713576,0.00540638265517646
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42184,-0.0085741535871004,0.00308494832668883,-0.0146206523074105,-0.0025276548667903,0.00545459581134243
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,42111,0.0114637892749571,0.00412469164911296,0.00337939364269571,0.0195481849072185,0.00545535522265939
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,42103,-0.011614929419705,0.00418064607303463,-0.0198089957228529,-0.00342086311655712,0.00547294940159498
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,41876,-0.0154927332190166,0.00558158988406749,-0.0264326493917889,-0.00455281704624434,0.00551663293642721
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42103,0.0256221715021995,0.00923288189609208,0.00752572298585901,0.04371862001854,0.00552640974237514
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42120,-0.00661690999121399,0.00238465225780081,-0.0112908284165036,-0.00194299156592441,0.00553166262933132
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,42186,-0.0160282528585828,0.00578295218560537,-0.0273628391423693,-0.00469366657479623,0.00558542979339743
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39784,0.0123245643986364,0.00444764652489674,0.00360717720983877,0.021041951587434,0.00559766522607675
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,39847,0.00595306255491866,0.00214943724185074,0.0017401655608912,0.0101659595489461,0.00562238208534774
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,0.0106657913548745,0.00385788795772461,0.00310433095773428,0.0182272517520147,0.00570608281094888
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,42223,-0.0159261880913854,0.00576141201776849,-0.0272185556462116,-0.00463382053655914,0.00571277549841521
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,39922,-0.00782203079212956,0.00283169448550046,-0.0133721519837105,-0.00227190960054866,0.00574908671745799
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39804,-0.0090791677458302,0.00328872893741354,-0.0155250764631607,-0.00263325902849967,0.00577781144999397
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39706,0.00918250760541476,0.00333630807734277,0.00264334377382293,0.0157216714370066,0.0059280472661496
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39804,-0.0237652569208519,0.0086411210976686,-0.0407018542722824,-0.00682865956942147,0.00596504285235401
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39867,-0.0181360816181776,0.0066068225545681,-0.0310854538251311,-0.00518670941122414,0.00606022451299235
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,41887,-0.0316663369636283,0.0115595953772402,-0.0543231439030192,-0.00900953002423748,0.0061637680767217
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,42115,0.0315889868047834,0.0115533524462655,0.00894441601010296,0.0542335575994638,0.00626203530626065
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,42127,-0.00936282286190802,0.00342751853638555,-0.0160807591932237,-0.00264488653059234,0.00631011924242553
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,42256,-0.0158452618618274,0.00580096479623385,-0.0272151528624457,-0.00447537086120904,0.00631338259567282
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40021,0.0195817880315927,0.00717764292245836,0.00551360790357431,0.0336499681596111,0.0063790637439299
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,39864,0.00599582162199051,0.00219930110109944,0.0016851914638356,0.0103064517801454,0.00641650744538759
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,40080,0.00783632153811027,0.00288254947250429,0.00218652457200186,0.0134861185042187,0.00656749025686182
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41876,-0.0099058431723784,0.00364456651005156,-0.0170491935320795,-0.00276249281267734,0.00657719013782691
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,42120,0.0333647294883188,0.0122857226739987,0.00928471304728137,0.0574447459293561,0.00662173239569192
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,42004,0.0156351414706833,0.00575972561629269,0.00434607926274966,0.026924203678617,0.00664520165660325
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40020,0.0123866421110031,0.00457204348612571,0.00342543687819672,0.0213478473438095,0.00675490234972514
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,40054,0.0099532557806126,0.00367390961729394,0.00275239293071647,0.0171541186305087,0.0067556993034669
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,40092,-0.00773482304395328,0.00285667033581299,-0.0133338969021467,-0.00213574918575982,0.00678700146487412
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42223,0.00940962799048042,0.00348250242783008,0.00258392323193346,0.0162353327490274,0.00690185746402454
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,40086,-0.00978097203353056,0.00362214008163348,-0.0168803665935322,-0.00268157747352894,0.00693778670576946
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,42137,0.0513154956898019,0.0190064476919349,0.0140628582136094,0.0885681331659944,0.00694506059244491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,42223,-0.0122858214693905,0.00455413406086822,-0.0212119242286922,-0.00335971871008882,0.00699040390001678
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42103,0.0133747327616459,0.00496717865947258,0.00363906258907963,0.0231104029342122,0.00709841626508098
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,40054,-0.00834371529771097,0.00311773474693599,-0.0144544754017055,-0.00223295519371642,0.00745715630443849
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,42004,0.0116278765558592,0.0043466794709208,0.00310838479285445,0.020147368318864,0.00747980666123452
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42103,-0.0106622040114581,0.00399362480546246,-0.0184897086301645,-0.00283469939275164,0.00759900618579114
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42111,0.0296930817612029,0.0111226792939216,0.00789263034511653,0.0514935331772893,0.00760371040190482
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,42103,0.0254907509264067,0.00955051596862102,0.00677173962790951,0.0442097622249039,0.00761625276490099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39719,0.016813834504503,0.0063008032171549,0.00446426019887936,0.0291634088101266,0.00763024811005879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,40028,0.015693516466406,0.00588649530587201,0.00415598566689689,0.0272310472659151,0.00768689545024041
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42004,0.0325479081512885,0.012233061158445,0.00857110828073634,0.0565247080218407,0.00780869002311795
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,42144,-0.0148895950048967,0.00559799093299251,-0.025861657233562,-0.00391753277623135,0.00782808948304655
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",40054,0.0284250460181109,0.010695473404971,0.00746191814436775,0.0493881738918541,0.00787979353199094
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,42208,0.0164110885596094,0.00618088005889809,0.0042965636441691,0.0285256134750496,0.00793725265782355
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,41810,-0.0127875983558861,0.00482372598554539,-0.022242101287555,-0.0033330954242171,0.00803589668663646
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,42094,0.0075633712500323,0.00285337189349178,0.00197076233878842,0.0131559801612762,0.00804283677911794
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39784,-0.0120731025947748,0.00456313011754286,-0.0210168376251588,-0.00312936756439082,0.0081619835394885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42248,-0.010277291676294,0.00388954527489396,-0.0179008004150861,-0.00265378293750181,0.00824466816440148
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,40021,0.0260549395419525,0.00986512383700526,0.00671929682142221,0.0453905822624828,0.00827520140717336
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,42004,0.0163360749457246,0.00619260722554362,0.00419856478365916,0.0284735851077901,0.00834982881914978
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42197,0.0085448223662874,0.00324025158884056,0.0021939292521599,0.0148957154804149,0.00837210525019188
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39719,0.00782411356817548,0.00296729491614274,0.00200821553253571,0.0136400116038153,0.00838192127727938
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,40054,0.0643484683630955,0.024417006800401,0.0164911350343095,0.112205801691881,0.00841587079692612
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",40097,-0.0109185329304981,0.00415794571289898,-0.0190681065277801,-0.00276895933321613,0.00865297308721306
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42024,0.0111948618937628,0.00426598032124152,0.00283354046412944,0.0195561833233962,0.00869510678856614
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,42186,-0.0220508440531144,0.0084059580138572,-0.0385265217602745,-0.00557516634595432,0.00871996691589781
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,42103,-0.0215849776276422,0.00823110195970337,-0.0377179374686608,-0.00545201778662359,0.00874236419178701
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40054,0.0263694608146356,0.0100740667603306,0.00662428996438755,0.0461146316648837,0.00886840690331433
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42076,-0.0204182204117821,0.00780180806544139,-0.0357097642200472,-0.00512667660351698,0.0088780341655055
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,40097,0.0127574098626191,0.00488170403390118,0.00318926995617275,0.0223255497690654,0.0089792856006137
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,42059,0.0109590649951071,0.00419725002770987,0.00273245494079571,0.0191856750494184,0.00903797826988128
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,42103,-0.0252084104137933,0.00966174815001327,-0.0441454367878193,-0.00627138403976732,0.00908869508623582
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,40020,0.0306903941862516,0.0117666031954667,0.00762785192313688,0.0537529364493664,0.00911280349847988
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,40054,0.0187028848619502,0.00718936458651499,0.00461173027238083,0.0327940394515196,0.00929522905445259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,40113,0.00398688876283681,0.00153469232826453,0.000978891799438321,0.0069948857262353,0.00939374923605115
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42256,0.0191120949862196,0.00738773614783497,0.0046321321364631,0.0335920578359762,0.00969218157339712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,42179,-0.00819142582518464,0.00316896005269485,-0.0144025875284665,-0.00198026412190274,0.00975169653503912
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,42197,0.0155144674131929,0.00600478669602268,0.00374508548898847,0.0272838493373974,0.00978595697376652
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42103,0.0314399255125043,0.0121763402682403,0.00757429858675318,0.0553055524382553,0.00983243448699048
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,42116,0.0252080369349353,0.00976740111228019,0.00606393075486616,0.0443521431150045,0.00986713034688032
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,42103,0.0176352660061669,0.00684930739365228,0.00421062351460842,0.0310599084977253,0.0100422411581817
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,39881,-0.00789092484344015,0.00306732189138458,-0.0139028757505539,-0.00187897393632637,0.0101077939359066
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39804,0.0104843531671713,0.00407613972340789,0.00249511930929184,0.0184735870250508,0.0101210307796895
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42144,-0.00990657766971457,0.00385336451722692,-0.0174591721234793,-0.00235398321594981,0.0101548077698835
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39768,-0.0126851226680897,0.00493460058814427,-0.0223569398208525,-0.00301330551532697,0.0101643910128243
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41887,0.0113592178152268,0.00442087747200127,0.00269429797010432,0.0200241376603493,0.0101973602523149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,40000,0.00728032672167084,0.00283565894856286,0.00172243518248764,0.012838218260854,0.0102591801496295
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,39784,0.0092957597098295,0.00362714713252015,0.00218655133009,0.016404968089569,0.0103959966791695
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,42192,0.0118553820294938,0.00462782453056131,0.00278484594959368,0.020925918109394,0.0104254603391937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,40054,-0.014872507920409,0.00581093311665664,-0.026261936829056,-0.00348307901176196,0.0104986950993172
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42296,-0.0099594108061061,0.00390198449361647,-0.0176073004135944,-0.00231152119861781,0.0107097169355968
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,40020,-0.0255128051447582,0.0100116391686079,-0.0451356179152297,-0.00588999237428675,0.0108381723570324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40020,-0.0184940412924328,0.00726019386392972,-0.0327240212657351,-0.00426406131913057,0.0108690740173048
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42186,0.00640074261766,0.00251287297340708,0.00147551158978213,0.0113259736455379,0.0108711298103654
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39784,0.00770428112170535,0.00302774063896563,0.00176990946933273,0.013638652774078,0.0109554834686356
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,40021,-0.0123075945968299,0.00484421225652003,-0.0218022506196092,-0.00281293857405064,0.0110775451200428
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42167,-0.0169480950933231,0.00667283685645177,-0.0300268553319686,-0.00386933485467764,0.0111011376777054
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,39881,0.00921035702268117,0.00362662309078873,0.00210217576473525,0.0163185382806271,0.0111103568512893
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42189,0.00708610038218197,0.00279079345751814,0.00161614520544642,0.0125560555589175,0.0111254010747917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,40054,-0.00585659429618779,0.00230802177972405,-0.0103803169844469,-0.00133287160792865,0.0111787522759568
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40097,0.016313421842328,0.00644895232836055,0.00367347527874131,0.0289533684059147,0.0114324639366476
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,41661,-0.0156892945763881,0.00620498737600266,-0.0278510698333533,-0.00352751931942285,0.0114674283313497
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42120,0.0106789970427219,0.00422536921638067,0.00239727337861582,0.018960720706828,0.0115044324763927
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,42099,0.00787132394225479,0.00311735949134165,0.00176129933922515,0.0139813485452844,0.0115818017298196
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39804,-0.00863163479719291,0.00341959925761993,-0.015334049342128,-0.00192922025225784,0.0116117962886211
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,40080,-0.0143559851845124,0.00569149237015887,-0.0255113102300238,-0.00320066013900105,0.0116712156042309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39706,0.0158048538632631,0.00626768466908221,0.00352019191186197,0.0280895158146642,0.0116955240395934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,39804,-0.0188126184413366,0.00747009181961877,-0.0334539984077893,-0.00417123847488378,0.0118037964037649
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,40054,-0.0134212890876599,0.00533691721566463,-0.0238816468303626,-0.00296093134495727,0.0119242574613376
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39784,-0.0146001845425258,0.00581384275083624,-0.0259953163341648,-0.00320505275088675,0.0120442040874312
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,41887,-0.00848896637496896,0.00338843625095871,-0.015130301426848,-0.00184763132308989,0.0122480283018616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39804,-0.0159100073439497,0.00635487430298463,-0.0283655609777995,-0.00345445371009978,0.0123088987527837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41813,0.0145224486343319,0.0058019682064506,0.00315059094968873,0.0258943063189751,0.0123263585317738
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,42043,0.0117053791757876,0.00467721450441571,0.00253803874713283,0.0208727196044424,0.012339442010001
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,42062,-0.0155069107195074,0.0061974462861047,-0.0276539054402726,-0.00335991599874216,0.0123566368304466
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41887,0.0166685863744501,0.00666463536225206,0.00360590106443602,0.0297312716844641,0.0123950676335377
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42004,-0.0146486508018977,0.00585762248769321,-0.0261295908777764,-0.00316771072601902,0.0124042491505413
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39784,-0.00857114098979022,0.00343095057449113,-0.0152958041157928,-0.00184647786378761,0.0124982297534054
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40021,-0.020103443729142,0.00805202771541233,-0.0358854180513502,-0.00432146940693385,0.0125504756623166
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,42112,0.0232767981813754,0.00933363700641999,0.00498286964879218,0.0415707267139585,0.0126485889030159
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42223,0.015163627888754,0.00608826879554188,0.0032306210494919,0.0270966347280161,0.0127640218526341
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,41797,0.0124197150731491,0.00498693487878639,0.00264532271072783,0.0221941074355705,0.0127708989061242
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,41861,-0.024166880999092,0.00970504954409235,-0.043188778105513,-0.00514498389267096,0.0127821852993771
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42144,0.0125578106620596,0.00504375912255496,0.00267204278185191,0.0224435785422674,0.0127949497241974
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39784,-0.0111502790724864,0.0044832701155619,-0.0199374884989877,-0.00236306964598503,0.0128946975118344
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,40054,-0.0153026999279008,0.00616845591790059,-0.027392873526986,-0.00321252632881566,0.0131238511262871
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39804,0.0153195340236623,0.00617556503759132,0.00321542654998331,0.0274236414973413,0.0131289857152462
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39784,-0.0200914717566019,0.00810237446113064,-0.035972125700418,-0.00421081781278589,0.0131646682439601
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42094,-0.00851182275608794,0.00343402726740837,-0.0152425162002083,-0.00178112931196754,0.0131999878281093
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,42146,-0.00747950012214091,0.00301969363377664,-0.0133980996443431,-0.00156090059993869,0.0132653132993345
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,42103,0.0116453873808421,0.00470250685943063,0.00242847393635807,0.0208623008253261,0.0132834128932934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,39991,0.0182416617316486,0.00736685148525652,0.00380263282054577,0.0326806906427513,0.0132948156196468
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39532,0.0268075529928213,0.0108446144524882,0.00555210866594447,0.0480629973196982,0.0134530892372738
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,41779,-0.0174642949004239,0.00706763038943352,-0.0313168504637136,-0.00361173933713422,0.0134857647622677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42094,0.00991292325747263,0.00401197627884111,0.00204944975094406,0.0177763967640012,0.0134927022967693
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39863,-0.0172958532046516,0.00701430603964658,-0.0310438930423589,-0.00354781336694427,0.0136865029730749
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39784,-0.0112523268646161,0.00456404884525581,-0.0201978626013175,-0.00230679112791476,0.0137007658271247
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41861,0.031109279401964,0.0126298925479787,0.00635469000792586,0.0558638687960022,0.0137855510762231
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,42202,-0.0233890860239379,0.0095070686102343,-0.0420229404999971,-0.00475523154787864,0.0138996974083404
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40021,-0.00735540535835955,0.0029904408617562,-0.0132166694474017,-0.00149414126931739,0.0139231949935085
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39719,0.00859128616969,0.00349452445690672,0.00174201823415282,0.0154405541052272,0.0139678891850657
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,40041,0.0102928143170509,0.00418672371591884,0.00208683583384995,0.0184987928002518,0.0139696738186682
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,41887,0.00853698699340105,0.0034759854697345,0.00172405547272144,0.0153499185140807,0.0140629914221269
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,40054,-0.0187061686927272,0.00762626962988493,-0.0336536571673016,-0.0037586802181527,0.0141881763230785
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39863,0.0132832126535535,0.00542351129458818,0.00265313051616064,0.0239132947909463,0.0143337378491016
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41876,-0.010594413355623,0.00432907652540528,-0.0190794033454174,-0.00210942336582867,0.0144078188060818
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,40054,0.0311620515041712,0.0127555806481842,0.00616111343373011,0.0561629895746123,0.014581025033937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,39948,0.0244703238805567,0.0100181609134767,0.00483472849014235,0.044105919270971,0.0145980182954372
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,42256,-0.0144387912951174,0.00591317156629979,-0.026028607565065,-0.00284897502516979,0.0146273522068645
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,42120,0.0133823894818222,0.0054834666627507,0.00263479482283083,0.0241299841408136,0.0146803616788608
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42217,-0.0078620926461447,0.00322439165315335,-0.0141819002863253,-0.00154228500596413,0.0147690553782775
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,40054,-0.00726202259271051,0.00298069776605462,-0.0131041902141776,-0.00141985497124345,0.0148522867881701
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,40080,0.0176665979226167,0.0072516224250044,0.00345341796960806,0.0318797778756253,0.0148572942417743
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,42296,0.00750929047781533,0.00308916787300775,0.00145452144672013,0.0135640595089105,0.0150769523583883
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39724,-0.0106364827882606,0.00437727553217285,-0.0192159428313194,-0.0020570227452018,0.0151182472304876
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,42094,-0.0203696386346203,0.00838723255939796,-0.0368086144510403,-0.00393066281820034,0.0151687955409538
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40054,-0.0170299932217499,0.00701760063839332,-0.0307844904730008,-0.00327549597049897,0.0152507278373885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,42144,0.01009739361385,0.00416369871558456,0.00193654413130432,0.0182582430963958,0.0153176740349066
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,40097,0.0222357835078517,0.00916912383456863,0.00426430079209715,0.0402072662236062,0.0153214943865059
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,42103,-0.0140670744486343,0.00580570881824234,-0.0254462637323893,-0.00268788516487933,0.0154077441853044
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,40102,0.00654834159027357,0.00270275994118645,0.00125093210554814,0.011845751074999,0.0154160904335535
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42103,0.0201738667256096,0.00832929354049814,0.0038484513862333,0.036499282064986,0.0154474109940105
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,41742,-0.0189001643303645,0.00780454558423649,-0.0341970736754681,-0.00360325498526101,0.0154627435560748
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,42162,0.00801018194305023,0.00330873707443371,0.00152505727716016,0.0144953066089403,0.0154949971923734
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41813,0.0139752879865106,0.00578398918556185,0.0026386691828094,0.0253119067902118,0.0156974468276581
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,41985,-0.0154998360946593,0.00644581077525338,-0.028133625214156,-0.00286604697516272,0.0162026509835185
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41861,-0.0181765072002803,0.00755947806740673,-0.0329930842123975,-0.00335993018816307,0.0162103795743355
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39804,0.00623721932930538,0.00259659436315879,0.00114789437751415,0.0113265442810966,0.0163193609407097
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,40054,-0.0129475696195191,0.005392710433212,-0.0235172820686146,-0.00237785717042356,0.0163697662332781
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,39921,-0.00588815756442876,0.00245859903824671,-0.0107070116793923,-0.0010693034494652,0.0166408634914196
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,39804,-0.0114358575069606,0.0047906929001969,-0.0208256155913465,-0.00204609942257468,0.0169993311477412
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,40021,-0.0259848761396413,0.0109014130121775,-0.0473516456435092,-0.00461810663577342,0.0171602124254728
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42111,0.0073419903306617,0.00308218761270602,0.00130090260975789,0.0133830780515655,0.0172299562858975
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40054,-0.0117045893302126,0.00491656813740827,-0.0213410628795328,-0.00206811578089242,0.0172996354209934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39881,0.00906374245621202,0.00380841690473173,0.00159924532293783,0.0165282395894862,0.0173336500178725
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,39804,0.0282502033960387,0.0118832512200579,0.00495903100472519,0.0515413757873521,0.0174569202595429
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,42186,0.0107772446812606,0.00453828348762919,0.00188220904550741,0.0196722803170138,0.0175757366576025
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42223,-0.007917904871287,0.00333709392351943,-0.0144586089613851,-0.00137720078118892,0.0176732870842791
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,42094,0.0178863587496195,0.00754306100476467,0.00310195918028078,0.0326707583189583,0.017743429612187
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39706,0.00503593940117701,0.00212623425118697,0.000868520268850543,0.00920335853350347,0.0178794145541296
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,42256,-0.0148142859552661,0.00625547831183022,-0.0270750234464533,-0.00255354846407882,0.0178888638823613
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,40020,-0.0169102255206671,0.00714326624858245,-0.0309110273678887,-0.00290942367344548,0.0179360798069306
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42094,0.0224196581840694,0.00947495887753581,0.00384873878409919,0.0409905775840396,0.0179863713223976
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,42256,-0.0226452130206167,0.00957164262782444,-0.0414056325711527,-0.00388479347008084,0.0180025245918487
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,41843,-0.0290440690617151,0.0122837212218927,-0.0531201626566248,-0.00496797546680537,0.0180725775465006
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,41866,0.0215003320511692,0.00909935141654982,0.00366560327473158,0.0393350608276069,0.0181504050710688
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,40020,0.00946510615457428,0.00400672802747185,0.00161191922072945,0.0173182930884191,0.0181793759332525
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41861,-0.0111299269321129,0.00471283759059059,-0.0203670886096704,-0.00189276525455533,0.0182103763358881
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39665,0.0124443927382773,0.00527018693297012,0.00211482634965583,0.0227739591268987,0.0182301308288836
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,40021,-0.0269953162663842,0.0114519011672455,-0.0494410425541853,-0.00454958997858306,0.0184271495038943
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42178,0.0174786640209954,0.00741597984253914,0.00294334352961872,0.0320139845123722,0.0184433663661121
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42004,-0.014912636118245,0.00633029700194639,-0.0273200182420599,-0.00250525399443004,0.0185000324408739
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,42095,0.0189254744044344,0.00804796295733252,0.00315146700806263,0.0346994818008061,0.0187085385387305
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,42172,-0.00770152440808217,0.00328181293664615,-0.0141338777639086,-0.00126917105225571,0.0189539951458899
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41876,0.00739434457428859,0.00315615954325905,0.00120827186950085,0.0135804172790763,0.0191534855438134
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42067,0.0051507869245361,0.00219911404737328,0.000840523391684471,0.00946105045738773,0.0191850813987918
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,42158,0.0263471717623634,0.0112515072020442,0.0042942176463568,0.0484001258783701,0.0192134040671008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39665,-0.0134501512319592,0.0057437060000557,-0.0247078149920684,-0.00219248747185,0.0192137538864564
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39753,-0.0116705788097569,0.00499245017308154,-0.0214557811489967,-0.00188537647051708,0.0194242232395666
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,40054,-0.0108535940765894,0.00464782817762296,-0.0199633373047304,-0.00174385084844841,0.0195512520988121
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,42004,0.00855649480480498,0.00366734907984987,0.00136849060829923,0.0157444990013107,0.0196553933589482
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40080,-0.0149540780289964,0.00641458347291867,-0.027526661635917,-0.00238149442207583,0.0197576785891667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,40097,0.0141852763187152,0.00608487543870161,0.00225892045886001,0.0261116321785703,0.0197590861754369
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39863,0.0263034138450256,0.0113006371360594,0.00415416505834913,0.0484526626317021,0.0199517207706045
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,40020,-0.00936256356192247,0.00403477966998318,-0.0172707317150895,-0.00145439540875544,0.0203342455611819
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39965,-0.0074353433134467,0.00321053731838203,-0.0137279964574755,-0.00114269016941792,0.0205813924331061
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,42103,-0.0219996308122667,0.00951468011264524,-0.0406484038330514,-0.00335085779148205,0.0207835502320194
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39793,-0.0187002931535798,0.00808902781506326,-0.0345547876711038,-0.00284579863605578,0.0208072473952443
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42120,-0.0106827426226154,0.0046298049357116,-0.0197571602966101,-0.00160832494862062,0.0210490858262203
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,39719,0.0215927039548676,0.00938000470758244,0.003207894728006,0.0399775131817292,0.0213550012550807
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42262,-0.0108067714187482,0.00469725929172617,-0.0200133996305315,-0.00160014320696488,0.0214268294213036
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,42184,0.0159237434807545,0.00692422325215815,0.00235226590652452,0.0294952210549845,0.0214801246730494
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41861,-0.0230898894350377,0.0100409412434417,-0.0427701342721835,-0.0034096445978919,0.0214885409548998
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,40054,-0.0128516299280191,0.00559216915267189,-0.023812281467256,-0.00189097838878221,0.0215723016688994
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41861,0.0132601392896155,0.00577234383369674,0.00194634537556986,0.0245739332036611,0.0216244716117665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42184,-0.00590337156724805,0.00256991729906382,-0.0109404094734131,-0.000866333661082961,0.0216285705750576
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,42213,-0.0151966440181686,0.00662098131607264,-0.028173767397671,-0.00221952063866621,0.021736040086182
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39706,0.0101804544343795,0.00443794546384258,0.00148208132524806,0.018878827543511,0.0218126184076249
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,42103,0.0141016424640795,0.00614798893584417,0.00205158414982497,0.0261517007783341,0.0218237225335372
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42213,-0.0122276297778132,0.00533685536379127,-0.0226878662908441,-0.00176739326478235,0.0219696236171578
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42079,0.0202684611036174,0.00884976576294805,0.00292292020823917,0.0376140019989955,0.0220210417009273
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,42262,-0.00664505815920996,0.00290733766104939,-0.0123434399748668,-0.000946676343553162,0.0222926565359859
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40054,0.00624613611970559,0.00273783307334195,0.000879983295955365,0.0116122889434558,0.0225431107140077
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42296,0.0166735921811557,0.00731355051225426,0.00233903317713736,0.0310081511851741,0.0226342553231843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,42296,0.00975919249801449,0.00428282938294616,0.00136484690744003,0.018153538088589,0.022702184509018
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42184,0.00988286059848131,0.00434972925785786,0.0013573912530799,0.0184083299438827,0.0230989563334069
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42167,-0.0118652055359718,0.00523649735597025,-0.0221287403536735,-0.00160167071827015,0.0234759456600025
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42126,0.00597039109871592,0.00263537744766427,0.000805051301293943,0.0111357308961379,0.0234997934541953
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39804,0.00910030158579588,0.00402494550817505,0.00121140838977279,0.016989194781819,0.0237809656860427
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,40054,0.00971645421286082,0.00430591390091716,0.00127686296706319,0.0181560454586585,0.0240568150814823
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,42296,0.00581223289609178,0.00257770024910188,0.000759940407852094,0.0108645253843315,0.024161487099555
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41861,-0.0122643631887645,0.00544002074408052,-0.0229268038471623,-0.00160192253036669,0.0241836303333502
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41716,0.0278899278778823,0.0123722793542144,0.00364026034362213,0.0521395954121425,0.024199093889284
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39665,0.0158234299991634,0.00702645327381288,0.00205158158249011,0.0295952784158366,0.0243441887605274
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41861,-0.0138333404101959,0.00614567179025186,-0.0258788571190895,-0.00178782370130227,0.0244084540733371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39881,-0.0121017882681249,0.00537715066391188,-0.0226410035693922,-0.00156257296685759,0.024431447342657
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,41783,-0.0166761631096433,0.0074167989967753,-0.0312130891433229,-0.00213923707596371,0.0245659262319212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42094,0.0167200054483635,0.00743790273315449,0.00214171609138065,0.0312982948053463,0.0245964376577656
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,40020,0.021496901440443,0.00956880894698546,0.00274203590435146,0.0402517669765345,0.0246882454197275
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41813,-0.0131805162215418,0.00588303772818372,-0.0247112701687819,-0.00164976227430169,0.0250805495593304
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,41887,-0.0171251795789165,0.00764452338608478,-0.0321084454156426,-0.0021419137421903,0.0250958692194107
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,41861,0.0382253093368428,0.0170673012512512,0.00477339888439046,0.0716772197892951,0.0251289222302541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42184,0.0297093236932505,0.0132860712832207,0.00366862397813793,0.0557500234083632,0.0253604586786943
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42103,-0.00961686522170088,0.00430707103869917,-0.0180587244575513,-0.0011750059858505,0.0255786460332175
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,42213,0.00652492177264381,0.00292367528229332,0.0007945182193489,0.0122553253259387,0.0256482274589558
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42094,0.00596720840279659,0.00267555030597277,0.000723129803089963,0.0112112870025032,0.0257464382718125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40021,0.026545667500944,0.011906135912072,0.00320964111328276,0.0498816938886052,0.0257958515635881
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,40092,0.00415904287033119,0.00186636824723232,0.000500961105755839,0.00781712463490655,0.0258731785773012
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39706,-0.016692174516049,0.007491123852067,-0.0313747772661003,-0.00200957176599764,0.0258842263216014
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,41887,0.017256203905066,0.00774478570002509,0.00207642393301686,0.0324359838771152,0.0258908956484463
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,39851,0.00922700698800842,0.00414318415468925,0.0011063660448175,0.0173476479311993,0.0259658915893311
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,42184,0.00809875187354868,0.00364016684002397,0.000964024867101697,0.0152334788799957,0.0261097727070102
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,42144,0.0195081552718394,0.00877612139532367,0.00230695733700497,0.0367093532066738,0.0262419319244657
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,41887,0.0143038567455058,0.00643783597303499,0.00168569823835724,0.0269220152526544,0.0263115247433248
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39906,0.00184478515255654,0.000830611326085752,0.000216786953428463,0.00347278335168461,0.0263720048822949
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41829,-0.00872312100931028,0.00393492831908456,-0.016435580514716,-0.00101066150390454,0.026651510307787
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,42172,0.00518871496927237,0.0023411012241357,0.000600156569966385,0.00977727336857835,0.026684369971032
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42094,0.0155521998396527,0.00702444576496981,0.00178428614031192,0.0293201135389936,0.0268454467138112
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,40097,0.00632109019160435,0.00285630726577218,0.000722727950690866,0.0119194524325178,0.0269162939989627
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41887,0.0161253407027574,0.00730097837503875,0.00181542308768145,0.0304352583178333,0.0272164637600359
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,42120,0.00547256727324387,0.00247932809024418,0.000613084216365281,0.0103320503301225,0.0273121215125239
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42094,-0.0172924532625763,0.00783707790948767,-0.0326531259651721,-0.00193178055998047,0.0273670913939712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39804,0.0118328144258155,0.00536706548531032,0.00131336607460729,0.0223522627770237,0.0274959428566832
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,39863,-0.0126588409839996,0.0057430118208116,-0.0239151441527903,-0.00140253781520889,0.0275303998189533
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40021,-0.0243012715628132,0.0110316347154124,-0.0459232756050215,-0.00267926752060495,0.0276248109008327
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41650,-0.00760652129809659,0.00345317684097687,-0.0143747479064113,-0.000838294689781917,0.0276298855498065
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39863,0.0198095018930912,0.00900909042033822,0.00215168466922833,0.0374673191169541,0.027911054908747
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39942,-0.00764020167208839,0.0034775226149907,-0.0144561459974702,-0.000824257346706626,0.0280399786576486
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42120,-0.00727174903829946,0.00331749308315356,-0.0137740354812804,-0.000769462595318494,0.0284015409511657
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,41887,0.0100544194594988,0.00458837638068612,0.00106120175335396,0.0190476371656436,0.0284496142757004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41476,-0.00986046618959059,0.00450295384106692,-0.0186862557180818,-0.00103467666109942,0.0285591344041893
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,42057,-0.00735635694046753,0.00336231850027457,-0.0139465012010057,-0.000766212679929362,0.0286961115143471
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42184,0.0244681436427501,0.0111848525476798,0.00254583264929768,0.0463904546362025,0.0287154673066794
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42103,0.0265895778549027,0.0121943693441051,0.00268861394045668,0.0504905417693488,0.0292398986223458
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39752,-0.0124591934754379,0.0057151503671729,-0.0236608881950968,-0.00125749875577907,0.0292773249404614
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,42112,0.0096353026116076,0.00442010648595994,0.000971893899126117,0.0182987113240891,0.0292843359572304
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42213,-0.0144300037740439,0.00663473787355125,-0.0274340900062043,-0.00142591754188342,0.0296542800600215
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,42103,-0.0196628123186371,0.00906026854623422,-0.0374209386692562,-0.00190468596801803,0.0300080526908573
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39719,0.0142898981526445,0.00659019017381163,0.00137312541197368,0.0272066708933153,0.0301537114269357
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42256,0.0145796372164321,0.00672548821977681,0.00139768030566951,0.0277615941271946,0.0301905057290722
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39881,0.0162694586599887,0.00751876459334809,0.00153268005702644,0.0310062372629509,0.0304981524299685
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42207,-0.00487899408607092,0.00225893436402083,-0.00930650543955175,-0.000451482732590101,0.0308012979244834
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,40021,-0.0584710853837416,0.0270978093817854,-0.111582791772041,-0.00535937899544232,0.0309669367760464
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,40040,0.0214479353958528,0.0099476975067964,0.00195044828253189,0.0409454225091738,0.0311000929517623
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,42103,-0.0183665727447265,0.00852925578974065,-0.0350839140926182,-0.00164923139683486,0.0313087250739874
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,40020,0.0106622077883682,0.00496380758063958,0.000933144930314654,0.0203912706464218,0.0317366935230463
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42162,-0.0186135850943692,0.00867312805727002,-0.0356129160866184,-0.00161425410211996,0.0318818008095999
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,40054,0.00793946855996168,0.00370053869888071,0.000686412710155497,0.0151925244097679,0.0319357994843721
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,42004,-0.0118923179088121,0.0055521493143727,-0.0227745305649826,-0.00101010525264164,0.0322178762909512
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39863,-0.0170496205744734,0.00796188359386967,-0.0326549124184579,-0.0014443287304888,0.032263943671727
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42077,-0.0229947380931025,0.0107418935310939,-0.0440488494140465,-0.00194062677215844,0.0323202098441786
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,42186,0.00689539434477974,0.00322733554909278,0.000569816668557894,0.0132209720210016,0.0326524660991499
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42094,0.0114836331040548,0.00540617543710391,0.000887529247331134,0.0220797369607784,0.0336749392010599
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,40102,0.00631852825988056,0.0029793253495253,0.000479050574810979,0.0121580059449501,0.0339618411100131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,42223,0.0138063462791294,0.00651488504684955,0.00103717158730432,0.0265755209709546,0.0340924067640335
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42120,-0.00653196507918157,0.00308895050428788,-0.0125863080675858,-0.000477622090777329,0.0344812004775458
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,39916,0.00736517077271484,0.00348312331916581,0.000538249067149847,0.0141920924782798,0.0344929911452843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,39959,0.00651189388293303,0.00307961461882038,0.000475849230045094,0.012547938535821,0.0344941573318008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39700,-0.00741897956762557,0.00350867282578391,-0.014295978306162,-0.000541980829089103,0.0344987282455099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,41861,-0.0140923186676938,0.00666547661020282,-0.0271566528236914,-0.00102798451169632,0.0345155232499532
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,40054,-0.0134793032686091,0.00637733651739781,-0.0259788828427088,-0.000979723694509368,0.034569977606388
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40021,-0.00879608736696581,0.00416331928143684,-0.016956193158582,-0.0006359815753496,0.0346442877273173
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42126,-0.0086462376785217,0.00409881384812466,-0.016679912820846,-0.000612562536197361,0.0349250327964617
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,41829,0.022629099989167,0.0107396948646352,0.00157929805448193,0.043678901923852,0.0351326934912467
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42080,-0.0394792169011813,0.0187621764629903,-0.0762530827686421,-0.00270535103372036,0.0353810453091375
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41887,-0.0145900031446787,0.0069474751246988,-0.0282070543890883,-0.000972951900269036,0.035744659022506
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42186,0.00939639906477098,0.00448662675372244,0.000602610627475001,0.018190187502067,0.0362514647148902
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42103,-0.0323431869861136,0.0154517601091453,-0.0626286368000384,-0.00205773717218874,0.036353297360274
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,42186,0.0118029065009397,0.00565207341745003,0.000724842602737648,0.0228809703991418,0.0367952830592273
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42200,-0.00882584044043022,0.00424012776688986,-0.0171364908635343,-0.000515190017326087,0.0374073614764848
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,40026,-0.0229082211389061,0.0110318792018555,-0.0445307043745429,-0.00128573790326932,0.0378668638864863
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,40041,-0.00722170817746246,0.00347778489900936,-0.0140381665795208,-0.000405249775404118,0.0378688864786891
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,40020,-0.0146564715205634,0.00706023242271675,-0.0284945270690882,-0.000818415972038552,0.0379249773593035
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42103,-0.0184315392901058,0.00888311092505422,-0.035842436703212,-0.00102064187699948,0.0380158541112646
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41887,0.0139860635489757,0.00674111625015857,0.000773475698664896,0.0271986513992865,0.0380307393473014
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,40020,-0.0238193132170618,0.011524657726645,-0.046407642361286,-0.0012309840728375,0.0387754906202476
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42094,-0.00796346612888717,0.00387030814200527,-0.0155492700872175,-0.000377662170556831,0.0396505817838989
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,40054,0.00780618088109735,0.00380347663955221,0.000351366667575007,0.0152609950946197,0.0401566238595359
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39881,-0.00772847085073625,0.00377104159613762,-0.015119712379166,-0.000337229322306523,0.040444831211399
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41959,0.0059234249147393,0.00289239875173468,0.000254323361339333,0.0115925264681393,0.0405874534768767
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39719,0.00930094825602907,0.00454412897505574,0.000394455464919813,0.0182074410471383,0.0407019669950472
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,40102,0.0303345564172994,0.0148215368441988,0.00128434420266983,0.059384768631929,0.0407159928599231
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42096,-0.0135076972912871,0.00660313467713771,-0.026449841258477,-0.000565553324097197,0.0408111303602514
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41861,-0.00829547773745614,0.00405610536989141,-0.0162454442624433,-0.000345511212468976,0.0408574379549805
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,41971,0.0122358260671857,0.0059843414779958,0.000506516770313981,0.0239651353640575,0.0409107770010273
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,40020,-0.00872733620153735,0.00427135732990263,-0.0170991965681465,-0.000355475834928199,0.0410545129213275
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41829,-0.0133238258019245,0.00653726927834944,-0.0261368735874894,-0.000510778016359566,0.0415573912614584
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,40080,0.0187505948484977,0.00921269673829527,0.000693709241438963,0.0368074804555564,0.0418449426152481
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42144,-0.00602572868049223,0.00296647184794045,-0.0118400135024555,-0.000211443858528959,0.0422471933163021
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,42122,-0.00767221507089929,0.00377827063656416,-0.015077625518565,-0.000266804623233546,0.0423144353166846
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42103,-0.00746902542081539,0.00367919278645871,-0.0146802432822745,-0.000257807559356323,0.0423697079604393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39863,0.0257271904467442,0.0126777027106766,0.00087889313381807,0.0505754877596704,0.0424498811344516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,40102,-0.00589591548711152,0.00290852135369506,-0.0115966173403538,-0.000195213633869198,0.0426746350325762
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39719,0.0100252178084808,0.00494799437903885,0.000327148825564635,0.0197232867913969,0.0427779219451481
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,40054,-0.0181886241580656,0.00897965649843927,-0.0357887508950065,-0.000588497421124622,0.0428366864277008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39706,-0.00926466650243854,0.00458403257541885,-0.0182493703502595,-0.000279962654617601,0.0432974604439846
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,40020,0.00817946789696983,0.00404791012064929,0.000245564060497231,0.0161133717334424,0.0433390879586232
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,42186,-0.011690523255027,0.00580044738333127,-0.0230594001263563,-0.000321646383697746,0.0438778632294613
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42094,-0.00701704751339809,0.00348437454183509,-0.0138464216153949,-0.000187673411401306,0.0440448060304594
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,42168,-0.00623798611669373,0.00309753721700542,-0.0123091590620244,-0.000166813171363096,0.044045522905357
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,40113,0.00377542632375273,0.00188129487165191,8.80883753149922e-05,0.00746276427219047,0.0447930901851282
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41983,-0.00589470611851345,0.00293756782004843,-0.0116523390458084,-0.000137073191218521,0.0448066604901352
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42256,-0.00734333842341823,0.00365972591048266,-0.0145164012079642,-0.000170275638872217,0.0448206366213557
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39665,0.00535212326716816,0.00266975478890483,0.000119403880914688,0.0105848426534216,0.0450181873066507
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42223,-0.00715558656819659,0.00357873365696088,-0.0141699045358399,-0.000141268600553269,0.0455777697983341
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40080,-0.0151876565894177,0.0075968031440377,-0.0300773907517316,-0.000297922427103829,0.0456097129499932
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,42237,0.00705096660335014,0.00353373066367891,0.000124854502539475,0.0139770787041608,0.0460274249031471
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41829,-0.011111932270538,0.00556930895305801,-0.0220277778185317,-0.000196086722544319,0.0460415879231825
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,41887,0.0123507994723641,0.00620094187594955,0.000196953395502996,0.0245046455492252,0.0464185844291086
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,40054,0.00673256539922146,0.00338258412791252,0.000102700508512915,0.01336243028993,0.0465761472085682
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41861,0.00943539231604405,0.00474691607155704,0.000131436815792254,0.0187393478162958,0.0468676033480305
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,42135,0.0134162472947255,0.00675404219557422,0.000178324591400084,0.026654169998051,0.0470096907168731
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,40021,0.00612305727511644,0.00308694099284277,7.26529291446123e-05,0.0121734616210883,0.0473328559089674
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39863,0.023872538997074,0.0120574852068204,0.000239867991705972,0.0475052100024421,0.0477411291523498
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,40113,0.00520951324703838,0.00263899519244409,3.70826698479626e-05,0.0103819438242288,0.0484010164964797
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40054,0.0167369923002068,0.00848834698697961,9.98322057267353e-05,0.0333741523946868,0.0486622260571182
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,40102,-0.00819054423533457,0.00415642725031022,-0.0163371416459426,-4.39468247265453e-05,0.048797960170586
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,39816,-0.00834814103876638,0.00423816659944391,-0.0166549475736764,-4.13345038563131e-05,0.0488926363781768
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39665,0.0160698008151964,0.00816509926152686,6.62062626038025e-05,0.0320733953677891,0.0490819055210713
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,42103,-0.0170298272053767,0.00865892979907096,-0.0340013296115558,-5.83247991976579e-05,0.0492350653993853
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,40097,0.00661639833781278,0.00336570306889308,1.9620322782337e-05,0.0132131763528432,0.0493436482972743
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,41876,-0.0231237039393711,0.0117758103591968,-0.0462042922433969,-4.31156353454254e-05,0.0495911889315478
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,40021,-0.0099683601473907,0.00507700887451823,-0.0199192975414464,-1.742275333496e-05,0.0496215891843767
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42144,0.0166139937182193,0.00846803610184922,1.66429585948744e-05,0.0332113444778438,0.0497879002296947
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,40085,-0.0219925289382905,0.0112186963965768,-0.0439811738755811,-3.88400099995273e-06,0.0499807942017907
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,41829,-0.0173902211585776,0.00887181543366409,-0.0347789794085592,-1.46290859594222e-06,0.0499984647254163
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39706,0.00952784401269353,0.00487276210910566,-2.27697211535715e-05,0.0190784577465406,0.0505709272888806
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,41821,0.021562639898424,0.0110284517670366,-5.31255649678306e-05,0.0431784053618157,0.0505835186294859
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,40080,-0.0134728172359555,0.00689486315248971,-0.0269867490148354,4.11145429242959e-05,0.0507224194204954
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,41861,0.0157949606461828,0.00809208740376679,-6.55306652001461e-05,0.0316554519575657,0.0509718585785569
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39432,-0.0224981228637276,0.0115456270190127,-0.0451275518209925,0.000131306093537311,0.05136724174909
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,39881,0.00558178381038948,0.00287430159919737,-5.18473240373714e-05,0.0112154149448163,0.0521679711424983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,42146,-0.00487507360921545,0.00251237354682354,-0.00979932576098959,4.91785425586946e-05,0.0523496774712915
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42103,-0.00759884920700022,0.00392017420657598,-0.0152823906518891,8.46922378886904e-05,0.0525967250872789
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39706,0.00950155429307185,0.00490978678143128,-0.000121627798533449,0.0191247363846772,0.0529891755791391
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,40054,-0.0071009986884539,0.00367837621210038,-0.0143106160641706,0.000108618687262853,0.0535745062251476
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41810,-0.00853257294703425,0.00442166918962302,-0.0171990445586954,0.00013389866462687,0.053664229939198
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40080,0.0119164904267652,0.00618396368064167,-0.000204078387292507,0.0240370592408228,0.0540057781147438
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42103,0.0194462772007765,0.0101060616752569,-0.000361603682727106,0.0392541580842801,0.0543490795737447
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,39755,-0.00570706646784578,0.00297352738305822,-0.0115351801386399,0.000121047202948334,0.054974342313558
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40080,-0.0152279416842182,0.00793439954490315,-0.0307793647922284,0.000323481423791934,0.0549812814992033
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,39706,0.00850971127884466,0.00443435881215126,-0.000181631992971805,0.0172010545506611,0.0550063361839169
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42296,0.00807265263779,0.00421449569456123,-0.000187758923550012,0.01633306419913,0.055456978824083
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,42197,0.0193812808485012,0.0101449459800341,-0.000502813272365694,0.039265374969368,0.0560989341825926
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39665,0.00611243580989083,0.00320503494856665,-0.000169432689299798,0.0123943043090815,0.0565303841793685
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39804,0.0167808223872591,0.00880589726533943,-0.000478736252806214,0.0340403810273244,0.0567246322828663
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39706,-0.00890035643804368,0.00467441033982265,-0.0180622007040961,0.000261487828008722,0.0569296832568371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,42126,-0.00712613171406244,0.00375151649107942,-0.0144791040365781,0.00022684060845323,0.0575165774272526
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,39768,-0.0100104077993343,0.00528155774031902,-0.0203622609703596,0.000341445371691007,0.0580731104402853
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,40113,0.00503543393162109,0.00265748870202385,-0.000173243924345659,0.0102441117875878,0.0581440824648271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,40020,-0.0100458515627707,0.00530249503581142,-0.020438741832961,0.000347038707419742,0.0581784278971928
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42213,-0.00452661190422335,0.0023905430057154,-0.00921207619542553,0.000158852386978825,0.0583069610291562
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42215,-0.00561394312930973,0.00296755863176927,-0.0114303580475775,0.000202471788958028,0.0585435878815702
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42178,-0.0138455452597362,0.00733475388232115,-0.0282216628690857,0.000530572349613215,0.0590934551908954
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41696,-0.0129096951801262,0.00684409145262703,-0.0263241144272751,0.000504724067022825,0.0592838857174322
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,42144,0.00659725511435562,0.00349900474319327,-0.000260794182303186,0.0134553044110144,0.0593892910564008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,42107,0.0197352240110643,0.0104684241357814,-0.000782887295067331,0.0402533353171959,0.0594233284121532
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39881,0.0133541996802961,0.00709549507393852,-0.000552970664623434,0.0272613700252156,0.0598540197169984
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,41985,0.0154672242895434,0.0082211541482937,-0.000646237841112248,0.0315806864201991,0.0599411297098238
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39665,0.00804583291213241,0.00427709414015594,-0.000337271602573224,0.0164289374268381,0.0599799624526752
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,41989,-0.00907116037190045,0.00482279931418752,-0.018523847027708,0.000381526283907084,0.0600094225441739
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40054,0.0153786956649464,0.00818296939294217,-0.000659924345220268,0.031417315675113,0.0602229373320093
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42120,0.00663048151446889,0.00353232437124129,-0.000292874253164042,0.0135538372821018,0.0605286226797455
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,40113,-0.003715916080437,0.00198444505140754,-0.00760542838119577,0.000173596220321768,0.0611611896373156
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40020,0.0121985293636476,0.00651641193936319,-0.000573638037504277,0.0249706967647994,0.0612376580616083
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39719,0.0188058452544533,0.0100484938802948,-0.000889202750924498,0.0385008932598311,0.061302301108139
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,39706,-0.0121298234792654,0.00649164226977429,-0.024853442328023,0.000593795369492242,0.0617161296880617
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41876,-0.0118768171772267,0.00636323995839934,-0.0243487674956894,0.000595133141236008,0.0619982439953264
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42186,0.00558627007532181,0.0029956442397907,-0.000285192634667961,0.0114577327853116,0.0622323146780677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39863,0.00716098392367724,0.00384450604829106,-0.000374247930973236,0.0146962157783277,0.0625384493909287
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39768,-0.0129907704413546,0.00697610748547502,-0.0266639411128857,0.0006824002301764,0.0626053872601557
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42296,-0.00448463484129254,0.00240916177867663,-0.00920659192749872,0.000237322244913647,0.0626971375501652
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,42073,0.0123781873790234,0.00667433467242561,-0.000703508578930791,0.0254598833369776,0.063676930345898
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,41887,-0.00592651882140262,0.00319727819817616,-0.0121931840898279,0.000340146447022653,0.063817625580041
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39768,0.0104188263565439,0.00563233717925444,-0.000620554514794763,0.0214582072278826,0.0643669604253696
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41861,-0.0098986018152041,0.00535130287039262,-0.0203871554411736,0.000589951810765443,0.0643720764018503
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,41727,0.0130888915346532,0.00708065386774525,-0.000789190046127536,0.0269669731154338,0.0645474013563625
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,39881,0.00665072521837372,0.00360074660198196,-0.000406738121510923,0.0137081885582584,0.0647688782693775
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41876,0.00600633695488883,0.00325229567324964,-0.00036816256468046,0.0123808364744581,0.064799533188491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,42144,-0.00469425294809463,0.00254311553329783,-0.00967875939335838,0.000290253497169123,0.0649343338364881
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,41861,0.0159232970172574,0.00862706759599475,-0.000985755470892278,0.0328323495054071,0.0649537366292122
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,42101,-0.00470551648997319,0.00255046476402782,-0.00970442742746771,0.000293394447521335,0.065065623914239
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,39706,0.0158871534059163,0.00861255576848212,-0.000993455900308703,0.0327677627121412,0.0651165432749213
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,42120,-0.00471060401824416,0.00255384756462629,-0.00971614524491169,0.00029493720842336,0.0651313369337107
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,39768,-0.00902926148779268,0.00490102829223605,-0.0186352769405753,0.000576753964989983,0.0654563651224144
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,40080,0.00685987501222685,0.0037295200203313,-0.000449984227622488,0.0141697342520762,0.0658916341713648
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,39784,0.010652990419296,0.00579232369548807,-0.000699964023860576,0.0220059448624527,0.0659201332942849
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,40054,-0.00513449744850107,0.00280043661661131,-0.0106233532170592,0.00035435832005711,0.0667610716064653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,42296,0.00563384111576876,0.00307437284427668,-0.000391929659013537,0.0116596118905511,0.0668970839574665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,40057,0.00371644169096837,0.00203115557209387,-0.000264623230335608,0.00769750661227235,0.0673195256182603
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,39706,0.00594158894392337,0.00324735758974359,-0.000423231931974055,0.0123064098198208,0.0673277821103629
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42184,-0.00528879920137071,0.00289449942616269,-0.0109620180766496,0.000384419673908161,0.0676942012808801
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,39706,0.0105208049565176,0.00575945209305762,-0.000767721145875375,0.0218093310589105,0.0677728709788601
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,41315,0.00934056831631308,0.00511602808836721,-0.000686846736886662,0.0193679833695128,0.0679131074193874
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42223,-0.0099931947318666,0.00547719307235696,-0.0207284931536862,0.000742103689953031,0.0680978627043623
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42126,-0.0070926455460677,0.00388916418552846,-0.0147154073497035,0.000530116257568074,0.0682214100788508
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39784,-0.00580139005017639,0.00318330913484627,-0.0120406759544751,0.000437895854122302,0.068416429647582
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40080,0.0180095698847908,0.00988329162417799,-0.00136168169859804,0.0373808214681797,0.0684484475495204
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,39847,0.00562813944214061,0.00309542036736426,-0.00043888447789335,0.0116951633621746,0.0690593639034695
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,39706,0.0107933482371231,0.00593786677364279,-0.000844870639216748,0.022431567113463,0.0691361898257463
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42094,-0.00845713037026208,0.00465994088703556,-0.0175906145088518,0.000676353768327614,0.069568969097246
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,42094,0.00282838035505622,0.00155948960335768,-0.00022821926752482,0.00588497997763727,0.0697536640803225
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42066,-0.00608027619420783,0.00335438465587663,-0.012654870119726,0.000494317731310376,0.0699113683347318
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,41861,-0.0180198230725568,0.00994410176537951,-0.0375102625327007,0.00147061638758701,0.0699926082196334
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41887,0.0115621074561121,0.00638379131345908,-0.0009501235182677,0.0240743384304919,0.0701387476151438
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,39575,0.00866802573766726,0.00478922015723518,-0.000718845770513701,0.0180548972458482,0.0703396786332985
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42057,-0.00527162420865175,0.00291620492117794,-0.0109873858541605,0.000444137436857003,0.070676523672811
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39768,-0.00891986715740516,0.0049363173732778,-0.0185950492090297,0.000755314894219336,0.0707925343574481
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41887,-0.00605438305105118,0.00335213247326159,-0.0126245626986439,0.000515796596541526,0.0709218983356521
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42144,0.00611666045320026,0.00339321793340873,-0.000534046696280843,0.0127673676026814,0.0714721758635008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,39706,0.00903286210875161,0.0050158626651504,-0.000798228714943169,0.0188639529324464,0.0717537356245669
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41876,-0.00996177694780481,0.00554312342734092,-0.020826298865393,0.000902744969783403,0.0723369475538802
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40054,-0.00541677555319768,0.00301445130423687,-0.011325100109502,0.000491549003106588,0.0723735830485484
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,40054,-0.00500298312217072,0.00278611543015072,-0.0104637693652661,0.000457803120924702,0.0725725640558954
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40020,-0.00622290496171001,0.00347245813646167,-0.0130289229091749,0.000583112985754872,0.073148888721185
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39706,0.00594688539476278,0.00332193578305887,-0.000564108740032604,0.0124578795295582,0.0734526652784335
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,39804,-0.0093839107989682,0.00526177844203584,-0.0196969965453584,0.000929174947422047,0.0745480852524456
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,40021,-0.00790674273165525,0.00443539831462744,-0.016600123428325,0.000786637965014532,0.07467204377113
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,40054,0.0167507003075458,0.00939678422106327,-0.00166699676573817,0.0351683973808298,0.0746794921347747
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,40020,0.0126941857820898,0.00712388723129552,-0.00126863319124945,0.026657004755429,0.07479055989558
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,42223,-0.00545023016257225,0.00306576840117537,-0.011459136228876,0.000558675903731471,0.0754650058674621
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39665,0.013907854553741,0.00782504872677355,-0.00142924095073517,0.0292449500582172,0.0755396031998618
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39784,0.00890061341999435,0.00500888260785738,-0.000916796491406118,0.0187180233313948,0.0756025535871012
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,41732,0.00497250495665066,0.00280071636682429,-0.00051689912232495,0.0104619090356263,0.0758494520695412
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39706,0.00723099134350756,0.00407585885939344,-0.000757692020903579,0.0152196747079187,0.0760751392809067
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,42186,-0.0039805545369005,0.0022441796743173,-0.00837914669856242,0.000418037624761414,0.0761322932769649
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39804,0.0087423662582653,0.00493166394608235,-0.000923695076056108,0.0184084275925867,0.0763069303580757
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42197,-0.00764342447138379,0.00431305471088445,-0.0160970117047173,0.000810162761949739,0.0763913581314397
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39706,0.0123709542712565,0.00698160988641217,-0.00131300110611139,0.0260549096486243,0.0764344201995668
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42186,0.00595185316071939,0.00336319717952911,-0.000640013311157665,0.0125437196325964,0.0768004276012945
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,42105,0.0239004577846985,0.0135091267538951,-0.00257743065293597,0.050378346222333,0.0768827399048624
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42144,-0.0155984526694683,0.00883389124711543,-0.0329128795138146,0.00171597417487792,0.0774611855443544
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,39784,-0.0147634799287582,0.00836324817121343,-0.0311554463443366,0.00162848648682007,0.0775454298217888
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,42094,-0.00586920124921712,0.00332716776701167,-0.01239045007256,0.000652047574125765,0.0777517325930924
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",40053,-0.0071351805233136,0.00404547140288345,-0.0150643044729652,0.000793943426337962,0.0778030136121952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39719,-0.015465590415937,0.00877742500462432,-0.0326693434250007,0.00173816259312668,0.0781027973791306
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39863,0.0154086793303739,0.00878384624635093,-0.00180765931247388,0.0326250179732218,0.0794238535984101
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41953,0.00613569499367207,0.00350185053346317,-0.000727932051915754,0.0129993220392599,0.0797755945002513
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,42193,-0.0101778285370075,0.00581057423473416,-0.0215665540370865,0.00121089696307142,0.0798654029537067
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,41876,0.00949134765206761,0.00542221006379839,-0.00113618407297724,0.0201188793771125,0.0800636008556717
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42120,0.00970033919597797,0.00554994762163184,-0.00117755814242043,0.0205782365343764,0.0805180155155725
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39881,0.00725321352229915,0.00414986653156523,-0.00088052487956869,0.015386951924167,0.0805241769148806
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,39706,0.00720064135243222,0.00412795345132569,-0.000890147412166129,0.0152914301170306,0.0811253732401181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39863,0.0167101323448408,0.00958287414232186,-0.00207230097411009,0.0354925656637916,0.0812315753689714
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41861,0.00736277627963381,0.00422852701411128,-0.000925136668024309,0.0156506892272919,0.0816701097158327
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39784,0.00593937495302625,0.00341954735507132,-0.000762937862913544,0.012641687768966,0.082435802740003
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39804,0.013578979151141,0.00783064514516352,-0.00176908533337954,0.0289270436356615,0.0829326181216089
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39881,-0.00800861771916019,0.00462300146174136,-0.0170697005841733,0.00105246514585287,0.0832416118456702
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,41876,0.00491096531810704,0.0028396640141228,-0.000654776149573654,0.0104767067857877,0.0837586906624053
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39719,0.0137282680548642,0.00793873171661374,-0.00183164610969875,0.0292881822194271,0.0837888096653098
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,41861,0.00979014623536829,0.00566766896857701,-0.00131848494304265,0.0208987774137792,0.0841260895248842
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,42099,0.0128850776056793,0.00746136670388099,-0.00173920113392739,0.0275093563452861,0.0842085082252713
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41829,-0.01161092236255,0.00672429621361119,-0.0247905429412279,0.00156869821612798,0.0842438578655629
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41985,-0.0195444322500747,0.0113376994710654,-0.0417663232133628,0.00267745871321345,0.0847600603589982
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42148,-0.00705569211899351,0.00409539756176794,-0.0150826713400587,0.000971287102071661,0.08494232804651
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,39830,-0.0115032185514886,0.00667752052731899,-0.0245911587850339,0.00158472168205658,0.0849758166766453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,39784,-0.00724951822193486,0.00421783055238611,-0.0155164661046116,0.00101742966074192,0.0856838619176025
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42144,0.0049899306351448,0.00290487639418534,-0.000703627097458465,0.0106834883677481,0.0858611554892579
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39665,0.00924911087781541,0.00538426848424675,-0.00130405535130823,0.019802277106939,0.0858621765760427
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42122,0.00571469396093475,0.00333033421009662,-0.000812761090854633,0.0122421490127241,0.086194769228633
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40021,0.0182041919417481,0.0106133805174078,-0.00259803387237121,0.0390064177558674,0.0863350766944162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,42162,0.00978798063124951,0.00570843197643802,-0.00140054604256902,0.020976507305068,0.0864327381060381
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,40021,-0.0122007106318048,0.00711617458378265,-0.0261484128160188,0.00174699155240918,0.0864647996341383
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39784,-0.00982781746316066,0.00573280782785595,-0.0210641208057583,0.001408485879437,0.0865008220088883
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,41949,-0.00746933071838687,0.00435980009413249,-0.0160145389028866,0.00107587746611281,0.0866949398658266
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39863,-0.00733280496640818,0.00428282476618815,-0.0157271415081369,0.0010615315753206,0.0868995281695188
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39706,-0.00498098253091706,0.00290949956560367,-0.0106836016795003,0.000721636617666137,0.0869312768758494
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39804,0.0164240657485354,0.00959616158193183,-0.00238441095205097,0.0352325424491218,0.0870135566641778
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42094,-0.014763371551298,0.00863207668069889,-0.0316822418454678,0.00215549874287178,0.0872359388387089
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,39863,0.00610446783702341,0.00357113362648571,-0.000894954070888587,0.0131038897449354,0.0874074117333581
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39867,0.00879926794225824,0.00514899278490844,-0.00129275791616231,0.0188912938006788,0.0874930001231954
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39989,-0.00901611250870567,0.00527807116985124,-0.0193611320016141,0.00132890698420275,0.0876240751833167
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41810,0.00849424957918826,0.00497318599579307,-0.00125319497256615,0.0182416941309427,0.0876591562990745
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,42162,0.0144703742215763,0.00847665905226244,-0.00214387752085808,0.0310846259640107,0.0878302656774686
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39768,0.00550176599972816,0.00322493973112528,-0.000819115873277394,0.0118226478727337,0.0880363594977112
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39719,0.00723897976091245,0.00424728089354659,-0.00108569079043886,0.0155636503122638,0.0883396700464527
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41968,0.00726544510803293,0.00426485832297916,-0.00109367720500623,0.0156245674210721,0.0884875087494167
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,39706,0.00901342088147876,0.00529629648141773,-0.00136732022209998,0.0193941619850575,0.0888159381935966
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,42120,-0.00698939041426988,0.0041096178566337,-0.0150442414132719,0.00106546058473216,0.0890159224877663
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,42154,0.00964070161271512,0.00567152184643765,-0.00147548120630268,0.0207568844317329,0.0891842938971271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,40102,-0.0140629543111779,0.00827593868696462,-0.0302837941376285,0.00215788551527277,0.0892991122105032
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42162,0.0151418948808582,0.00891203113039226,-0.00232568613471065,0.032609475896427,0.0893356852409293
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39784,-0.00936270599142375,0.00552232505214658,-0.020186463093631,0.00146105111078354,0.0900236035821452
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,39881,0.00664170838547627,0.00392819518321517,-0.00105755417362546,0.014340970944578,0.0909082542693181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,41876,-0.0245636868749302,0.0145363639755135,-0.0530549602669367,0.0039275865170763,0.0910889716387327
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39784,-0.00665419490111322,0.00394542511605585,-0.0143872281285827,0.00107883832635625,0.0917175057690813
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39719,0.00867699357976449,0.00515370087314838,-0.00142426013160633,0.0187782472911353,0.0922802937380015
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42099,-0.00407054657451619,0.00241862242805908,-0.00881104653351199,0.000669953384479612,0.0923988779741366
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41861,-0.0102047204062389,0.00606678297629689,-0.0220956150397809,0.00168617422730295,0.0925809773887588
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,42223,-0.00378842317306974,0.00225672056285375,-0.00821159547626309,0.000634749130123609,0.0932287719561825
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,40054,-0.00804479182683599,0.00480039247625785,-0.0174535610803014,0.0013639774266294,0.0937941556391731
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40097,0.00675552967461215,0.00403589272128099,-0.00115482005909859,0.0146658794083229,0.0941862998973785
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41829,-0.0145053110272614,0.00867290301692593,-0.0315042009404363,0.0024935788859134,0.0944532358079767
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39706,-0.0105539314903096,0.00631838220561406,-0.0229379606133132,0.00183009763269394,0.0948792254082866
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39706,0.0125976702625822,0.00756882718701001,-0.00223723102395738,0.0274325715491219,0.0960593080414399
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,42094,0.0138264472255053,0.00830849038824432,-0.00245819393545359,0.0301110883864641,0.0961098001216536
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42223,-0.006771129073337,0.0040710414770932,-0.0147503703684397,0.00120811222176568,0.0962879609661297
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,40002,0.0116685993201567,0.00702290257863633,-0.00209628973397053,0.0254334883742839,0.0966407373144406
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39719,0.00970383786543657,0.00584968520260067,-0.00176154513166074,0.0211692208625339,0.0971728007953615
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,40054,-0.0131997669277098,0.00795852502874358,-0.0287984759840473,0.0023989421286276,0.097231448953054
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,39640,-0.0122033790985798,0.00735895402829701,-0.0266269289940419,0.00222017079688233,0.0972862504086273
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42213,-0.00782265200854189,0.00471771994561718,-0.0170693831019516,0.00142407908486779,0.0973127956687264
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40036,-0.0134862057934082,0.00813328464130962,-0.029427443690375,0.00245503210355869,0.0973161255242133
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39804,-0.010590898924779,0.00639442322683774,-0.023123968449381,0.00194217059982294,0.0976964836260385
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39881,-0.00581466276750745,0.0035158693221637,-0.0127057666389483,0.00107644110393341,0.0981906988782387
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,42103,-0.00607097504560625,0.0036719094839248,-0.0132679176340989,0.00112596754288636,0.0982826664282402
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40054,0.0162456346096048,0.00985699227156305,-0.00307407024265878,0.0355653394618684,0.0993543015514552
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,42223,-0.00775363849846829,0.00471013604043849,-0.0169855051377277,0.00147822814079116,0.0997548994055648
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,42186,0.0116272074555997,0.00708202137144693,-0.00225355443243632,0.0255079693436356,0.100657279113858
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42197,-0.00771388899833071,0.00471830942628481,-0.0169617754738489,0.00153399747718752,0.102097554878161
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",40054,0.0100226025323919,0.00613038422410691,-0.00199295054685763,0.0220381556116415,0.102097716930771
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,40113,-0.00688392461040755,0.00421154920438982,-0.0151385610510116,0.00137071183019649,0.102175388929271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,39719,0.0183030650850567,0.0112041203303819,-0.00365701076249186,0.0402631409326052,0.102372513117389
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,41861,0.0125585191891719,0.00768865782019887,-0.00251125013841789,0.0276282885167617,0.102413426598516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39719,0.00469124706070261,0.00287256219060357,-0.000938974832880387,0.0103214689542856,0.102473065551666
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,42186,0.00623973441617298,0.00382676343983946,-0.00126072192591235,0.0137401907582583,0.103009254897388
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41861,-0.00771163443397766,0.00472947074044686,-0.0169813970852535,0.00155812821729819,0.103010350940896
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,41876,0.00825808303256139,0.00506496223247229,-0.00166924294308431,0.0181854090082071,0.103034786668191
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40020,-0.0087306948434169,0.00535662932760871,-0.01922968832553,0.00176829863869618,0.103154697279408
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,39784,0.00751278665231826,0.00461816515798968,-0.00153881705734151,0.016564390361978,0.103811377213035
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39706,0.0113951471072559,0.00702875899293288,-0.00238122051889257,0.0251715147334043,0.105000991929474
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,40080,-0.0122010067587596,0.00752585345479871,-0.0269516795301651,0.00254966601264585,0.105001060902699
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,39719,0.0127056581554731,0.00784363886832715,-0.00266787402644813,0.0280791903373943,0.105290634026297
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,40000,-0.00414966343852949,0.00256260000133645,-0.00917235944114894,0.000873032564089965,0.105408114611194
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,40102,-0.00448488822286262,0.00277103602250465,-0.00991611882697174,0.000946342381246502,0.105586407798023
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,40054,-0.00383167108804129,0.00237152320568329,-0.00847985657118053,0.000816514395097959,0.10618814342741
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,39706,0.00556911901052547,0.00344759014820299,-0.00118815767995239,0.0123263957010033,0.106261525264193
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,42126,0.004034179319071,0.0024995327863981,-0.000864904942269279,0.00893326358041127,0.106557603598151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,42021,0.0214617013888153,0.0133045037126744,-0.00461512588802638,0.0475385286656571,0.106744012891543
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39804,-0.00653609098961859,0.00405465996609838,-0.0144832245231714,0.00141104254393423,0.106992803118198
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41829,-0.0103848223653315,0.00644986669911549,-0.0230265610955979,0.00225691636493483,0.107404662958675
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,41829,-0.00865997538169695,0.00537934870319427,-0.0192034988399577,0.00188354807656382,0.107454334711623
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39706,0.00675069991303519,0.00419422300543677,-0.00146997717762088,0.0149713770036913,0.107531978077011
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39804,-0.00720832730605315,0.00448233283792892,-0.0159936996683938,0.00157704505628754,0.107828970064277
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,40102,0.0148654676423993,0.00924485064320384,-0.00325443961828021,0.0329853749030788,0.107870094626865
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40054,0.0108461977386178,0.00675781840646605,-0.00239912633805564,0.0240915218152913,0.108526164087919
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,39784,-0.00777544682432575,0.00484586452827985,-0.0172733412997543,0.00172244765110276,0.108622014616977
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,40054,-0.0106721814960796,0.00665508655192726,-0.0237161511378571,0.00237178814569779,0.108828523539576
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,40043,0.0112643392027413,0.00702926053904249,-0.00251301145378195,0.0250416898592646,0.109075796820871
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39665,0.00679342353657779,0.00424411306762547,-0.00152503807596813,0.0151118851491237,0.109480244903903
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42126,-0.048655805128606,0.0303998194151177,-0.108239451182237,0.0109278409250246,0.109505613965768
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,40002,-0.00671676540707029,0.00419703180972995,-0.014942947754141,0.00150941694000042,0.109547781694861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,39881,0.00572330212728199,0.0035778058218241,-0.00128919728349325,0.0127358015380572,0.109701774342298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,42090,-0.00694403780299337,0.00434839887536965,-0.0154668995987179,0.00157882399273114,0.110308418224352
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41876,0.0178486451956753,0.0111813008463784,-0.00406670446322639,0.0397639948545769,0.110448050282684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39706,0.00810049297965284,0.005088602775928,-0.00187316846116604,0.0180741544204717,0.111439618802368
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,39768,-0.00751947294733531,0.00472568230650124,-0.0167818102680777,0.00174286437340711,0.111596024662655
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42184,0.01408680604131,0.00885604397793438,-0.00327104015544139,0.0314446522380614,0.111714233006818
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,42079,0.0107869088176416,0.00678188072295022,-0.00250557739934085,0.024079395034624,0.111735801361391
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,39863,-0.0088051859399466,0.00553593336857996,-0.0196556153423633,0.00204524346247013,0.111740223068542
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,42223,0.00485413241745567,0.00305354665081888,-0.00113081901814933,0.0108390838530607,0.111933404694495
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39651,0.00842265855091969,0.0053009437211449,-0.00196719114252432,0.0188125082443637,0.112113668434342
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,40020,-0.00746022870378319,0.00470311003020721,-0.0166783243629893,0.00175786695542294,0.112715652254671
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,42144,0.010901010328118,0.00687550378623939,-0.00257497709291121,0.0243769977491472,0.112880525935294
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39863,0.00351462263056423,0.00222379314635078,-0.000844011936283305,0.00787325719741177,0.114030533719846
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39768,0.0116010458087374,0.00734634436600304,-0.00279778914862851,0.0259998807661034,0.114329503743134
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,42120,-0.00442872959530392,0.00280835023101148,-0.00993309604808642,0.00107563685747858,0.114823168724615
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,40080,0.0157123459473719,0.0099662098775473,-0.00382142541262081,0.0352461173073646,0.114925441972438
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,41887,0.0225017819573601,0.0142835597917846,-0.00549399523453769,0.0504975591492578,0.115197757484045
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,41949,-0.00773415167661888,0.00491859860216349,-0.0173746049368593,0.00190630158362155,0.115875679824367
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39768,-0.00835205905196777,0.00531302226735007,-0.0187655826959739,0.00206146459203837,0.115980992406913
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,42144,0.00757916013121854,0.00482615115495426,-0.0018800961324918,0.0170384163949289,0.116338210572451
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,42103,0.00583678012796517,0.00371827809842575,-0.00145104494494931,0.0131246052008796,0.116496974266862
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41876,-0.0135196074328105,0.00861513783009905,-0.0304052775798046,0.00336606271418362,0.116606470744149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39706,-0.00878663985583336,0.00560193003387465,-0.0197664227222277,0.00219314301056095,0.116794064343017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,39719,0.00912896219267141,0.00582500846206964,-0.00228805439298508,0.0205459787783279,0.117097654729304
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42075,0.0062246348795726,0.0039749235988013,-0.00156621537407794,0.0140154851332231,0.117378805102185
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40054,-0.00925092899195367,0.00591800812115869,-0.0208502249094247,0.00234836692551737,0.118038722603554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,41876,0.0133731863621344,0.00856556165010153,-0.00341531447206465,0.0301616871963334,0.118484131817041
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39719,0.0113139099529458,0.00725130201630743,-0.00289864199901678,0.0255264619049084,0.118728730555414
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,40021,-0.01337867320409,0.00858336712748792,-0.0302020727739664,0.00344472636578629,0.119102730311901
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39881,0.00587642327937497,0.00377023080915274,-0.0015132291065644,0.0132660756653144,0.119111802951526
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,40054,0.00501011307942414,0.00321466891741081,-0.00129063799870105,0.0113108641575493,0.119140107046848
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42240,-0.00497697821129434,0.00319563348083226,-0.0112404198337256,0.00128646341113689,0.119392479899592
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,39784,0.00741202916119711,0.00475967346702466,-0.00191693083417123,0.0167409891565654,0.119439644661165
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41829,-0.0124257559711371,0.00798223718380418,-0.0280709408513933,0.00321942890911911,0.11957250747848
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,41876,0.00531998869846622,0.00342510636329943,-0.00139321977360065,0.0120331971705331,0.120392400795036
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39863,0.0111677037151329,0.00719943378750735,-0.00294318650838148,0.0252785939386473,0.120885352417994
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39804,-0.0116910559603746,0.0075447237020612,-0.0264787144164146,0.00309660249566534,0.121275269719893
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,40080,-0.0143754565815104,0.00928434506997326,-0.032572772918658,0.00382185975563715,0.12156606173285
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39881,-0.00852497736970376,0.00552768136830138,-0.0193592328515745,0.00230927811216693,0.123046382785348
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,39665,0.00491133626761502,0.00318811049472076,-0.00133736030203767,0.0111600328372677,0.123464763868212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39784,0.00922631635673542,0.00599026930544335,-0.00251461148193355,0.0209672441954044,0.123537274570385
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39719,0.0110788624962243,0.00719312409887822,-0.00301966073757701,0.0251773857300256,0.123541240038748
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,40080,-0.00606784584988869,0.00394372789013978,-0.0137975525145626,0.00166186081478527,0.123929425108966
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,40054,-0.00530520543258541,0.00345160958504456,-0.0120703602192728,0.00145994935410193,0.124316659939242
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,40048,0.0131010468756399,0.00853953153374741,-0.00363643493050507,0.0298385286817848,0.125018313372042
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39863,-0.00419376085736053,0.00273479153111352,-0.00955395225834303,0.00116643054362196,0.125186134790188
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41869,0.00863848018192869,0.00563525533346344,-0.00240662027165965,0.019683580635517,0.125316826953297
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,40021,0.00726198468406898,0.00474161164326072,-0.00203157413672203,0.01655554350486,0.125664330401933
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,39784,-0.00513806420794492,0.0033664567468203,-0.0117363194317127,0.00146019101582288,0.126976769419217
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,38671,-0.0171707636393082,0.0112590351435521,-0.0392384725206704,0.00489694524205397,0.127276183804228
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,40028,-0.0089384290065081,0.00586999260854916,-0.0204436145192644,0.00256675650624826,0.127854808731853
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,40054,0.0130844417679598,0.00860670831700841,-0.00378470653337671,0.0299535900692962,0.128474539735131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,42004,-0.00932808327100502,0.00613678712406241,-0.0213561860341673,0.0027000194921573,0.128528823231393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41829,0.0120604511708385,0.00793551350471786,-0.00349315529840852,0.0276140576400855,0.12858444160115
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',39706,0.0067409841814069,0.00443668315596438,-0.00195491480428328,0.0154368831670971,0.128698278645181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39706,-0.00954829443177831,0.00629142719328301,-0.021879491730613,0.0027829028670564,0.129128318501125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39804,-0.00998964333705399,0.00659337557839122,-0.0229126594707008,0.00293337279659279,0.129776102680947
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,40097,0.0127371279183824,0.00841948096142305,-0.00376505476600675,0.0292393106027716,0.130355314866541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42240,0.00537183505789962,0.00355495370241352,-0.00159587419883088,0.0123395443146301,0.130791170654744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,40054,-0.00502794515314623,0.00332740969760579,-0.0115496681604536,0.00149377785416112,0.130800004807156
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,40097,0.00501064279105978,0.00331782331140746,-0.00149229089929884,0.0115135764814184,0.131016301164614
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,40097,-0.00428074299574671,0.0028381010454974,-0.00984342104492162,0.00128193505342821,0.131503566072437
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41876,-0.00678922412114301,0.00450208999372963,-0.0156133205088531,0.00203487226656708,0.131575320300945
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39651,-0.013379188661316,0.00890764553815075,-0.0308381739160914,0.00407979659345951,0.133130056291449
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42103,-0.00542750851536314,0.00361642681088536,-0.0125157050646984,0.00166068803397216,0.133433533056716
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41887,0.00855779310550624,0.00570291461231102,-0.00261991953462335,0.0197355057456358,0.133483949693572
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,39863,-0.00775434851582173,0.00517335791422585,-0.0178941300277044,0.00238543299606092,0.133929045944078
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,41829,-0.00794783913579348,0.00530291395789511,-0.0183415504932679,0.00244587222168093,0.133958743792533
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39665,-0.00894375940474121,0.00599767595797072,-0.0206992042823638,0.0028116854728814,0.135938022465286
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41861,0.00556497909791393,0.00373374280619822,-0.00175315680223458,0.0128831149980624,0.136129295769863
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39804,-0.0146065328707664,0.00980038085613394,-0.0338152793487889,0.00460221360725615,0.136147605807107
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39665,0.0037918581177636,0.00254746738133373,-0.00120117794965051,0.00878489418517772,0.136654067135138
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42094,0.0100663179846022,0.00676587303967859,-0.00319479317316786,0.0233274291423722,0.136826057859467
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,42213,-0.00777213808128288,0.00523031040682111,-0.0180235464786523,0.00247927031608649,0.137308553472102
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,40054,0.0148936147421054,0.0100518594926647,-0.0048080298635173,0.0345952593477281,0.13845512157336
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,41861,-0.00586886104292065,0.00397534667609798,-0.0136605405280727,0.00192281844223139,0.139884401807422
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39665,0.00682155361403335,0.00462889201886019,-0.00225107474293262,0.0158941819709993,0.140595036190677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41829,0.00601873519356895,0.00408749531408692,-0.00199275562204143,0.0140302260091793,0.140917526235631
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,40054,0.0117316439513344,0.00797075340186863,-0.00389103271632811,0.0273543206189969,0.141094073371216
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42094,0.00843116196301438,0.00574675609811443,-0.0028324799892899,0.0196948039153187,0.142368684274931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39784,-0.0126209141670111,0.00860259922000335,-0.0294820086382177,0.00424018030419543,0.142377258017102
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,39665,0.00710715589851641,0.00485004744214802,-0.00239893708809371,0.0166132488851265,0.142847668603914
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,39719,0.00925681466933268,0.00635249360197816,-0.00319407279054451,0.0217077021292099,0.145092708508509
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41861,0.00863530834203107,0.0059294159059812,-0.00298634683369208,0.0202569635177542,0.145320512755877
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,40069,0.00701885450103426,0.00482633862393494,-0.00244076920187822,0.0164784782039467,0.145897163881068
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,42296,0.00608372881733506,0.00418384817705496,-0.00211661360969267,0.0142840712443628,0.145942856135295
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39706,0.00755474140240836,0.00520149911892813,-0.00264019687069077,0.0177496796755075,0.146415770807209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,40097,-0.00758008320772877,0.00522641356447708,-0.0178238537941039,0.00266368737864631,0.146992145983222
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,39804,0.00627262196062109,0.00432951277835748,-0.00221322308495957,0.0147584670062018,0.147421457506567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,39706,0.00671956394966395,0.00464368110715643,-0.00238205102036266,0.0158211789196906,0.147917249707451
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,40097,-0.0144447037706863,0.00999158403214817,-0.0340282084736967,0.00513880093232416,0.148293736804818
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,-0.0086483459073814,0.0059840405313451,-0.0203770653488178,0.003080373534055,0.148416062359937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,41813,-0.00898605454798238,0.00622218959171834,-0.0211815461477503,0.00320943705178557,0.148708982736613
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39706,0.0055859746363775,0.00386952492284156,-0.00199829421239196,0.013170243485147,0.148886528421557
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41861,0.0126825485939394,0.00878591861317684,-0.00453785188788717,0.0299029490757661,0.148901996833008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,39784,-0.00659424506309187,0.00457116394055455,-0.0155537263865788,0.00236523626039505,0.149169913150441
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39804,0.00945190981820965,0.00655227945639751,-0.00339055791632947,0.0222943775527488,0.149180276576503
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39706,0.0072550660393406,0.00503982766805663,-0.0026229961900504,0.0171331282687316,0.150025535678817
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39881,0.01189171030757,0.00826893897691228,-0.00431541008717807,0.0280988307023181,0.150429846411383
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42184,-0.00409464799405021,0.0028486808317577,-0.0096780624242953,0.00148876643619489,0.150633024582981
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42174,0.0163266260814613,0.0113695047647762,-0.0059576032575,0.0386108554204227,0.151026008453555
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42103,-0.00623875933591036,0.00435048152708178,-0.0147657031289907,0.00228818445716994,0.151585410690715
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",40080,-0.00767029828477111,0.00535044602501828,-0.0181571724938069,0.00281657592426471,0.151720561043167
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,39881,0.0103848994445586,0.00724734823690267,-0.00381990309977068,0.0245897019888878,0.151908800105084
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40054,0.00686395182338502,0.00479127596679511,-0.0025269490715334,0.0162548527183034,0.15200276286667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39881,0.00509538574129196,0.00355823950832031,-0.00187876369501584,0.0120695351775998,0.152174131272682
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,42103,0.00699974039560957,0.00489015449018444,-0.00258496240515194,0.0165844431963711,0.152341383392868
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,39881,0.00800044956202113,0.00560397425727401,-0.00298333998223592,0.0189842391062782,0.153425146814202
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42262,-0.00280952694579554,0.00196957904349488,-0.00666990187104551,0.00105084797945443,0.153759315211311
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,42101,0.00966430671506709,0.00677806046904445,-0.00362069180426003,0.0229493052343942,0.153943956170772
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,41887,0.0071291877243593,0.00500051683892205,-0.00267182527992791,0.0169302007286465,0.153982384895177
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39719,0.01315850957552,0.00923030381245459,-0.00493288589689098,0.031249905047931,0.154020110974284
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,42213,-0.00336885058727301,0.00236593412087066,-0.00800608146417951,0.00126838028963348,0.154499755700279
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,41861,0.00564740042645107,0.00397212092837073,-0.00213795659315556,0.0134327574460577,0.155120718148259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39706,0.00743766100582161,0.00523921246112817,-0.0028311954179896,0.0177065174296328,0.155749648798796
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39719,0.0113014430995126,0.00796596406486929,-0.00431184646763118,0.0269147326666565,0.156011352166195
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39804,0.0146451127388673,0.0103229632091205,-0.0055878951510088,0.0348781206287435,0.156017993949621
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41829,0.0124606226017259,0.00878603374949777,-0.00476000354728975,0.0296812487507415,0.15614809090611
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40097,0.00533896439362419,0.00376870672241471,-0.00204770078230864,0.012725629569557,0.156611833333691
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39706,0.00374464603445211,0.00264384059582498,-0.00143728153336485,0.00892657360226906,0.156697992501394
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42144,-0.00914558900967713,0.00645813647493992,-0.0218035365005594,0.00351235848120511,0.156760218980253
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,42103,-0.0118062877020071,0.00835498917502716,-0.0281820664850604,0.00456949108104611,0.157655623884329
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42094,-0.00490278209659119,0.00347093096004861,-0.0117058067782865,0.00190024258510409,0.157819106098271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39804,0.0109628422934433,0.00776782765141047,-0.00426209990332121,0.0261877844902078,0.158181431937419
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,40021,-0.011868418292924,0.00841169339985969,-0.028355337356649,0.00461850077080101,0.158290210794198
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,42154,-0.00661090010056632,0.00468833424468175,-0.0158000352201426,0.00257823501900992,0.158541713434949
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,40080,-0.00565540612145019,0.00401161609365623,-0.0135181736650164,0.00220736142211603,0.158639849730053
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,42280,-0.00344643220616976,0.0024453253977665,-0.00823926998579209,0.00134640557345257,0.158741824449729
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42168,0.00711330293991993,0.00505135327469114,-0.0027873494784747,0.0170139553583146,0.159096564286547
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,40020,0.00760883530958485,0.00540445871422056,-0.00298390377028745,0.0182015743894572,0.159194991964951
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,42144,0.00558117990326204,0.00396430853449936,-0.00218886482435669,0.0133512246308808,0.159197393131076
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39881,0.0130128422323185,0.00924812339637883,-0.005113479624584,0.031139164089221,0.159432980759829
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,42030,0.00625113556450463,0.00444296523595649,-0.0024570762979701,0.0149593474269794,0.159459377322482
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",40113,-0.00240146185183182,0.00170727035996055,-0.00574771175735451,0.000944788053690865,0.159571822834692
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,42094,0.00278154069249193,0.00197818668100346,-0.00109570520227485,0.00665878658725871,0.159716657523041
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42193,0.00986636628629503,0.00702130368807924,-0.00389538894234027,0.0236281215149303,0.15998442685454
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,41854,-0.0106957802314315,0.00761314019626713,-0.0256175350161151,0.00422597455325206,0.160072443779846
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41876,0.00877145033178259,0.00624385601527301,-0.00346650745815251,0.0210094081217177,0.160101373668313
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39804,-0.00596463292191005,0.00425177699421419,-0.0142981158305699,0.00236884998674977,0.160688900491003
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39719,0.0139465257582489,0.00994252823575962,-0.00554082958383997,0.0334338811003377,0.160731570631761
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,42144,0.00931534436704389,0.00665995887329164,-0.00373817502460772,0.0223688637586955,0.16192421431274
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39975,-0.00685161456204194,0.00492419191730413,-0.016503030719958,0.00279980159587414,0.164127093123548
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,41759,0.010050096247227,0.00722791868889944,-0.0041166243830159,0.0242168168774699,0.16441535798544
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,39784,-0.00865355440828993,0.00622596352063095,-0.0208564429087266,0.00354933409214673,0.164584182193001
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41887,-0.00522488100370615,0.00376077511632476,-0.0125960002317027,0.00214623822429038,0.164762994085308
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,42144,0.00580427308153099,0.00417832391922788,-0.00238524180015565,0.0139937879632176,0.164814345394537
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39665,0.00817323138529076,0.00588615168354881,-0.00336362591446491,0.0197100886850464,0.164998366983813
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39904,0.00788030182697337,0.00567927563544111,-0.00325107841849121,0.019011682072438,0.16530175483572
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39803,-0.00787424504386878,0.00567568679360034,-0.0189985911593254,0.00325010107158788,0.165359857450711
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,39768,-0.00585045464466841,0.00421760523747473,-0.0141169609101189,0.00241605162078206,0.165425009021098
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,40021,0.00933865891626182,0.00674145903416623,-0.003874600790704,0.0225519186232276,0.166002181284977
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,40020,0.00372007011911625,0.00269034905359013,-0.00155301402592041,0.00899315426415291,0.166771199124669
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39768,-0.0056629546059608,0.00409547697831974,-0.0136900894834675,0.00236418027154589,0.166775691639961
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42120,-0.00424033484929292,0.00306667346322835,-0.0102510148372205,0.00177034513863465,0.16677621208613
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39863,-0.00931217659853833,0.00674488176601927,-0.0225321448599361,0.00390779166285943,0.167422110140004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,40021,-0.0145880324850008,0.0105786035381797,-0.035322095419833,0.00614603044983136,0.167919212086543
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40054,0.0101773000526017,0.00738229078639416,-0.0042919898887309,0.0246465899939342,0.168043421640486
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,42162,0.0120612242254156,0.00875126550425164,-0.00509125616291765,0.0292137046137488,0.168157209148542
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42296,0.00447988699628788,0.00325222547023753,-0.00189447492537768,0.0108542489179534,0.168386335120256
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39719,0.00852150400028543,0.00619076898831039,-0.00361240321680292,0.0206554112173738,0.168700642253544
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39881,0.0146986909843822,0.0106803078359362,-0.00623471237405272,0.0356320943428172,0.16877547825668
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39768,0.00850892000126821,0.00619471485963315,-0.00363272112361276,0.0206505611261492,0.169602053689459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,42132,0.00771151164542442,0.00561672444622113,-0.00329726826916899,0.0187202915600178,0.169790035578388
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41861,-0.00879331988216984,0.00640688940606044,-0.0213508231180483,0.00376418335370862,0.169938734586611
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39706,0.00615803980226117,0.00449135226791772,-0.00264501064285756,0.0149610902473799,0.170376752736029
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,40020,-0.0108372352743219,0.00791756391072076,-0.0263556605393346,0.00468118999069081,0.171103083273934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41829,0.0155035122356455,0.0113279577015304,-0.00669928485935416,0.0377063093306451,0.17114676257453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,42144,-0.016543033755756,0.012089306528915,-0.0402380745524294,0.00715200704091739,0.171209952473612
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39863,-0.00406613563207526,0.00297182800126323,-0.00989091851455119,0.00175864725040067,0.171269811683894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41861,0.00678227031170034,0.00495865109564263,-0.00293668583575921,0.0165012264591599,0.171409854615803
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39784,0.00494865040820482,0.00362070484341677,-0.00214793108489205,0.0120452319013017,0.171728185518789
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,40069,-0.00609533187448034,0.00446212388087408,-0.0148410946809935,0.00265043093203287,0.171962240836165
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,39706,-0.00915234725073172,0.00670069501479829,-0.0222857094797364,0.00398101497827293,0.172005761455474
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,39706,0.00728380627897208,0.00533285072142548,-0.00316858113502186,0.017736193692966,0.172019265985897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,39768,0.00685300626539977,0.00502265360126869,-0.00299139479308686,0.0166974073238864,0.172464626189556
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39706,0.00527160848520731,0.00387110633516895,-0.00231575993172383,0.0128589769021385,0.173295423303512
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,39768,0.00896406505080203,0.00658685501970267,-0.0039461707878152,0.0218743008894193,0.173573622399217
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41829,0.00934666495543213,0.00686866672746269,-0.00411592183039474,0.022809251741259,0.173611147538718
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,40054,0.00525501611782961,0.00386236619564054,-0.00231522162562585,0.0128252538612851,0.17367813692366
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,39719,-0.0117384159388143,0.00864213347374361,-0.0286769975473518,0.00520016566972315,0.174404742021808
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,41969,0.00789657219324,0.00581488456984048,-0.00350060156364734,0.0192937459501273,0.174489907650683
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,41991,0.00966329570369397,0.0071176642705609,-0.00428732626660539,0.0236139176739933,0.174598761897558
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,42120,0.00281509496306854,0.00207529496989353,-0.00125248317792277,0.00688267310405985,0.174970363109671
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41829,0.00690706241686987,0.00509620596591445,-0.00308150127632246,0.0168956261100622,0.175335319504714
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,42179,0.00581455574807147,0.00429383775179629,-0.00260136624544926,0.0142304777415922,0.175707979932424
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42144,-0.0160110768292116,0.0118503105540071,-0.0392376855150654,0.0072155318566423,0.176683701612208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,42059,-0.00320625619207778,0.0023735045503373,-0.0078583251107389,0.00144581272658334,0.176766223564063
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,39863,0.00791281823308342,0.00586402635320807,-0.00358067341920441,0.0194063098853712,0.177242569888387
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,41813,-0.00505885507888572,0.0037526430706537,-0.012414035497367,0.00229632533959552,0.177657535802448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,42184,-0.00583534918093111,0.00433785083418016,-0.0143375368159242,0.00266683845406202,0.17857876261003
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,42144,0.00417243798818881,0.00310190509796112,-0.00190729600381499,0.0102521719801926,0.178609685759338
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,42186,-0.00953067225867967,0.0070916837596945,-0.0234303724276809,0.00436902791032155,0.178996968212689
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41861,0.0103554952248267,0.0077195817531602,-0.00477488501136727,0.0254858754610207,0.179795824268603
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,39784,0.00768628989132895,0.00573678052191754,-0.00355779993162943,0.0189303797142873,0.180330545019233
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41861,-0.0115502717095929,0.00863320008462836,-0.0284713438754645,0.00537080045627869,0.1809563284316
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39847,-0.00866835207460108,0.006483253111921,-0.0213755281739662,0.00403882402476407,0.181238968792948
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,42226,-0.00297037383848724,0.00222312681982941,-0.00732770240535289,0.0013869547283784,0.181531967752468
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,40020,-0.00455813420953608,0.00341320989912413,-0.0112480256118194,0.00213175719274721,0.181760726911043
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41861,-0.0041050081626483,0.00308255335030496,-0.010146812729246,0.00193679640394943,0.182985751673663
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39804,-0.00973887033755053,0.00733816969905625,-0.0241216829477008,0.00464394227259972,0.184486795897946
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39784,-0.00541006643889742,0.00408232276936033,-0.0134114190668437,0.00259128618904882,0.185119420823897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39706,0.00448669021678867,0.00338608113594377,-0.00215002880966112,0.0111234092432385,0.185186952606228
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,42133,0.0101808056940811,0.00770570670505918,-0.00492237944783495,0.0252839908359971,0.186456924678353
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42256,-0.0131954702732634,0.00999458054069605,-0.0327848481330277,0.00639390758650082,0.186770512675387
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39784,0.00956897525984401,0.00725026047735794,-0.00464153527577755,0.0237794857954656,0.186926577518023
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,42161,-0.00618299231720528,0.00468841916655652,-0.0153722938836561,0.00300630924924551,0.18726604152933
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42144,-0.00236098355629975,0.00179359587925368,-0.00587643147963696,0.00115446436703746,0.188082957223708
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,39719,0.00825470836595559,0.00627202548229127,-0.00403846157933531,0.0205478783112465,0.188164026735852
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42103,-0.00558635934954657,0.00425464851485419,-0.0139254704386608,0.00275275173956765,0.189205824349352
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,42222,-0.00340052052748456,0.00259156672666134,-0.00847999131174079,0.00167895025677168,0.189493135013206
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,40054,0.0111062762653636,0.00848393580286753,-0.00552223790825672,0.027734790438984,0.190529937423153
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,40113,-0.0027237953550033,0.00208355954734649,-0.00680757206780243,0.00135998135779582,0.191145221555575
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,39784,-0.00737251880363913,0.00564810395790215,-0.0184428025611274,0.00369776495384909,0.191816137319352
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39719,0.0100479034161002,0.00770981743440929,-0.00506333875534205,0.0251591455875424,0.192514222216122
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40080,0.0069818378333918,0.00535853888807648,-0.0035208983872381,0.0174845740540217,0.192623877973628
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,39881,0.00746809563392943,0.00573176741186063,-0.00376616849331741,0.0187023597611763,0.192626499797884
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,39665,0.00456020397174802,0.00350302149098505,-0.00230571815058268,0.0114261260940787,0.19301627165616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",40020,0.00560120676951717,0.00430454585831008,-0.00283570311277058,0.0140381166518049,0.193207227477457
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39665,0.00770276932053419,0.00591962123936651,-0.00389968830862416,0.0193052269496925,0.193209492803893
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39784,-0.00465746102053727,0.00358446500076315,-0.0116830124220331,0.00236809038095851,0.19385342754309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39768,0.00502933431910525,0.00387726342425195,-0.00257010199242856,0.0126287706306391,0.194613021557423
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,41947,-0.00995648284828863,0.00767698059561962,-0.0250033648157031,0.00509039911912582,0.194679794130853
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39768,-0.0101023248611285,0.00779793352097399,-0.0253862745622375,0.00518162483998048,0.195171573356316
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,42176,0.00368512140495358,0.00284743020267095,-0.00189584179228149,0.00926608460218865,0.195622128988524
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39784,-0.00543578034435098,0.00420074037443932,-0.013669231478252,0.00279767078955008,0.195691806166405
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39665,-0.00475826183777617,0.00367964246038935,-0.0119703610601393,0.00245383738458696,0.195994085913677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,39804,0.00917311783010141,0.00711230049402647,-0.00476699113819047,0.0231132267983933,0.197164204755019
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,40102,0.0077292900233807,0.00599652750339774,-0.00402390388327886,0.0194824839300403,0.197438983176299
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,39665,0.00411945213340952,0.00319812228584884,-0.0021488675468542,0.0103877718136732,0.197744971513324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,42107,0.00616603630939848,0.0047908971708477,-0.00322412214546301,0.01555619476426,0.198106325093874
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40054,-0.006258705977879,0.00486452092156692,-0.0157931669841502,0.00327575502839217,0.198260211248037
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,39784,-0.00585034749943562,0.00454730784912766,-0.0147630708837258,0.00306237588485459,0.198278646057261
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,40020,0.00792274298435294,0.00616766947974249,-0.00416588919594235,0.0200113751646482,0.198973485858356
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,39719,0.00648160881030786,0.00505438523541713,-0.00342498625110971,0.0163882038717254,0.199739959107298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,40020,-0.00727712446841496,0.0056792693715895,-0.0184084924367304,0.00385424349990046,0.200098656161298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39706,0.00357874467386828,0.00279385174889174,-0.00189720475395953,0.00905469410169609,0.200244482038345
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39768,0.00563045417081277,0.00439649323622945,-0.00298667257219694,0.0142475809138225,0.200337916391745
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42256,0.00799229237757743,0.0062415223351586,-0.00424109139933342,0.0202256761544883,0.200390785459712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,41853,0.00663573528076117,0.0051919067244435,-0.00354040189914809,0.0168118724606704,0.201240367430123
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39768,-0.00669506054856258,0.00523937874297244,-0.0169642428847886,0.00357412178766341,0.201335728982202
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42197,0.00362958169292396,0.00284198571098842,-0.00194071030061335,0.00919987368646127,0.201579596116809
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41887,-0.00602030896914221,0.00471613615127915,-0.0152639358256493,0.00322331788736493,0.201790108558713
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,40113,-0.00936642856233652,0.0073511149024996,-0.0237746137712357,0.00504175664656269,0.202637113359898
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41810,-0.00863284985726187,0.00679477283423095,-0.0219506046123545,0.00468490489783078,0.203925245548622
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,39984,0.0120752904344236,0.00951067694032813,-0.00656563636861956,0.0307162172374667,0.204234484649985
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39768,0.00663138680057437,0.00522434341226824,-0.00360832628747137,0.0168710998886201,0.204353308125006
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39706,0.0120217085739865,0.00947835366226985,-0.00655586460406244,0.0305992817520354,0.204707150979195
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39768,-0.00503802833350478,0.00397510863825198,-0.0128292412644787,0.00275318459746911,0.205042399628191
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,39916,-0.0140136840655412,0.0110679128343695,-0.0357067932209055,0.00767942508982312,0.20548539741733
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39804,-0.00588754531275207,0.00465225391787832,-0.0150059629917936,0.00323087236628944,0.205710853279115
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42094,0.00258298554750312,0.00204166506828111,-0.00141867798632785,0.0065846490813341,0.205845156473384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,39784,0.0053294166412405,0.00421404535308217,-0.00293011225080055,0.0135889455332815,0.206014082987657
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,42144,-0.0140130657310697,0.0110839330133922,-0.0357375744373183,0.00771144297517902,0.206156478699712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39719,0.00959073307957979,0.00758991533043143,-0.00528550096806581,0.0244669671272254,0.206396129498524
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40054,0.00701511140750259,0.00555445661495935,-0.00387162355781773,0.0179018463728229,0.206627119606392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,39873,0.00315018502642875,0.00250297368393504,-0.00175564339408393,0.00805601344694143,0.20821068466552
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,42013,0.00620897966816002,0.00494724320971645,-0.00348761702288421,0.0159055763592043,0.209487738685382
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42186,0.00918847780656594,0.00732421033404251,-0.00516697444815738,0.0235439300612893,0.209670201048536
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,42213,0.00750555493446463,0.00598324941398213,-0.00422161391694034,0.0192327237858696,0.209709041244001
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,39863,-0.00857260826278509,0.006836057041731,-0.0219712800645779,0.00482606353900767,0.209859233166
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40021,0.00552784713311292,0.00441361523766823,-0.0031228387327168,0.0141785329989426,0.210431773495302
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,41829,-0.00863015075807022,0.00689282913192044,-0.0221400958566343,0.00487979434049384,0.210575664975176
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,39706,-0.00580433845476253,0.00463677137200818,-0.0148924103438986,0.0032837334343735,0.210668398429296
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41633,0.00625807482356336,0.00501137502027952,-0.00356422021618449,0.0160803698633112,0.211771247550765
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42120,-0.00642918955939073,0.00516252004639175,-0.0165477288503185,0.0036893497315371,0.213022480208496
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39784,0.00686919471875804,0.00551867723139538,-0.0039474126547769,0.017685802092293,0.213263116162457
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,42127,-0.00515190528639806,0.00414167265702787,-0.0132695836941727,0.00296577312137657,0.213551922895159
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,42213,-0.00406837336617817,0.00328023309975367,-0.0104976302416954,0.00236088350933902,0.214898047831353
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41702,-0.0109230026023521,0.00880711526375612,-0.0281849485193141,0.00633894331460989,0.21490713270773
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,40102,-0.00334133716320952,0.00269445811145577,-0.00862247506166282,0.00193980073524379,0.214973366038763
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,40054,0.020109277833531,0.0162672703461662,-0.0117745720449548,0.0519931277120168,0.216418317125295
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42213,0.00845038239304253,0.00684649925951694,-0.00496875615561067,0.0218695209416957,0.217127105641738
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39804,0.011055328386825,0.00897070614603122,-0.00652725565939618,0.0286379124330462,0.217834079051751
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40020,0.00630248551696986,0.00511931296399677,-0.0037313678924638,0.0163363389264035,0.218304954191777
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40020,0.00691776673425812,0.00562878507316313,-0.00411465200914161,0.0179501854776579,0.219099192660109
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39706,0.00894296339772865,0.00731552762770701,-0.00539547075257709,0.0232813975480344,0.221559915862209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39804,0.00293209158307914,0.00239910271151093,-0.00177014973148227,0.00763433289764055,0.221673613349411
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41861,-0.00546614933011422,0.00447318547245643,-0.0142335928561288,0.00330129419590038,0.221737409758588
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41829,-0.00761400523426812,0.0062332634822001,-0.0198312016593803,0.00460319119084407,0.221915070569484
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41887,-0.00537389871953099,0.00440275225266261,-0.0140032931347497,0.00325549569568772,0.222268842985271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39784,0.00519661242476548,0.00426262372208831,-0.00315813007052761,0.0135513549200586,0.222829133835629
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,39706,-0.00472359209804282,0.00388383961350168,-0.0123359177405061,0.00288873354442047,0.223929545404255
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,40020,-0.00350622957480228,0.00288303591532103,-0.00915697996883149,0.00214452081922693,0.223950940791836
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40054,0.00482850694431227,0.00397709894023244,-0.00296660697854332,0.0126236208671679,0.224744473340489
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39784,-0.00460904182129137,0.00379738946787187,-0.0120519251783202,0.00283384153573749,0.224874260852739
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,41887,-0.00608053561367579,0.00501202708629895,-0.0159041087028217,0.00374303747547015,0.225080184201004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39784,-0.00997556102377163,0.0082327659703047,-0.0261117823255688,0.00616066027802558,0.22565806529067
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,40054,0.00623953675615591,0.00515818343429428,-0.00387050277506087,0.0163495762873727,0.226444007311917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42120,-0.00414078429313721,0.00342346596188579,-0.0108507775784334,0.00256920899215895,0.226481468777732
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,40080,0.00863306821754942,0.00713806363154835,-0.00535753650028534,0.0226236729353842,0.226519654524222
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,40054,-0.0105814479965156,0.00876897988201105,-0.0277686485652573,0.00660575257222603,0.227577499112307
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42256,-0.00822820183200666,0.00682274302327675,-0.0216007781576291,0.00514437449361578,0.22784081817599
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,39706,-0.00471707017568711,0.00391826980538235,-0.0123968789942365,0.0029627386428623,0.228668642660665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42256,0.0044963505486484,0.0037357839515658,-0.00282578599642056,0.0118184870937174,0.228770070137913
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39719,0.00657343695433125,0.00546359584917959,-0.00413521091006074,0.0172820848187232,0.228951601204857
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39665,0.00376884465859661,0.00313285746713172,-0.00237155597698156,0.00990924529417479,0.229001404709914
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,39784,0.00376462927852792,0.00312996212258563,-0.00237009648173992,0.00989935503879575,0.229091641364749
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39665,0.0042552361921634,0.00354393781682009,-0.00269088192880397,0.0112013543131308,0.229891464435468
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,42184,0.00268975792168657,0.00224498466272523,-0.00171041201725487,0.00708992786062802,0.230892700972798
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,39706,0.00450528112453684,0.00376492457593516,-0.00287397104429607,0.0118845332933698,0.23147163406991
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39719,-0.00543222280660338,0.00454648072254019,-0.0143433250227821,0.00347887940957539,0.232184570522884
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,42296,-0.00212584237634427,0.00178117547465621,-0.00561694630667045,0.00136526155398191,0.232693146195625
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39863,0.0100145480087336,0.00839506387090026,-0.00643977717823096,0.0264688731956981,0.232931506557897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39686,0.0076536756262829,0.00641853713549984,-0.00492665715929679,0.0202340084118626,0.233118466455288
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,40021,0.00914495359028424,0.0076984056294996,-0.00594392144353499,0.0242338286241035,0.234897969765505
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,42067,0.0101318605612138,0.00854223489125956,-0.0066109198256549,0.0268746409480826,0.235608595744632
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39625,-0.00396922610391279,0.00334702495480417,-0.010529395015329,0.00259094280750339,0.235690078863269
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41861,-0.00687057222899166,0.00579721321158813,-0.0182331101237044,0.00449196566572108,0.235980038149665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39665,0.0104915694443007,0.0088624705062665,-0.00687887274798167,0.027862011636583,0.236511214114082
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,42103,0.00333050325285113,0.0028165857023896,-0.00219000472383248,0.00885101122953474,0.237044538979655
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,42223,0.0131751331037583,0.0111431001986904,-0.00866534328567487,0.0350156094931915,0.237085277621942
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39665,0.00577064418028508,0.00488377257943419,-0.00380155007540594,0.0153428384359761,0.237393035595858
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,39784,-0.00538226681417921,0.00455531222902256,-0.0143106787830634,0.00354614515470502,0.237416268710822
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,40020,0.00504348129306878,0.00428351402321766,-0.00335220619243784,0.0134391687785754,0.239055078785926
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,42078,-0.00556799230791575,0.00473935780180697,-0.0148571335994574,0.00372114898362591,0.240080007975811
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42094,-0.0163906663838172,0.0139536436938635,-0.0437398080237896,0.0109584752561552,0.240155913540149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,39665,0.0113569872139086,0.00966917497079057,-0.00759459572884091,0.0303085701566581,0.240199116764485
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,39706,0.00482471306170166,0.00411190265816513,-0.00323461614830199,0.0128840422717053,0.240680886855173
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,42103,0.00663808979628518,0.00565989964176636,-0.00445531350157688,0.0177314930941472,0.240886356223586
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39881,0.00903323884568346,0.00770520053429892,-0.00606895420154242,0.0241354318929093,0.241080249431953
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39784,-0.0104684430614541,0.00895753059735193,-0.0280252030322639,0.00708831690935564,0.242560860151331
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,40020,-0.00577334197475441,0.00495939562717852,-0.0154937574040243,0.00394707345451548,0.244400193729841
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,39784,0.00443892362144484,0.00381867111262183,-0.00304567175929395,0.0119235190021836,0.245088552149604
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39665,-0.0109981705504798,0.00947260159210512,-0.0295644696710058,0.00756812857004621,0.245647756260232
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,40054,0.00729163514115609,0.0062905921813538,-0.00503792553429736,0.0196211958166095,0.24642732261153
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42094,0.0136359400526888,0.0117695979821554,-0.00943247199233573,0.0367043520977133,0.246651671212146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,41787,0.0105976832553515,0.00916041728399852,-0.00735673462128556,0.0285521011319886,0.247335319382099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39881,0.00869252907266505,0.00751718539749442,-0.00604115430642401,0.0234262124517541,0.247562146427015
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,42213,-0.00679316483020244,0.00587470183496278,-0.0183075804267295,0.00472125076632461,0.247562488425771
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,40020,0.00441694573181132,0.00382067352210987,-0.00307157437152402,0.0119054658351467,0.247680210963199
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39706,0.00439200875197155,0.00380243366994841,-0.00306076124112733,0.0118447787450704,0.248095372787102
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39665,0.00756380716693221,0.00655228476229211,-0.00527867096716033,0.0204062853010247,0.248371964242284
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41935,0.0203205228356635,0.0176145015756988,-0.0142039002527061,0.0548449459240331,0.248675736639921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41861,0.00513103755902977,0.00444849388163772,-0.00358801044898016,0.0138500855670397,0.24875465870111
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40113,0.00220760428302091,0.00191393455373375,-0.00154370744229723,0.00595891600833906,0.248756019512396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,40054,0.00883134435645692,0.00765679433505072,-0.00617597254024249,0.0238386612531563,0.248771744908791
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,40021,0.00685288330533763,0.00594736324268929,-0.00480394865033338,0.0185097152610086,0.249241448433902
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41861,-0.00685775487821502,0.00595236572575327,-0.0185243917006914,0.00480888194426139,0.249299356807284
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39706,-0.00767686767463063,0.00668936703259142,-0.0207880270585098,0.00543429170924855,0.251150581612219
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42197,-0.00284838171271039,0.00248359419601426,-0.00771622633689834,0.00201946291147757,0.251452788125277
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42004,-0.0110898690017502,0.00967711532368362,-0.0300570150361701,0.00787727703266971,0.251821055386626
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39719,0.009848850046559,0.00862277934153591,-0.00705179746285138,0.0267494975559694,0.253401145139518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41876,-0.0108157369639616,0.00947607552699381,-0.0293888449968695,0.00775737106894628,0.253736277362869
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,42296,-0.00621180895090116,0.00544433247598518,-0.0168827006038321,0.0044590827020298,0.253904108058719
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,40021,-0.00299459721414206,0.00262570570044709,-0.00814098038701836,0.00215178595873425,0.254106473253807
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,39768,-0.00414943787758895,0.00363916020350689,-0.0112821918764624,0.00298331612128455,0.254221097428204
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,39847,0.0118273021662433,0.0103855385367046,-0.00852835336569764,0.0321829576981843,0.2548021122047
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,39961,-0.00517160337843836,0.00454273143688881,-0.0140753569947404,0.0037321502378637,0.254964315630424
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,39706,-0.00830656246542829,0.00730359625828628,-0.0226216111316694,0.00600848620081282,0.255428379072232
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,40080,-0.00858529256716182,0.00755306952721614,-0.0233893088405055,0.00621872370618181,0.255704329109343
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39804,0.00504792760001032,0.00444143329819936,-0.00365728166446041,0.0137531368644811,0.255750559519715
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,42103,0.00781927106493014,0.00688716113704123,-0.00567956476367066,0.0213181068935309,0.256253873895607
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,41829,-0.00534493858715545,0.0047087185240675,-0.0145740268943277,0.00388414972001684,0.256348531106391
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39665,0.00759054519320974,0.00668804382263988,-0.00551802069916442,0.0206991110855839,0.256425389131027
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,41897,-0.00534650384764316,0.00471641634913901,-0.0145906798919556,0.00389767219666931,0.256986055161603
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39784,-0.0102608100097024,0.00906408819215844,-0.0280264228663329,0.00750480284692815,0.257647905805119
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,40035,0.00276698162483679,0.00244641844051859,-0.00202799851857965,0.00756196176825322,0.258065940272737
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41829,0.00776584222826917,0.00686949900990566,-0.00569837583114593,0.0212300602876843,0.258294806079603
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41861,-0.00550432442227674,0.00487079967577445,-0.0150510917867947,0.00404244294224118,0.258469871831631
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,41887,0.00540109730455307,0.00477992123548387,-0.00396754831699532,0.0147697429261015,0.258516414840363
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,40020,-0.00440280102175659,0.00389757530594921,-0.012042048621417,0.00323644657790386,0.258659027959051
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42101,-0.00508797948211117,0.00450438120778994,-0.0139165666493795,0.00374060768515711,0.258681669404543
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,42094,-0.0117383358371431,0.010396508326006,-0.0321154921561148,0.00863882048182864,0.258891322230971
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39706,0.0054751137878623,0.00485636935622008,-0.00404337015032905,0.0149935977260537,0.259595392065945
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,39477,-0.00283579195678262,0.00251760497470829,-0.00777029770721086,0.00209871379364563,0.260028966527954
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39804,-0.00497477643201481,0.00441836071512621,-0.0136347634336622,0.00368521056963255,0.260219509847252
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,42004,0.010404781227908,0.00925179168973536,-0.00772873048397328,0.0285382929397893,0.260769734941237
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41985,-0.00833650887702798,0.00743277678469889,-0.0229047513750378,0.00623173362098185,0.262058961271905
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,42120,0.00579895809975455,0.00517384194437349,-0.00434177211121748,0.0159396883107266,0.2623842774755
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,42094,0.00326216171635197,0.00291472090774079,-0.00245069126281999,0.00897501469552393,0.263074775191567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,41859,0.00442175438498472,0.00395382072633346,-0.00332773423862886,0.0121712430085983,0.263438862312479
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,42049,0.00672060337951573,0.00602325454058423,-0.00508497552002935,0.0185261822790608,0.264538849026163
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39768,-0.00487939360853538,0.00437403848664585,-0.0134525090423613,0.0036937218252905,0.26464652236905
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39863,-0.00947324849543263,0.00849979882883829,-0.0261328541999557,0.00718635720909042,0.265078616280665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42157,0.00243743017158252,0.00218738517747666,-0.00184984477627175,0.00672470511943678,0.265165898650089
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39706,0.00557525250569269,0.00500407902710749,-0.00423274238743799,0.0153832473988234,0.265243926698055
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,41829,-0.00489848034401632,0.00439723895376352,-0.0135170686933928,0.00372010800536018,0.265304655250338
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42016,-0.00333448374526079,0.00299373793823601,-0.00920221010420338,0.00253324261368179,0.265377500834206
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39719,-0.00661754709938452,0.00594288623801943,-0.0182656041259026,0.00503050992713357,0.265508829367865
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40020,0.00930397723068664,0.00835782334946798,-0.00707735653427061,0.0256853109956439,0.265644778507383
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39804,-0.00553279235437633,0.00497418581818821,-0.0152821965580252,0.00421661184927255,0.266033912815813
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39706,0.00565452704822724,0.00509317972564712,-0.00432810521404113,0.0156371593104956,0.266931572364336
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,40054,0.00846614692604309,0.00763819190444963,-0.00650470920667819,0.0234370030587644,0.267715062769063
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,42186,0.00393099010925604,0.0035505716475855,-0.00302813032001154,0.0108901105385236,0.26825265782979
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,39784,0.00462773229535023,0.00418072564535102,-0.00356648996953777,0.0128219545602382,0.268353302237146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39706,0.00765257830615924,0.00691693241641063,-0.00590460923000559,0.0212097658423241,0.268598491262423
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42248,-0.00594110879056102,0.0053706221378116,-0.0164675281806718,0.00458531059954972,0.268650149337347
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,41813,0.0100459315446311,0.00910937084609591,-0.00780843531371692,0.027900298402979,0.270129462456306
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40054,0.00293263336799365,0.00265966489166673,-0.00228030981967314,0.00814557655566044,0.270211156045861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40054,-0.00551967800018252,0.00501453198594764,-0.0153481606926399,0.00430880469227485,0.271035786070721
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39784,0.00452223619138447,0.0041086690091576,-0.00353075506656443,0.0125752274493334,0.271070890952411
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,41861,0.00898820437155497,0.0081793169428924,-0.00704325683651414,0.0250196655796241,0.271835079863298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42075,0.00340583109641223,0.00310144346928074,-0.00267299810337802,0.00948466029620248,0.272162202991651
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39768,0.00352127132796275,0.00320653922127053,-0.00276354554572749,0.009806088201653,0.272162599833472
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,39665,0.0131579881770212,0.012035931066712,-0.0104324367137342,0.0367484130677767,0.274319901481196
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42004,-0.00340352126973954,0.00311678129306283,-0.00951241260414268,0.0027053700646636,0.274854188469118
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42184,-0.00450369470381985,0.0041277809491356,-0.0125941453641256,0.00358675595648592,0.275262666323245
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42094,0.00973661557033788,0.00894526843822993,-0.00779611056859279,0.0272693417092686,0.276410018773037
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41829,0.00550694581694894,0.00506229605935778,-0.0044151544593923,0.0154290460932902,0.27668844521861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,39804,-0.0100476661155412,0.00923651765791886,-0.0281512407250622,0.00805590849397978,0.276699409104822
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42248,-0.0044880287152309,0.00413871084610576,-0.0125999019735982,0.00362384454313639,0.278206367631783
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39768,0.0078887539891688,0.00727585584716222,-0.00637192347126916,0.0221494314496068,0.278284336656358
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,42122,0.00431498980378056,0.00398701835841428,-0.00349956617871143,0.0121295457862726,0.279157276567397
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39665,-0.00296813571396558,0.0027429569906248,-0.00834433141559018,0.00240805998765902,0.279235937631275
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42296,0.00358444402804195,0.00331465785873607,-0.00291228537508076,0.0100811734311647,0.279542744140191
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,39706,0.00522601954298672,0.00484238958248554,-0.00426506403868493,0.0147171031246584,0.280512968171522
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39707,-0.0108669259164532,0.0100845764569091,-0.030632695771995,0.00889884393908865,0.281246486985482
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,42146,0.00377052243568112,0.00350339343117799,-0.00309612868942775,0.01063717356079,0.281836115564235
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42223,-0.00455814153911495,0.00423557957670001,-0.012859877509447,0.00374359443121707,0.281877719936012
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,42296,-0.00301073550782368,0.0028006602693603,-0.00850002963576987,0.00247855862012251,0.282390413069277
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,39706,-0.00718970060405008,0.00669832500491822,-0.0203184176136898,0.00593901640558962,0.283135168286061
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,39665,-0.0060719284265537,0.00566085426878384,-0.01716720279337,0.00502334594026264,0.283467721099148
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,40021,0.0110929720786363,0.0103614107897453,-0.00921539306926457,0.0314013372265371,0.28437120530637
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,42256,0.00539255138495023,0.0050384780528265,-0.00448286559858971,0.0152679683684902,0.284515830408519
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,42175,0.00327437991125149,0.00306089530135421,-0.00272497487940276,0.00927373470190574,0.284753632596162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42186,-0.0099480841186869,0.00930499343650927,-0.0281858712542451,0.00828970301687127,0.285038875400698
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,42004,-0.00131718611962913,0.00123211412858554,-0.00373212981165678,0.00109775757239852,0.285069291316937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,42282,-0.00389416851220368,0.00364708043343986,-0.0110424461617458,0.00325410913733845,0.285653192081908
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,40054,0.0072794017574937,0.00682630596333554,-0.00610015793064397,0.0206589614456314,0.286277881549327
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,40020,0.00601404478458117,0.00563977243180709,-0.00503990918176073,0.0170679987509231,0.286283349887138
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,42296,0.00944236824388214,0.00885685837582921,-0.00791707417274311,0.0268018106605074,0.286394434088585
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39881,-0.00724609527175142,0.00683266473615328,-0.0206381181546118,0.006145927611109,0.288937541429178
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41968,-0.00323266206857613,0.0030498616557407,-0.00921039091382789,0.00274506677667564,0.289193174617448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,42193,-0.00540046554304024,0.00509572756451375,-0.0153880915694872,0.0045871604834067,0.289254085430906
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,39768,0.00753685181388234,0.00712706434740688,-0.00643219430703515,0.0215058979347998,0.290308811609802
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,39784,-0.00537025948694822,0.00507992891479948,-0.0153269201599552,0.00458640118605877,0.290466114129421
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41876,-0.00335495109500833,0.00317513980613072,-0.00957822511502454,0.00286832292500789,0.290700161551338
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41888,-0.00517022984417514,0.00489349338571223,-0.0147614768801711,0.00442101719182083,0.290736238910964
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,39665,0.00483658911579784,0.00457812333249569,-0.00413653261589371,0.0138097108474894,0.290783981615628
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,39706,0.00369672358770999,0.00350807113708502,-0.00317909584097664,0.0105725430163966,0.292009388583056
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39706,0.00521641057721057,0.00495452613958788,-0.00449446065638167,0.0149272818108028,0.292430454333569
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42091,0.00220758162633381,0.00209740783731096,-0.00190333773479567,0.00631850098746329,0.292576838889599
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,40080,-0.00522136088361285,0.00496696090513634,-0.0149566042576801,0.00451388249045438,0.293181611357362
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39881,0.00758617127461623,0.00722452475656664,-0.00657389724825439,0.0217462397974869,0.293715111367541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,39706,0.00468908792040039,0.0044691023897067,-0.00407035276342474,0.0134485286042255,0.294099317641102
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42296,-0.00703727119960854,0.00671668144545596,-0.0202019668327022,0.00612742443348514,0.294782173645101
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,42120,0.00257589957034544,0.0024612300801963,-0.0022481113868393,0.00739991052753019,0.295308139530476
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39784,0.00936497130475468,0.00895161910120889,-0.00818020213361475,0.0269101447431241,0.295503543560313
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39784,-0.0108571548566458,0.0103836132690041,-0.0312090368638938,0.0094947271506022,0.295767442773433
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,39784,0.00784957947308831,0.00751559086907065,-0.00688097863029015,0.0225801375764668,0.296305966957994
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39881,0.00472956873707615,0.00455502085720851,-0.00419827214305253,0.0136574096172048,0.299144644742472
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,40033,-0.00768817600252233,0.007407957492448,-0.0222077726877204,0.00683142068267576,0.299373899928616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42296,-0.00698965572547833,0.00673896723541068,-0.0201980315068833,0.0062187200559266,0.299661874982572
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,42044,0.00740940477631368,0.00714668089846239,-0.00659808978467261,0.0214168993373,0.299866455053128
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39665,-0.00582543620620384,0.00563373963399527,-0.0168675658888346,0.00521669347642689,0.301147644384226
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,42182,0.00457430828724349,0.00443169993790954,-0.00411182359105921,0.0132604401655462,0.302007418656105
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39784,-0.00575342033021642,0.00557437626437274,-0.016679197808387,0.00517235714795416,0.302039887448477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42120,0.00399286164661414,0.00387059787056513,-0.00359351017969352,0.0115792334729218,0.302284546244346
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39863,-0.00720742673124167,0.0069868819177343,-0.0209017152900009,0.00648686182751756,0.302299066300742
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,42073,0.00803935849084356,0.00779824743759197,-0.00724520648683669,0.0233239234685238,0.302598342993981
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39227,-0.00577910531756129,0.00562092387599885,-0.016796116114519,0.00523790547939646,0.303908039582779
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,39804,-0.00703954788980453,0.00687504822825723,-0.0205146424171887,0.00643554663757964,0.305893074228359
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39665,0.00611240817316206,0.00597257656415796,-0.00559384189258755,0.0178186582389117,0.306136600305155
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,42182,0.00603285228824955,0.00591833831968148,-0.00556709081832614,0.0176327953948252,0.30805629267435
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40054,-0.00693430805679736,0.00680552128167639,-0.0202731297688831,0.00640451365528836,0.308261810141573
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39804,-0.00330034796836185,0.00324133226358666,-0.00965335920499171,0.00305266326826801,0.308602697638625
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39706,0.00389191862448486,0.00382935465995555,-0.00361361650902802,0.0113974537579977,0.309491853774554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,42109,-0.00316292899790272,0.00311664159864567,-0.00927154653124823,0.00294568853544279,0.310195540402538
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39665,0.00600092227730213,0.00591714388952961,-0.00559667974617591,0.0175985243007802,0.310530519564766
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,41829,-0.00334168103586622,0.00329733821063552,-0.00980446392871183,0.00312110185697939,0.310865596257672
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42296,-0.00425297125331405,0.00420854178528156,-0.0125017131524659,0.00399577064583781,0.312247179219331
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41861,0.005415181275515,0.00536456031697099,-0.00509935694574814,0.0159297194967781,0.312784775656738
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,42296,-0.00273088648416094,0.00271100856870856,-0.00804446327882972,0.00258269031050785,0.313793717871451
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39706,0.00374073209832287,0.00371387041882514,-0.00353845392257442,0.0110199181192202,0.313846098520091
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41887,0.00596936743743238,0.00593032688501815,-0.00565407325720321,0.017592808132068,0.314154297132027
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41810,-0.00481498152660324,0.00478916006900911,-0.0142017352618611,0.00457177220865461,0.314727583131725
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39768,0.00805112993780296,0.00801405621311226,-0.00765642023989706,0.023758680115503,0.315099919356726
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39881,0.00503778799101863,0.0050146815772781,-0.00479098790044645,0.0148665638824837,0.315108507734373
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,42094,-0.00469541823920019,0.00467747660770712,-0.0138632723903061,0.00447243591190577,0.315476618354424
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,39804,-0.0030722945180988,0.0030678520834464,-0.00908528460165374,0.00294069556545615,0.316633077244197
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,40020,-0.00442659554001173,0.00442316454208173,-0.0130959980424919,0.00424280696246845,0.316957633334334
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39863,-0.00588194099571997,0.00589340798697171,-0.0174330206501845,0.00566913865874459,0.318275679285704
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41829,0.00521201732312987,0.00523417760222284,-0.0050469707772269,0.0154710054234866,0.319382808796962
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40020,0.00979281681995817,0.0098627520723572,-0.00953817724186194,0.0291238108817783,0.320776419514206
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,41865,-0.00437393159769245,0.0044135495286198,-0.0130244886737873,0.00427662547840235,0.321692996503057
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,41887,0.00482246563106656,0.00488652343883872,-0.00475512030905734,0.0144000515711904,0.323714925563429
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39784,0.00915389832963519,0.00927584058779255,-0.00902674922243821,0.0273345458817086,0.323736872583786
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39784,-0.0028698081567922,0.0029081176376251,-0.0085697187265374,0.00283010241295301,0.323750144382094
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39863,0.00840910417890126,0.00852299120996907,-0.00829595859263813,0.0251141669504406,0.323842671042861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39719,0.0064383694688526,0.00655006432041644,-0.00639975659916361,0.0192764955368688,0.325655863345915
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41985,0.00958754671800574,0.00977393517143984,-0.00956936621801635,0.0287444596540278,0.326645790265923
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40020,0.00906611408065486,0.00925794252449953,-0.00907945326736421,0.0272116814286739,0.327463739054355
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42223,-0.00808869514678493,0.00826325181323518,-0.0242846687007259,0.00810727840715602,0.327659650349405
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39768,-0.00693446734645252,0.00709132410750495,-0.0208334625971622,0.00696452790425717,0.328155817214298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,39739,-0.00684404616426033,0.00702046548178745,-0.0206041585085637,0.00691606618004308,0.329646759339796
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42226,0.00283853306923179,0.00291220586137711,-0.00286939041906734,0.00854645655753092,0.329726159556045
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39719,0.00315741768514844,0.00323961528798927,-0.00319222827931052,0.00950706364960741,0.329767537628851
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40054,0.00469029488485428,0.00481365162199012,-0.00474446229424635,0.0141250520639549,0.329892793145086
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,39665,0.00573093721669546,0.00588686499839036,-0.00580731818014965,0.0172691926135406,0.330321092104746
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39706,0.00482787812649647,0.0049601471964253,-0.00489401037849712,0.0145497666314901,0.330409904577604
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,39768,0.00484023894990062,0.00499250119773141,-0.00494506339765294,0.0146255412974542,0.332317052276619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42094,0.00263575651715002,0.00272232902453543,-0.00270000837093942,0.00797152140523946,0.332963094761591
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,39622,0.0034644251725514,0.0035788536236606,-0.00355012792982337,0.0104789782749262,0.333053581813214
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42076,0.00428630224454584,0.0044364440229722,-0.00440912804047967,0.0129817325295713,0.333983673395113
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41861,0.00832941344895847,0.00862673049066574,-0.00857897831274638,0.0252378052106633,0.334295159994327
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,39719,0.00344706196098975,0.00357124832810636,-0.00355258476209873,0.0104467086840782,0.334453772664609
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39881,-0.0073615288986795,0.00762877582498498,-0.0223139295156501,0.00759087171829106,0.334582389129941
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,40020,-0.00812697093390156,0.00842484131199091,-0.0246396599054037,0.00838571803760061,0.334744800274934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,40054,0.00516294796144604,0.00535582873059663,-0.00533447635052336,0.0156603722734154,0.335074030353076
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39665,0.00421770207024466,0.00437603671556485,-0.00435932989226244,0.0127947340327518,0.335159539640847
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39665,0.00820461871306999,0.00851634512854522,-0.00848741773887864,0.0248966551650186,0.335370734013293
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39793,0.00543408267429037,0.00564703799033147,-0.00563411178675931,0.01650227713534,0.335926393828969
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,40054,0.0045536121272861,0.00474124905510929,-0.00473923602072812,0.0138464602753003,0.336862954855161
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42184,-0.00278106741819978,0.00290050405661219,-0.00846605536915968,0.00290392053276012,0.337666214215101
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42094,0.00229828332603474,0.00239875183402009,-0.00240327026864464,0.00699983692071412,0.338022053101837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39768,0.0035441327547548,0.00369961924931179,-0.00370712097389632,0.0107953864834059,0.338098629747821
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39733,-0.00374233931197249,0.0039112515630872,-0.0114083923756234,0.00392371375167842,0.33868321343365
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,39784,0.0101976689222368,0.0106915856805316,-0.0107578390116051,0.0311531768560788,0.340205025779546
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39764,-0.00372232301825853,0.00391246813403485,-0.0113907605609668,0.00394611452444977,0.341423005859375
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39706,-0.00419643552272682,0.00441191563261817,-0.0128437901626584,0.00445091911720479,0.341545275903346
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39768,0.00605417625585817,0.00636564558112481,-0.00642248908314647,0.0185308415948628,0.341590443754629
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41985,0.00725257511822543,0.00762858817675565,-0.00769945770821564,0.0222046079446665,0.341769569951007
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,41887,-0.00467146098543075,0.00491381296070509,-0.0143025343884127,0.00495961241755121,0.341785226103496
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39804,0.00383086944357666,0.00404215642440656,-0.0040917571482602,0.0117534960354135,0.343288945131025
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,40054,0.0103064921479085,0.0108771145125654,-0.0110126522967196,0.0316256365925367,0.343385185186454
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42094,0.00375728076341255,0.00396673492471222,-0.0040175196890234,0.0115320812158485,0.343555973661428
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,41887,-0.00821104752062009,0.00868093392201536,-0.0252256780077702,0.00880358296653001,0.344232164253806
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39784,-0.00270593400141444,0.00286268631331231,-0.00831679917550656,0.00290493117267768,0.344556432042502
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,40021,-0.0066918218703902,0.00709695638569324,-0.020601856386349,0.00721821264556855,0.345745763839462
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39881,0.00522488838133108,0.00554623728117402,-0.00564573668976999,0.0160955134524322,0.346183208158787
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42121,-0.00586177633930472,0.00624073543978919,-0.0180936178012915,0.0063700651226821,0.347606334129518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39674,0.00837151079657545,0.00891596932396817,-0.00910378907840215,0.0258468106715531,0.347786036742658
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39881,0.00633435202634989,0.00675101182860667,-0.00689763115771919,0.019566335210419,0.348120776736718
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39784,-0.00825061676780354,0.00884175800009451,-0.0255804624479888,0.00907922891238169,0.350767870894739
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39719,0.00287898117137252,0.00308759505981864,-0.003172705145872,0.00893066748861705,0.351133240849492
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,39863,-0.00881299886423441,0.00946174139876754,-0.0273580120058188,0.00973201427734996,0.351649572590873
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39784,-0.00791863045437754,0.00850972571605569,-0.0245976928578467,0.00876043194909162,0.35211336581794
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42296,0.00237956502782608,0.00255941078179095,-0.00263688010448418,0.00739601016013635,0.352527208604375
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,39881,0.00390289581565307,0.00419843527572351,-0.00432603732476501,0.0121318289560711,0.352595475649484
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42120,-0.0053838752838179,0.00579283389884799,-0.01673782972556,0.00597007915792415,0.352697800981382
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39665,0.00325238601778665,0.0035053529250035,-0.0036181057152202,0.0101228777507935,0.353515012590535
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,41963,0.0064082187293292,0.00690924022189254,-0.00713389210558018,0.0199503295642386,0.353692151831607
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42285,-0.00563720285032232,0.00608261846885071,-0.0175591350492697,0.00628472934862507,0.354061808776462
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,42094,-0.00562445084020071,0.00607790971672614,-0.017537153884984,0.00628825220458254,0.354779194334364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,40020,0.00495931410818324,0.00536202339659912,-0.00555025174915104,0.0154688799655175,0.355040611288671
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,39606,0.00369014120806542,0.00399676933162819,-0.00414352668192583,0.0115238090980567,0.355882178585245
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,41810,0.00330661502001602,0.00358401350007861,-0.00371805144013805,0.0103312814801701,0.35623273325762
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39804,0.00331040905446602,0.00359093017003376,-0.00372781407880015,0.0103486321877322,0.35661179271653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,39804,-0.00170455148448723,0.00185138197534082,-0.00533326015615523,0.00192415718718077,0.357232493991607
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42144,-0.002398178944866,0.00260944639458272,-0.00751269387824813,0.00271633598851614,0.358093104624235
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42075,-0.00246185498419414,0.00268063869969417,-0.00771590683559472,0.00279219686720643,0.358435198252212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,42213,-0.00220032792567582,0.00240063805077716,-0.00690557850519905,0.0025049226538474,0.359390423932334
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40021,-0.016389502532661,0.0178827012536578,-0.0514395969898303,0.0186605919245084,0.35942492020814
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,39768,-0.00508750982328357,0.00555124655132291,-0.0159679530638765,0.00579293341730932,0.359445217794946
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,40021,-0.00371873397379951,0.00405786890818906,-0.0116721570338501,0.00423468908625104,0.359464250626838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,40097,-0.00409033005456991,0.00446456079249148,-0.0128408692078532,0.00466020909871339,0.359594078425851
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,40054,-0.00447240640472444,0.00489139208893133,-0.0140595348990298,0.00511472208958096,0.360557340888914
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39881,-0.0041152867666948,0.00450145237054651,-0.012938133412966,0.00470755987957635,0.360625502341371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,42162,0.00290068009179823,0.00317724920761887,-0.00332672835513475,0.00912808853873122,0.361284084867149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,42237,0.00337293235506919,0.00370224528872034,-0.00388346841082268,0.0106293331209611,0.362285612146572
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39881,0.00655656905746771,0.00719834947711925,-0.00755219591768602,0.0206653340326214,0.36239843878156
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39665,-0.00342521736056077,0.00376780199985754,-0.0108101092802815,0.00395967455916001,0.363331074866757
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,40055,-0.00238837015096881,0.00262956539950959,-0.00754231833400761,0.00276557803206998,0.363752771245089
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42256,0.00507934049160874,0.00559679274022429,-0.00589037327923087,0.0160490542624484,0.364135479770455
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42004,0.00545298873600503,0.00601280723727772,-0.00633211344905931,0.0172380909210694,0.364479039607751
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,40097,-0.00584689598689949,0.00645305577279346,-0.0184948853015747,0.00680109332777568,0.364920814859944
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,42197,-0.00442791445318262,0.00489569398866387,-0.0140234746709638,0.00516764576459857,0.365773156331882
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39706,0.00474353459046682,0.00525743878080678,-0.00556104541991446,0.0150481146008481,0.366943696465782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,42213,0.00332447558062251,0.0036857090360549,-0.0038995141300451,0.0105484652912901,0.367078450324046
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41861,-0.0117061417613292,0.0130161124485703,-0.037217722160527,0.0138054386378687,0.368479225567709
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41829,0.0137690681919203,0.0153474837112252,-0.0163119998820811,0.0438501362659217,0.369653431028451
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,40021,-0.00400119020349642,0.00446257898623589,-0.0127478450165188,0.00474546460952592,0.36994732291931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,40054,-0.00349015370031845,0.00389271095231826,-0.0111198671668622,0.00413955976622533,0.369959257114201
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,39881,0.0157981956658646,0.0176313911485813,-0.0187593309853548,0.050355722317084,0.370258732376076
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39784,0.0067224001823828,0.00753789642541044,-0.00805187681142165,0.0214966771761873,0.372512996947072
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39719,0.00568545125436616,0.00638104617858005,-0.00682139925565074,0.0181923017643831,0.372954656489453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42243,-0.00478492799516535,0.00537395027110666,-0.0153178705265344,0.00574801453620371,0.373271286147698
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,40020,0.00332967449926334,0.00374113108495899,-0.00400294242725628,0.010662291425783,0.37347592725744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39881,-0.0101243679383504,0.0113814577179063,-0.0324320250654469,0.012183289188746,0.373727953850785
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,40021,0.00813902384998938,0.0091554769636561,-0.00980571099877658,0.0260837586987553,0.374034286605077
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39863,0.00332756551002972,0.00374487982566383,-0.00401239894827138,0.0106675299683308,0.374257461979631
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,40020,-0.00370797053443361,0.00418472558417655,-0.0119100326794196,0.00449409161055242,0.375598106668933
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,41861,-0.00675354343110858,0.00763184265853723,-0.0217119550418416,0.0082048681796244,0.376218469443386
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42178,0.00317274839530653,0.00358618474831748,-0.00385617371139573,0.0102016705020088,0.376327204080276
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,39768,0.00688034154227363,0.00778142610316955,-0.00837125361993869,0.022131936704486,0.376608044248576
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39719,0.00448980437283832,0.00508112366718158,-0.00546919801483758,0.0144488067605142,0.376919236672669
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,41887,-0.00436885366573406,0.00495115333042535,-0.0140731141933677,0.00533540686189962,0.377582053435901
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,39784,-0.00241481728312448,0.00274049089980275,-0.00778617944673788,0.00295654488048891,0.378249975189948
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,40054,-0.00203554514186402,0.00231063065279128,-0.00656438122133494,0.00249329093760689,0.378365533721568
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42144,0.00708044988065796,0.00805018639472893,-0.00869791545301074,0.0228588152143267,0.379125619767984
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39706,0.0043441596188374,0.00495426907746415,-0.00536620777299234,0.0140545270106671,0.380587192312675
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39784,-0.00358912467241513,0.00409341030073378,-0.0116122088618533,0.00443395951702309,0.380612179334423
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41861,0.00467701443966457,0.00533785415485531,-0.00578517970385184,0.015139208583181,0.380939293257648
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,39719,0.00455621282397051,0.00520502033331648,-0.00564562702932978,0.0147580526772708,0.381403651898071
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,39719,0.0044872550011238,0.00512865895230035,-0.00556491654538488,0.0145394265476325,0.381627988869876
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,40054,-0.00580487420278005,0.00663464017592913,-0.0188087689476011,0.00719902054204104,0.381629008290679
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39784,-0.00218794998804761,0.00250104685039988,-0.00709000181483137,0.00271410183873615,0.381695134226626
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,42103,0.00508143847781521,0.00581111968648658,-0.00630835610769849,0.0164712330633289,0.381898417604248
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41829,0.00653245813790218,0.00747572737566683,-0.00811996751840481,0.0211848837942092,0.382231579927855
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39804,-0.00378657957808097,0.00433528484940209,-0.0122837378829091,0.00471057872674713,0.382447038044017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,42296,-0.00641171048425014,0.00734656669091369,-0.020810981198441,0.00798756022994069,0.382815767217592
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39706,-0.00596456482127228,0.00683632246546096,-0.0193637568535758,0.0074346272110312,0.382965688670465
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39847,-0.00754725733635331,0.008657326863123,-0.0245156179880744,0.00942110331536777,0.383349760381429
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,40097,0.00291309438968983,0.00334903094969669,-0.00365100627171568,0.00947719505109535,0.384411353349613
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,40020,-0.00774692358351432,0.00891991186874198,-0.0252299508462486,0.00973610367921997,0.385141143756504
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,41782,0.00412915158965306,0.00475793834523969,-0.00519640756701672,0.0134547107463228,0.38549589782601
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41876,0.00668187415972117,0.0077118691336536,-0.00843338934223989,0.0217971376616822,0.386265146834965
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,39706,0.00361707653493238,0.00417997504271869,-0.00457567454879624,0.011809827618661,0.38687497793002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39804,-0.00667546305652159,0.00773659792527144,-0.0218391949900536,0.00848826887701042,0.388243744388117
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,39665,0.0045979681133353,0.00533942458172363,-0.00586730406684302,0.0150632402935136,0.389183131380741
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,39768,-0.00274787266455767,0.00319203133586512,-0.00900425408285331,0.00350850875373798,0.389338026504979
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,42128,0.00283545550794245,0.00329679573118779,-0.00362626412518562,0.00929717514107052,0.389769674756933
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42094,0.0030977768866365,0.00360874883044597,-0.00397537082103759,0.0101709245943106,0.39068346344806
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,39665,0.00370478109625618,0.00432208466522858,-0.00476650484759183,0.0121760670401042,0.39136802758475
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42296,0.00240516921191358,0.00280693415157456,-0.00309642172517255,0.00790676014899971,0.391534070774581
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41861,0.00419433700431121,0.00490844556987981,-0.00542621631265322,0.0138148903212756,0.392836241606804
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,40097,0.00853124532331727,0.0099856107577908,-0.0110405517619527,0.0281030424085872,0.392927711303085
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,42184,0.00796324234974659,0.00934157384045625,-0.0103462423775477,0.0262727270770408,0.393979042247522
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,42184,0.00590801336474742,0.0069446208734441,-0.00770344354720302,0.0195194702766979,0.394933751060217
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,39719,0.00361795992483944,0.00426514551476411,-0.00474172528409823,0.0119776451337771,0.396311488576254
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,39719,0.0081385046972848,0.00959624316160847,-0.0106701318994678,0.0269471412940374,0.396405579410452
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41985,-0.00202861488916689,0.00239618204354438,-0.00672513169451387,0.00266790191618009,0.397232283773162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,40021,0.00746077307228904,0.0088225991645404,-0.00983152129021015,0.0247530674347882,0.397770374429667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42094,-0.00382801039141021,0.00453378844622243,-0.0127142357460062,0.00505821496318576,0.398501079196885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39804,0.0017962817023462,0.00212817775610436,-0.00237494669961835,0.00596751010431075,0.398662263542413
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41796,0.00644182134501742,0.00764111333130822,-0.00853476078434669,0.0214184034743815,0.399217890006657
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40080,0.00624341528354127,0.00740596836841859,-0.00827228271855916,0.0207591132856417,0.399233074833818
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,40013,0.00247597527299789,0.00293704645959733,-0.00328063578781287,0.00823258633380866,0.399238491015972
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,40020,-0.00306723007194126,0.00364853225704773,-0.0102183532957548,0.00408389315187229,0.400548562970983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,41664,0.0021610179543161,0.0025747799996847,-0.00288555084506591,0.0072075867536981,0.401315961217352
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,42146,-0.00291234463754491,0.00347040520182507,-0.00971433883312205,0.00388964955803223,0.401375713380501
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40021,-0.00543566172702778,0.00649592715596044,-0.0181676789527102,0.00729635549865468,0.402734726910043
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,42146,0.00435749037984931,0.00521819287433654,-0.00587016765385031,0.0145851484135489,0.403700814251208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39719,0.00306222203779755,0.0036676113430926,-0.00412629619466394,0.010250740270259,0.403772496576221
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42094,0.00285643737582038,0.00342223042247102,-0.00385113425222282,0.00956400900386358,0.403918284850921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,40080,0.00412684931320898,0.0049756711705643,-0.00562546618109705,0.013879164807515,0.40689314488397
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42162,0.00438264590909738,0.00529835414681863,-0.00600212821866713,0.0147674200368619,0.408155258161633
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39706,0.00842302912547195,0.0101966803418271,-0.0115624643445092,0.0284085225954532,0.408791064873104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,40021,-0.00490589325636728,0.00594201344398104,-0.0165522396065701,0.00674045309383556,0.409033282593125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,41861,0.00457367446471759,0.00554503800868679,-0.00629460003230852,0.0154419489617437,0.409487661700427
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,41887,-0.00368447630830713,0.00446707389624868,-0.0124399411449546,0.00507098852834029,0.409496355188509
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39804,0.00467450088153817,0.00567745427551475,-0.00645330949847074,0.0158023112615471,0.410330606992757
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,42213,0.00543528923910839,0.00660183852248395,-0.00750431426496015,0.0183748927431769,0.410352874327676
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41985,0.00283460933154189,0.00344432492994209,-0.0039162675311446,0.00958548619422838,0.410534907349364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,40080,-0.0068699362728493,0.00834922189761099,-0.0232344111921668,0.00949453864646824,0.410626374574731
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,39881,0.00343119440726523,0.00418370177324115,-0.00476886106828743,0.0116312498828179,0.412158239277045
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,39752,-0.00374022706082997,0.00456195162082067,-0.0126816522376385,0.00520119811597855,0.41230625583101
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,39768,-0.00409307830257555,0.00499417509305794,-0.0138816614849691,0.00569550487981801,0.412479500178385
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39881,-0.00563717260300499,0.00688512383470797,-0.0191320153190326,0.00785767011302263,0.412949187200194
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39881,0.00569571724963748,0.00696869079851602,-0.00796291671545392,0.0193543512147289,0.413758316887289
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42296,-0.00289470967520915,0.00354224554649147,-0.00983751094633242,0.00404809159591413,0.413831160855366
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,40054,-0.00446047149345015,0.00546495535896638,-0.0151717839970243,0.00625084101012396,0.414406282069015
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,41887,-0.00323773383853944,0.00396763855133399,-0.0110143053991541,0.00453883772207518,0.414495155561572
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39980,-0.00902208598080922,0.0110617921195496,-0.0307031985351264,0.012659026573508,0.414742391040472
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41887,0.00330225391817173,0.00405355497579561,-0.00464271383438766,0.0112472216707311,0.415284383563661
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42109,-0.00401598732228791,0.00493833006056445,-0.0136951142409942,0.0056631395964184,0.41610245105002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39719,0.00428124020184089,0.00527494408001665,-0.00605765019499174,0.0146201305986735,0.417029144311911
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39706,0.0043548460631857,0.00536571054908417,-0.00616194661301928,0.0148716387393907,0.417035782971966
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40080,0.00735561094521514,0.00907669739894213,-0.0104347159567114,0.0251459378471417,0.417737187646941
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,42186,0.00574022309426477,0.00708983296667915,-0.00815584952042636,0.0196362957089559,0.418161069246156
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,39665,0.00340647356268498,0.00420800158996034,-0.00484120955363729,0.0116541566790073,0.418232842834841
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39784,-0.00320680010439605,0.0039647829200459,-0.010977774627686,0.00456417441889391,0.418636224542587
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,39784,0.00716888349944949,0.00886674962672101,-0.0102099457689237,0.0245477127678227,0.41881341249651
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39665,0.00320695083136919,0.00397356969186232,-0.00458124576468096,0.0109951474274193,0.419644205046478
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39881,0.00236866214814742,0.00293604546563811,-0.00338598696450327,0.00812331126079812,0.419827018035827
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",40054,0.0036699823940576,0.0045660562594256,-0.00527948787441657,0.0126194526625318,0.421557106919291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41861,0.00424353499409186,0.00527976223393421,-0.00610479898441919,0.0145918689726029,0.42156453896617
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,41741,-0.00680831342826126,0.00847670246626669,-0.023422650262144,0.00980602340562146,0.421886221994871
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42197,-0.00354866259452144,0.00442065694753993,-0.0122131502116997,0.00511582502265682,0.422136504265257
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40021,-0.00176396668560733,0.00219864211792413,-0.00607330523673862,0.00254537186552397,0.422398073816298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,42274,-0.00251951745138871,0.00314872039506015,-0.00869100942570662,0.00365197452292919,0.423625764119528
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39719,0.00310208963460636,0.00388303448984087,-0.00450865796548175,0.0107128372346945,0.424376374679903
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39804,0.00590633070856718,0.00740865171074266,-0.00861462664448844,0.0204272880616228,0.42534068978884
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,40054,-0.00228955243853993,0.00288000743084224,-0.00793436700299072,0.00335526212591085,0.42664167506312
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,39719,0.00424874665086558,0.00534472361291931,-0.00622691163045627,0.0147244049321874,0.42666501725276
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41861,-0.00892368359065012,0.0112414749426539,-0.0309569744782518,0.0131096072969515,0.427316343303409
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,42204,0.0124982116078264,0.0157524971958645,-0.018376682896068,0.0433731061117208,0.427552612643484
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,42213,0.0036294076038839,0.00457802052387932,-0.00534351262291958,0.0126023278306874,0.42791479411484
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39998,-0.00242867444172233,0.00307436280454681,-0.00845442553863408,0.00359707665518942,0.429558816305663
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39784,-0.00778904577328702,0.00986079882820378,-0.0271162114765664,0.0115381199299924,0.429603811311207
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,42213,-0.00244410454917872,0.00309707299181928,-0.00851436761314451,0.00362615851478707,0.430029391457392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41876,0.00395322234618927,0.0050095223550194,-0.00586544146964876,0.0137718861620273,0.43004401914853
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41876,-0.00223688209321634,0.00284106004824076,-0.00780535978776823,0.00333159560133555,0.431097187630036
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39784,-0.00379466923332934,0.00482006403282217,-0.0132419947376608,0.00565265627100211,0.431144187465944
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,40054,0.00290146605657867,0.00369238612248133,-0.00433561074348474,0.0101385428566421,0.432003549392479
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,40080,-0.00255341500326858,0.00325376473506018,-0.00893079388398653,0.00382396387744937,0.432613069544552
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39719,-0.00626935784570871,0.00799681089709073,-0.0219431072040065,0.00940439151258911,0.433068164850605
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39706,0.00317137978693852,0.00404583411229771,-0.004758455073165,0.011101214647042,0.433138146004492
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42223,-0.004823341246761,0.00615543184405595,-0.0168879876611107,0.00724130516758866,0.433294358193376
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,40020,-0.00414192981712595,0.00530930787348734,-0.0145481732491611,0.00626431361490924,0.435333691369334
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40054,-0.00629596968370317,0.00807219002157803,-0.0221174621259961,0.00952552275858977,0.435432558573732
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42186,0.00779344445323572,0.00999955056865813,-0.0118056746613342,0.0273925635678056,0.435770408288035
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,42074,0.00575589744860708,0.00741172168043937,-0.00877107704505409,0.0202828719422683,0.437412694205112
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,41829,-0.00568241971518627,0.00731787591194257,-0.0200254565025937,0.00866061707222116,0.437461172808872
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40054,0.00845021565089323,0.0109078236891356,-0.0129291187798126,0.029829550081599,0.43853790043855
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,40097,-0.00236208701897287,0.00306200552565974,-0.00836361784926595,0.00363944381132022,0.440475764436883
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,40113,0.00123529128822853,0.00160176197257357,-0.00190416217801566,0.00437474475447272,0.440600474004081
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39881,-0.00515525462903814,0.00668640400181413,-0.0182606064725938,0.00795009721451756,0.440720684075267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,40021,0.00495389283607643,0.00643292253081094,-0.00765463532431302,0.0175624209964659,0.441266672350566
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39768,0.00498485974460501,0.00648830409880406,-0.00773221628905095,0.017701935778261,0.442335679567702
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39706,-0.00461905033552027,0.00601756239502645,-0.0164134726297721,0.00717537195873158,0.442745121024621
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39665,0.00518114102052577,0.0067546770400368,-0.00805802597794635,0.0184203080189979,0.44307207493817
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41887,-0.00434823807804222,0.00568816187380587,-0.0154970353507017,0.0068005591946173,0.44462142488843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39784,-0.00485348616837903,0.00635157013231961,-0.0173025636277255,0.0075955912909674,0.444801089332697
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,40054,-0.00303113202287107,0.00397226625209128,-0.01081677387697,0.00475450983122784,0.445436001264397
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,42186,0.00627140756419663,0.00822272858915894,-0.00984514047055489,0.0223879555989481,0.445661076617311
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,42180,0.0029617137668915,0.00388622615346583,-0.00465528949390153,0.0105787170276845,0.446010967461967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,39706,-0.00461145116426202,0.00605938217127459,-0.0164878402199602,0.00726493789143618,0.446648378499646
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39706,-0.00372182692559764,0.00489816541481423,-0.0133222311386335,0.00587857728743826,0.447366669693292
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,42096,0.00523804675029768,0.00689455660291775,-0.00827528419142111,0.0187513776920165,0.447425948828535
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,41829,0.00563243404760841,0.00741778407190362,-0.00890642273332269,0.0201712908285395,0.44767836574831
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39719,0.00933753834268921,0.0122993474424665,-0.0147691826445452,0.0334442593299236,0.447756066879144
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,39784,-0.00336048873538715,0.00443863845828948,-0.0120602201136345,0.00533924264286022,0.449007397440615
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40080,0.00694502657525378,0.00918359577598592,-0.0110548211456786,0.0249448742961862,0.449520105432719
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39881,0.00338786688464688,0.00448019070758813,-0.00539330690222585,0.0121690406715196,0.449553096248676
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42213,-0.00445194167679843,0.00589053511389974,-0.0159973905000419,0.00709350714644505,0.44979549127847
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,42151,-0.00391381097407893,0.0051850980645776,-0.014076603180651,0.00624898123249316,0.45037126031248
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39706,-0.00373913115336463,0.00495511000486583,-0.0134511467629017,0.0059728844561724,0.450505304868512
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41887,0.00708525121139503,0.00938974226859975,-0.0113186436350605,0.0254891460578505,0.450518894591888
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,39665,0.00409685081165365,0.00542959321344435,-0.00654515188669727,0.0147388535100046,0.450541391650025
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39768,-0.00385555451288044,0.00511299696908455,-0.0138770285722861,0.00616591954652527,0.450824347059209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42181,-0.00442662080825968,0.0058846185680556,-0.0159604732016487,0.0071072315851293,0.451922895938396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,42103,-0.00299042795068415,0.00398169888823115,-0.0107945577716172,0.00481370187024891,0.452640336307291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,42063,0.00189123203696588,0.00251998896322751,-0.00304794633096004,0.0068304104048918,0.452972046793661
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41876,0.00272911479924346,0.00364180003361816,-0.00440881326664812,0.00986704286513505,0.45363834764025
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39881,-0.00533130180451501,0.00712014437037899,-0.0192867847704578,0.0086241811614278,0.45401644597747
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40020,0.00501677907441654,0.00673341752590106,-0.00818071927634954,0.0182142774251826,0.456253506943359
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39719,-0.00434061990167719,0.00582729695866851,-0.0157621219406675,0.00708088213731309,0.456362668157168
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39706,-0.00405070177590924,0.00545834909721336,-0.0147490660064474,0.00664766245462894,0.45803656990004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42120,0.00576581089168812,0.00779271465896161,-0.00950790983987665,0.0210395316232529,0.45937556695663
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,42074,0.00289037264189571,0.00391019145941827,-0.0047736026185641,0.0105543479023555,0.459805379664503
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39706,0.00293924623955304,0.00398164089800619,-0.0048647699205391,0.0107432623996452,0.460409565713927
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41828,-0.00588341052756187,0.00798753999176498,-0.0215389889114212,0.00977216785629749,0.461395413404011
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,42103,-0.00232979624571556,0.00316522309028121,-0.00853363350266673,0.0038740410112356,0.461707147524207
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,42094,0.00671056134476056,0.00913821649079983,-0.0112003429772071,0.0246214656667282,0.462754662416763
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,42094,-0.00248881979051628,0.00339854827859111,-0.00914997441655486,0.00417233483552229,0.463987492509413
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39784,0.00215278205873785,0.00295972703138201,-0.00364828292277089,0.00795384704024659,0.467022564158396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41876,-0.00579752841895078,0.00799925262197216,-0.0214760635580162,0.00988100672011466,0.468613410289492
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,39665,0.00494728835450433,0.00682778572631563,-0.00843517166907431,0.018329748378083,0.468724899786481
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39719,0.00429352397580475,0.0059464342317957,-0.00736148711851482,0.0159485350701243,0.470289999272819
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,39665,-0.00300064536756767,0.00415675991796858,-0.0111478948067861,0.00514660407165074,0.47038977428555
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,42059,-0.00273790490189226,0.00379334626069433,-0.0101728635728531,0.00469705376906862,0.470452034088596
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,42120,0.00665651742214925,0.00923705573601034,-0.011448111820431,0.0247611466647295,0.471149026969065
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,42094,0.00219746237662375,0.00305996606545315,-0.00380007111166442,0.00819499586491191,0.472688336867489
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42103,-0.00425859055264773,0.00595582738471844,-0.0159320122266959,0.00741483112140041,0.474603924675593
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40080,0.00233632247817801,0.00327833275517583,-0.00408920972196661,0.00876185467832263,0.476074118747265
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,41887,-0.00378793051734575,0.00531582579565689,-0.0142069490768333,0.00663108804214175,0.476121191605766
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39706,-0.00436980070211017,0.00614311369468359,-0.01641030354369,0.00767070213946967,0.476893568560428
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,41783,-0.00224357500519932,0.00315468338046434,-0.00842675443090942,0.00393960442051079,0.47698051933355
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,40020,-0.0032341894288434,0.00454957718501098,-0.0121513607114649,0.00568298185377811,0.47717582212392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,41974,-0.00491051280014947,0.00692528166148453,-0.0184840648566591,0.00866303925636021,0.478293674591123
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41984,0.00294056876969968,0.00415091553211118,-0.00519522567323824,0.0110763632126376,0.47870079823407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,42103,-0.00567247860693652,0.00800954044595314,-0.0213711778810047,0.0100262206671316,0.478824390942087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,42103,0.00448260940182675,0.00633066733016792,-0.00792549856530237,0.0168907173689559,0.478909297149744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41829,-0.00485651419104796,0.00686102187634673,-0.0183041170686876,0.00859108868659163,0.479056913329704
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,42256,-0.00447386526502984,0.00632229453891487,-0.016865562561303,0.00791783203124331,0.479185720053823
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,41965,0.00298555949535904,0.00421920006033729,-0.00528407262290205,0.0112551916136201,0.479198724088957
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,39784,0.00890802374752642,0.0126109991581533,-0.015809534602454,0.0336255820975068,0.47997399313865
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,42256,-0.00541175918454126,0.00766455569916732,-0.0204342883549092,0.00961076998582668,0.480153440071238
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40020,0.00771820250988165,0.0109396187496319,-0.0137234502393969,0.0291598552591602,0.48049716794106
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,41829,0.00501513801615386,0.00710970947085552,-0.00891989254672296,0.0189501685790307,0.480578814560372
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,40080,0.00212797188249649,0.00302512335682896,-0.00380126989688827,0.00805721366188125,0.481800932715113
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41861,-0.00413522771158102,0.00588804545590173,-0.0156757968051484,0.00740534138198637,0.482499344713916
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,40031,0.00656997062795675,0.00935985938147704,-0.0117753537597382,0.0249152950156517,0.482737591298489
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,42120,-0.00451070877989239,0.00645026553556374,-0.0171532292295973,0.00813181166981254,0.484373460448143
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39804,-0.00237733371796348,0.00339990062496101,-0.00904113894288705,0.00428647150696009,0.484419736148291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39881,0.00215371260865284,0.00309941205034393,-0.00392113501002126,0.00822856022732694,0.487146996784146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39706,0.00368725175885967,0.00530708081694413,-0.00671462664235083,0.0140891301600702,0.487208758221802
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41887,0.00404852045965541,0.00583260602521058,-0.00738338734975732,0.0154804282690681,0.487620524001777
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,42155,0.00250272964121662,0.00360592352944746,-0.00456488047650041,0.00957033975893365,0.487656611674391
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,39768,-0.00421346219910119,0.00608084414382854,-0.0161319167210051,0.00770499232280275,0.488382852815322
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,40020,-0.00775805059108942,0.0112343071725561,-0.0297772926492993,0.0142611914671205,0.489852004592525
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,42094,-0.013570783010471,0.019679985883371,-0.052143555341878,0.0250019893209361,0.490475279723154
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,40102,0.00176071139778565,0.00256212006251153,-0.00326104392473696,0.00678246672030826,0.491965783445237
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,39653,0.003095882206149,0.00451109898000738,-0.00574587179466547,0.0119376362069635,0.492551045042386
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,39768,-0.00427205683211007,0.00622750754264204,-0.0164779716156885,0.00793385795146832,0.492729499862851
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42103,0.00343024272700119,0.00500076851505392,-0.00637126356250449,0.0132317490165069,0.49276130007073
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40544,0.00222896057383645,0.00325414936860657,-0.00414917218863242,0.00860709333630532,0.493383455750161
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,42213,0.00917478883871629,0.0133961942235704,-0.0170817518394818,0.0354313295169143,0.493431682817642
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,42120,0.00313113690550713,0.00457831799376572,-0.00584236636227368,0.0121046401732879,0.494047093895994
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41876,0.0023314476900125,0.00340945129706577,-0.00435107685223642,0.00901397223226142,0.494101940140783
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41861,-0.00540730724443248,0.00791370549534239,-0.0209181700153036,0.0101035555264386,0.494439987592055
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,39665,0.00431371705071012,0.00632850924047951,-0.00809016106062972,0.01671759516205,0.495486486830127
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39719,0.00522558550510688,0.00767279423650361,-0.00981309119844019,0.0202642622086539,0.495852445699688
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,42120,0.00513543090946865,0.00755228705925833,-0.00966705172667767,0.019937913545615,0.496527059195395
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,39768,-0.00476811841802979,0.00703515673533321,-0.0185570256192829,0.0090207887832233,0.49794135706634
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40054,-0.0027547243315975,0.00406766696763205,-0.0107273515881563,0.00521790292496132,0.498277856746034
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,39959,0.00218012100352583,0.00322148722533411,-0.00413399395812903,0.00849423596518069,0.498583160994181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,39719,0.00657753797593939,0.00973735786407141,-0.0125076834376406,0.0256627593895194,0.49937607415705
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,42237,-0.00474804043572389,0.00706347048534231,-0.0185924425869948,0.00909636171554704,0.501470488889817
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42186,0.00572692762274864,0.00852895095726292,-0.0109898162534867,0.022443671498984,0.501933631487772
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40097,0.00185242863581525,0.00276022286420532,-0.00355760817802718,0.00726246544965768,0.502161103956467
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39706,0.00265506875357822,0.00397109325624357,-0.00512827402865917,0.0104384115358156,0.50376602814099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39768,0.00355417971594664,0.00531938494807661,-0.00687181478228351,0.0139801742141768,0.504048512666765
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40020,0.00319438926579786,0.00478449711499946,-0.00618322507960108,0.0125720036111968,0.504368627200823
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,39768,-0.00275381513595882,0.00413020515699188,-0.0108490172436629,0.00534138697174526,0.504946251919935
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,40080,0.0043364633792838,0.00652394026334621,-0.00845045953687478,0.0171233862954424,0.506256445736022
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,42126,-0.00190745409005365,0.00287339498805031,-0.00753930826663226,0.00372440008652496,0.506809108799498
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,40054,0.00510453804454417,0.00769310177456971,-0.00997394143361247,0.0201830175227008,0.507010730736558
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,40102,-0.00162126473466464,0.00244891925822991,-0.00642114648079526,0.00317861701146597,0.507964222955513
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42120,0.00249406007419592,0.00377222629832827,-0.00489950347052749,0.00988762361891933,0.508518955664022
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,39665,0.00489177952340454,0.0074164141022488,-0.00964439211700311,0.0194279511638122,0.509532609368898
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,41861,0.00214750642663818,0.00326304064016505,-0.00424805322808532,0.00854306608136169,0.510466267079704
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39665,-0.00436326010637203,0.00665798506282068,-0.0174129108295006,0.00868639061675651,0.512261705671909
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,42120,0.00226130278937333,0.00345109564823214,-0.00450284468116166,0.00902545025990831,0.512323622180045
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,41829,-0.00304373087657729,0.00464948824582601,-0.0121567278383963,0.00606926608524168,0.512712880364111
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,40097,0.00287150043297742,0.00439845143427894,-0.00574946437820931,0.0114924652441641,0.51387094080004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,41829,0.00355505067964533,0.00546417100608998,-0.00715472449229104,0.0142648258515817,0.51530934974452
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,42144,-0.00280981039288744,0.00432301076803557,-0.0112829114982372,0.00566329071246228,0.515725656973253
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42103,-0.00472424097064473,0.00727364083860204,-0.0189805770143047,0.00953209507301526,0.516025803529773
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39881,-0.00571382693403207,0.00883089408580734,-0.0230223793422145,0.0115947254741503,0.517628363724021
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,42213,0.00843343267827488,0.0130393583292666,-0.0171237096470876,0.0339905750036373,0.517793856711568
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,39804,-0.00191815683111582,0.00296955694810911,-0.00773848844940968,0.00390217478717804,0.518331918032934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42079,0.00582662987776103,0.00904195514604388,-0.011895602208485,0.023548861964007,0.5193279872145
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,39518,0.00457888425865426,0.00712162869106595,-0.00937950797583501,0.0185372764931435,0.520267808034838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,42163,0.00209053903191736,0.0032519669295467,-0.00428331614999417,0.0084643942138289,0.520330387776169
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,41829,0.00362862203481019,0.00566291084650868,-0.00747068322434682,0.0147279272939672,0.521683902567153
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,41829,0.00472888438242364,0.00738476774595427,-0.00974526039964673,0.019203029164494,0.521952437359807
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,40021,-0.00224908870443963,0.00351408196203024,-0.0091366893500189,0.00463851194113964,0.522172036031744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,39831,0.00557077151956287,0.00870516473492948,-0.0114913513608989,0.0226328944000246,0.522226256819511
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41887,-0.00191774954595449,0.00300535266297074,-0.00780824076537714,0.00397274167346816,0.523412731843312
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,39719,0.0029880842130945,0.00468308085872455,-0.00619075427000563,0.0121669226961946,0.523448833010455
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,40020,-0.00403901752666579,0.00633043560455616,-0.0164466713115959,0.00836863625826428,0.523466649296653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40054,-0.00211083613713754,0.00330941972912916,-0.00859729880623069,0.00437562653195561,0.523599969688417
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42171,0.00773699999792127,0.0121308078229469,-0.0160393833350547,0.0315133833308973,0.523616701642885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41829,0.00197066713333859,0.00309432106207951,-0.00409420214833726,0.00803553641501444,0.524223825782532
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,42072,-0.0023430879495708,0.00367948807247362,-0.0095548845716191,0.00486870867247751,0.524268225273719
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,40054,0.00221742961313726,0.00348819558710044,-0.00461943373757961,0.00905429296385413,0.524988421734807
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,39881,0.00353982870786,0.00557054991163541,-0.00737844911894541,0.0144581065346654,0.525145907903937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,40113,-0.00205571421666958,0.00324584214808816,-0.00841756482692237,0.00430613639358322,0.526526400635977
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,39784,-0.00211363475387985,0.00333913225154223,-0.00865833396690262,0.00443106445914292,0.526754343905104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,41887,0.00607767554628502,0.00962346869564568,-0.0127843230971805,0.0249396741897506,0.527694113748569
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39784,0.00300425470519992,0.00475747626225206,-0.00632039876881412,0.012328908179214,0.527739858165658
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39719,0.00476307998507643,0.00755285454569339,-0.0100405149244826,0.0195666748946355,0.528294151420703
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39706,0.00391962338576856,0.00623683383723809,-0.0083045709352181,0.0161438177067552,0.529713903188347
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39784,-0.00132033514740284,0.00210402548605466,-0.00544422510006998,0.00280355480526429,0.530326642621552
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39690,0.00348387301748451,0.00556136539569703,-0.00741640315808167,0.0143841491930507,0.531038673598754
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,39601,0.00515979539519422,0.00824241621242009,-0.0109953403811492,0.0213149311715376,0.531325260500961
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39706,-0.00307677684837774,0.00494384268848239,-0.0127667085178032,0.00661315482104774,0.533728393632768
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,41876,0.0067587174274971,0.0108733126133653,-0.0145529752946988,0.0280704101496931,0.534224180962978
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41887,0.00249107682973913,0.00401076609813648,-0.00537002472260836,0.0103521783820866,0.534546621620867
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41876,-0.0035226303674444,0.00569537706337623,-0.0146855694116618,0.00764030867677301,0.536252317865926
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39719,0.00203051060735527,0.00330341886581768,-0.00444419036964738,0.00850521158435791,0.538786336547491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,40054,0.00727677094077283,0.0118410895983484,-0.0159317646719901,0.0304853065535358,0.538874338976008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,42120,0.00155079314693769,0.00252356417016462,-0.00339539262658497,0.00649697892046035,0.538879307061808
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,39706,-0.00703544897521665,0.0114502460433755,-0.0294779312202327,0.0154070332697994,0.538940227794387
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,39719,-0.0033890619335057,0.00553560782261973,-0.0142388532658404,0.00746072939882896,0.540399208976351
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,39784,0.00198837585072885,0.00325492632791787,-0.00439127975199017,0.00836803145344788,0.54129082385832
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,42144,-0.00242497359735554,0.00397132619372611,-0.0102087729370587,0.00535882574234763,0.541461495470219
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41887,-0.00376761087571219,0.00619035180314227,-0.015900700409871,0.00836547865844666,0.542783063210107
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41887,-0.00241927662920918,0.00398353251701762,-0.0102270003625637,0.00538844710414535,0.543649821577854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,42144,0.00785064265276551,0.0129843065081315,-0.0175985981031723,0.0332998834087033,0.545438460742921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,42120,0.00274859664944367,0.00455589362634986,-0.00618095485820205,0.0116781481570894,0.546315919219257
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39768,0.00335778918173193,0.00557306183107154,-0.00756541200716829,0.0142809903706321,0.546851963436275
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39665,-0.0048110699280787,0.0079859837483948,-0.0204635980749325,0.0108414582187751,0.546894846447802
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39784,-0.00216282013573401,0.00359347512241605,-0.00920603137566947,0.00488039110420145,0.547270732265104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39719,0.00211240538259199,0.00351533779634563,-0.00477765669824544,0.00900246746342941,0.547912162419732
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39706,0.00205401285120788,0.00342786213968399,-0.00466459694257274,0.00877262264498849,0.549045072334439
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,41887,0.00307398741635362,0.00513106372277932,-0.00698289748029386,0.0131308723130011,0.5491211640247
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,39863,0.002008299040531,0.00335717226257542,-0.00457175859411681,0.00858835667517882,0.549711520346827
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,40055,-0.00187345813639226,0.00313726407603209,-0.00802249572541516,0.00427557945263063,0.550410984683884
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,42094,0.00535611784317543,0.00898373434979223,-0.0122520014824173,0.0229642371687682,0.551050939918799
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41829,0.00217227548545979,0.0036464622592278,-0.0049747905426267,0.00931934151354628,0.551372051390322
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,41887,-0.00490594217800063,0.0082625975211866,-0.0211006333195264,0.0112887489635251,0.552687900348204
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41861,-0.00489790568928987,0.00825122224309943,-0.0210703012857648,0.011274489907185,0.552791888315099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,39784,-0.00344755956543645,0.00581493859370423,-0.0148448392090967,0.00794972007822384,0.553274264973646
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41861,-0.00241309010446075,0.00407420288011399,-0.0103985277494842,0.00557234754056267,0.553670190499745
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,41876,0.0043440688898475,0.00733938146034209,-0.010041118772423,0.018729256552118,0.553938232542401
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,42106,0.00247697550176508,0.0041849624185049,-0.00572555083850453,0.0106795018420347,0.553944519305797
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42186,0.00576207669675169,0.00976682314380137,-0.013380896665099,0.0249050500586024,0.55522486350364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39881,-0.00284588395463612,0.00483973855280206,-0.0123317715181282,0.00664000360885592,0.556528396416631
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39768,-0.00253927492918213,0.00431844552070129,-0.0110034281497567,0.0059248782913924,0.55654034857578
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,41861,-0.00258190741786727,0.00440597239269779,-0.0112176133075549,0.0060537984718204,0.557884797187301
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41829,0.00246245064021343,0.0042104224920585,-0.00578997744422124,0.0107148787246481,0.55866141258485
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,39768,0.00235357120074697,0.00402889772382929,-0.00554306833795844,0.0102502107394524,0.559116732346066
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39881,0.00433374090762715,0.00743465530073266,-0.0102381834818089,0.0189056652970632,0.559965645392957
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,42213,-0.00445969974338605,0.00770655222438209,-0.0195645421031749,0.0106451426164028,0.56280881008271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,41887,0.00277984479758432,0.00480723589705437,-0.00664233756064225,0.0122020271558109,0.56309708993572
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,39768,-0.001639391186243,0.00283613951038156,-0.00719822462659086,0.00391944225410485,0.563252016943219
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42094,-0.0018829500384168,0.00326630609200287,-0.00828490997874244,0.00451900990190883,0.564302931479428
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39706,-0.00404860568492305,0.00704614111875345,-0.0178590422776798,0.00976183090783371,0.565584420481272
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39784,-0.00367066592716981,0.00639608211009868,-0.0162069868629632,0.00886565500862361,0.566052485288726
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40097,-0.00831347178030139,0.0144959182535285,-0.0367254715572172,0.0200985279966145,0.566315101795426
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,42256,0.00160587177865214,0.00280566072368238,-0.00389322323976533,0.00710496679706961,0.567082212363859
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41887,-0.0066625819100564,0.0116426028678542,-0.0294820835310506,0.0161569197109378,0.567156794216359
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,39706,-0.0042735573756614,0.00746992612209758,-0.0189146125749727,0.0103674978236499,0.567265316432438
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,42094,0.0024562726735585,0.00430137016578749,-0.00597441285138497,0.010886958198502,0.567979599647766
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,40007,-0.00347571472280763,0.00609457090573126,-0.0154210736980409,0.00846964425242563,0.568488211640396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39784,-0.0037493657905024,0.00657900434687587,-0.0166442143103791,0.00914548272937431,0.568758519899868
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,39665,-0.00425508885657241,0.00746825641805802,-0.0188928714359661,0.0103826937228213,0.568854975338422
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42004,-0.00453945467713409,0.00797735489482859,-0.0201750702709981,0.0110961609167299,0.569337214953492
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39881,0.00329625998129528,0.00580678560178322,-0.00808503979819984,0.0146775597607904,0.570280113195007
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39881,0.0035704822650666,0.00629723432351561,-0.00877209700902399,0.0159130615391572,0.57073144077756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,42120,0.00211719423142887,0.00373921131804931,-0.00521165995194778,0.00944604841480551,0.571258064852727
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,40021,-0.00205533811726434,0.00363035272468522,-0.00917082945764736,0.00506015322311868,0.571300943401122
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39804,0.00162569952490264,0.0028725574618106,-0.00400451310024614,0.00725591215005142,0.5714455068007
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,40054,-0.00277786425989804,0.00491636748625046,-0.0124139445329489,0.00685821601315286,0.572069299731871
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39784,0.00184463502962469,0.00326521172962376,-0.00455517996043788,0.00824445001968726,0.572129392760945
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39768,-0.00321182036437639,0.00569197045021563,-0.014368082446799,0.00794444171804625,0.572580904909589
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39706,0.00251834400105559,0.0044807649884505,-0.0062639553763074,0.0113006433784186,0.5741045741967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39706,-0.0034640368379996,0.00617897044239521,-0.0155748189050942,0.00864674522909501,0.575070501466562
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41887,-0.00324606111890398,0.0057904184652822,-0.0145952813108571,0.00810315907304914,0.575085736374677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,39881,-0.0025459670144247,0.00454598516828694,-0.0114560979442671,0.00636416391541769,0.57545886946118
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",40061,0.00128465676017739,0.0022971348834223,-0.00321772761133032,0.00578704113168511,0.576007368739215
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39719,0.00320170302364893,0.00573758023732948,-0.00804395424151685,0.0144473602888147,0.5768403945634
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39706,-0.00222486346198382,0.00400192207034131,-0.0100686307198528,0.00561890379588514,0.578257741875321
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41861,-0.00368549373069179,0.00664552981229633,-0.0167107321627926,0.00933974470140901,0.579190136047147
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,42098,-0.00318321327538118,0.00574181885799119,-0.0144371782370439,0.00807075168628155,0.579320823045507
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42184,-0.00159108808674341,0.00287595487136074,-0.00722795963461047,0.00404578346112365,0.580109835813889
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39665,-0.00163193965727419,0.00295119705182543,-0.00741628587885203,0.00415240656430364,0.580291993512026
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41861,-0.00180719224976911,0.00327647463506992,-0.00822908253450615,0.00461469803496794,0.581255415311133
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41829,-0.00301775312926024,0.00547244575235009,-0.0137437468038664,0.00770824054534593,0.581338376305661
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39863,0.00336723727416606,0.00610951489406006,-0.00860741191819165,0.0153418864665238,0.58154484609981
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,39784,0.00148882645899285,0.00270523905482323,-0.00381344208846068,0.00679109500644637,0.582091414007066
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42262,-0.00188401169759486,0.00342369248650698,-0.00859444897114853,0.00482642557595881,0.582132299322398
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41829,0.00285567930620475,0.00519577515266555,-0.00732803999301972,0.0130393986054292,0.582592740586513
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,42178,0.00342658785189165,0.00627498682540333,-0.00887238632589887,0.0157255620296822,0.585026567875121
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42223,0.00148605656158376,0.00272908226254485,-0.00386294467300414,0.00683505779617165,0.586088801722917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42213,-0.00288303577569849,0.00529799534017804,-0.0132671066424474,0.00750103509105047,0.586330481775834
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39922,0.00237377389887974,0.00436673447866208,-0.00618502567929794,0.0109325734770574,0.586725370078017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,41829,0.0021728823837277,0.00400415378801376,-0.00567525904077928,0.0100210238082347,0.58737550512022
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39804,-0.00140671323621171,0.00261573633977094,-0.00653355646216275,0.00372012998973932,0.590734269023329
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42144,0.00251183146326329,0.00469280004885632,-0.00668605663249511,0.0117097195590217,0.592484678559672
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42105,0.00178306067540678,0.00333276535811496,-0.00474915942649853,0.0083152807773121,0.592652595859894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39768,0.00159499267554607,0.00298282606533377,-0.00425134641250811,0.00744133176360025,0.592851041177121
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,42213,-0.00342394708873788,0.0064036746003277,-0.0159751493053802,0.00912725512790441,0.592877006396192
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40054,0.00419281427865013,0.00784876474126622,-0.0111907646142317,0.0195763931715319,0.593213737774234
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,39665,0.00186226875434873,0.00348712575266399,-0.00497249772087269,0.00869703522957015,0.593324380065949
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41953,-0.0062629282928098,0.0117634948709715,-0.0293193782399139,0.0167935216542943,0.594455688341562
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39784,0.00432068505684336,0.00812424408542125,-0.0116028333505823,0.020244203464269,0.594857599149088
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39784,-0.00305180557436662,0.00579951341947624,-0.01441885187654,0.0083152407278068,0.598748101537321
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39784,-0.00294336238967172,0.00559985940286643,-0.0139190868192899,0.00803236203994647,0.59916769455441
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,40102,0.00146374909901066,0.00278883660647396,-0.00400237064967831,0.00692986884769963,0.599691105218068
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41829,0.0024585317871414,0.00468530688739906,-0.00672466971216076,0.0116417332864436,0.599778516861163
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39881,-0.00232618748294419,0.00443311216868567,-0.0110150873335681,0.00636271236767974,0.599781699400764
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42200,-0.00351281389533149,0.00671161566051681,-0.0166675805899444,0.00964195279928146,0.600709582996187
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39665,0.00226744686615009,0.00433597725306118,-0.00623106854984982,0.01076596228215,0.601028529439263
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40021,-0.00545964361705822,0.0104408797547605,-0.0259237679363888,0.0150044807022724,0.601047373301878
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,39784,0.00164673180017825,0.00316753981693945,-0.00456164624102307,0.00785510984137957,0.603160018764278
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,39999,-0.00283617721693476,0.00545682395495069,-0.0135315521686381,0.00785919773476859,0.603249378338009
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,40021,0.00277785480227919,0.00535155255861448,-0.00771118821260519,0.0132668978171636,0.603719356011967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39768,-0.00196075426029955,0.00377859383909105,-0.00936679818491801,0.00544528966431892,0.603833600998563
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41876,-0.00500640900478931,0.00965257089019384,-0.0239254479495692,0.0139126299399906,0.604006433677024
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,40038,-0.0034277446889987,0.00661471111455851,-0.0163925784735334,0.00953708909553599,0.604329160612046
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,39768,0.00123144194400274,0.00238026979771686,-0.00343388685952231,0.0058967707475278,0.604919932541425
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,40054,-0.00143711107878517,0.00278294263092146,-0.00689167863539123,0.0040174564778209,0.605585704649475
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39881,0.00207832565615967,0.00402906925389919,-0.00581865008148273,0.00997530139380208,0.605981935527285
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39706,0.00352468584737024,0.00683307418197089,-0.0098681395492927,0.0169175112440332,0.605985918857626
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40054,0.00124818180816612,0.0024204573775281,-0.00349591465178895,0.00599227826812119,0.606088322672894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42256,0.00252349781684124,0.00489517357387519,-0.00707104238795413,0.0121180380216366,0.606207279302435
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,39665,0.00200575408406105,0.00389147557491689,-0.00562153804277605,0.00963304621089815,0.606268691645834
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,42150,0.00492657636725191,0.00960856883668444,-0.0139062185526496,0.0237593712871534,0.608150772431286
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39719,0.00280240282774609,0.00546718023798071,-0.0079132704386961,0.0135180760941883,0.608251349561425
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,41876,-0.00358593342706157,0.00700869306023092,-0.0173229718251142,0.010151104970991,0.608911323257617
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,40021,0.00311036180746861,0.00610655152695993,-0.00885847918537284,0.0150792028003101,0.610518469320362
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40021,0.00747400885117902,0.014761786093954,-0.0214590918929708,0.0364071095953288,0.612650830353743
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42095,0.000976574973912441,0.00193878218835,-0.00282343811525355,0.00477658806307844,0.614477044198754
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41967,-0.00179275080113283,0.00356067438439713,-0.00877167259455121,0.00518617099228555,0.614631086682928
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39768,-0.00253134400466071,0.00503861272699075,-0.0124070249495626,0.00734433694024116,0.615404321872517
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42213,0.002429922792727,0.00484254167090553,-0.00706145888224784,0.0119213044677018,0.615826085851812
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39768,0.00235354930665916,0.00470415869388838,-0.00686660173336207,0.0115737003466804,0.616865479398896
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,42150,-0.00348169469102069,0.00695971315349685,-0.0171227324718745,0.0101593430898331,0.616897620268315
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42095,-0.00214242030575079,0.00430218191454077,-0.0105746968582507,0.00628985624674912,0.618503390692865
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,42004,0.00407166985467168,0.00818218956512626,-0.0119654216929758,0.0201087614023192,0.618756251521793
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,42144,0.00181880859087249,0.00366992606488118,-0.00537424649629461,0.0090118636780396,0.620186363757771
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,39784,-0.00298370320544902,0.00602066007882887,-0.0147841969599536,0.00881679054905557,0.620202868436082
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39804,-0.0136506429109966,0.0276115408255033,-0.0677692629289832,0.0404679771069899,0.621046809305193
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,40054,0.00242811877978549,0.00493185549334894,-0.00723831798717843,0.0120945555467494,0.622493395949212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40020,0.00384407351479869,0.00780944847884575,-0.011462445503739,0.0191505925333364,0.62256414332333
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41861,0.00154449755451684,0.00314345657591335,-0.00461667733427332,0.007705672443307,0.623196395615661
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41887,0.00331326476863894,0.00674821161656684,-0.00991322999983207,0.0165397595371099,0.6234461647903
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39646,0.00132760908751457,0.00271217542989535,-0.00398825475508031,0.00664347293010946,0.624498232125858
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42144,-0.00174080320664262,0.00356713161386334,-0.00873238116981476,0.00525077475652951,0.625549569047892
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,40054,-0.00331390065549145,0.00680856471722088,-0.0166586875012444,0.0100308861902615,0.626462841139101
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39784,0.0021457049268569,0.00441059946329232,-0.00649907002119604,0.0107904798749098,0.626631083366964
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39719,0.00200743367717162,0.00414482798096153,-0.00611642916551298,0.0101312965198562,0.628167049079975
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41984,-0.00132560588908905,0.00274825149811794,-0.0067121788254002,0.00406096704722211,0.629569005004944
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41887,0.00219350028543203,0.00459237091851031,-0.00680754671484819,0.0111945472857122,0.632914643345443
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,40054,-0.00177126860360976,0.003731183626606,-0.00908438851175751,0.00554185130453799,0.634995893889939
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,40021,-0.00143637405777379,0.00303625085366955,-0.00738742573096612,0.00451467761541853,0.636169282974282
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",40054,0.0017808051257055,0.00377687942060059,-0.00562187853867166,0.00918348879008266,0.637291966821288
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39706,0.00422716328013969,0.00898438186639522,-0.0133822251779949,0.0218365517382743,0.638006672772204
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,40080,0.00177257648067928,0.00377235317932222,-0.00562123575079228,0.00916638871215084,0.638445778156662
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,40054,-0.00358498746187209,0.0076398750370135,-0.0185591425344186,0.0113891676106744,0.63890260589913
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41861,0.00216879439016237,0.00462694994621747,-0.00690002750442386,0.0112376162847486,0.639270066820101
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42208,-0.0014131458753177,0.00301525993696931,-0.00732305535177754,0.00449676360114214,0.639317176951071
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,40102,0.00223887643921812,0.00478258158419388,-0.00713498346580189,0.0116127363442381,0.639700004923904
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,40054,-0.00201237866132002,0.00430565834754884,-0.0104514690225158,0.00642671169987571,0.640237396127994
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,39784,0.00142237203172758,0.00306011850721559,-0.00457546024241497,0.00742020430587013,0.642077468736617
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39719,-0.00288245359571603,0.00622594306436845,-0.0150853020018782,0.00932039481044613,0.643392134664471
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,42103,0.00277927054631542,0.0060479568535091,-0.0090747248865624,0.0146332659791933,0.645855068747587
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39706,0.00324839315310736,0.00711618286482887,-0.0106993252619572,0.017196111568172,0.648054482843126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39768,0.00313690616818,0.00690170064958542,-0.0103904271050074,0.0166642394413674,0.649469644855734
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39784,0.00351455326364985,0.0077580169958731,-0.0116911600482614,0.0187202665755611,0.650542098606586
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,42213,-0.00138905416085244,0.00310837274982508,-0.00748146475050959,0.00470335642880471,0.654972728473463
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,42103,-0.00161856896220014,0.00362644199944375,-0.00872639528110989,0.00548925735670962,0.65537053676113
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,41829,0.00215911871193232,0.00485843261996879,-0.00736340922320651,0.0116816466470712,0.656756374554174
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39784,-0.00278061388121564,0.00625938236047299,-0.0150490033077427,0.00948777554531142,0.656884405319372
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,40020,-0.00244615239323001,0.00550820820538026,-0.0132422404757753,0.00834993568931531,0.656984789526008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39719,0.00146990988114189,0.0033147552814497,-0.00502701047049951,0.00796683023278329,0.65745339513643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39768,-0.00275244786037526,0.00624878438207561,-0.0150000652492435,0.00949516952849294,0.659600432021263
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,39768,0.00579735369792759,0.0131951357026631,-0.0200651122792922,0.0316598196751474,0.660413039368091
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,42094,-0.00246504106163227,0.00561820031942293,-0.0134767136877012,0.00854663156443666,0.660842860531534
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39881,0.00357510447011711,0.00816017487765522,-0.0124188382900871,0.0195690472303213,0.661310936478433
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,41887,-0.00128276349318482,0.00294220302001689,-0.00704948141241792,0.00448395442604828,0.66285327408273
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,42256,-0.00209732530754007,0.00481761061822909,-0.0115398421192691,0.00734519150418895,0.663318825481678
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,39706,0.00295773479851403,0.00680911482190243,-0.0103881302524147,0.0163035998494428,0.664022340459998
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41861,-0.00158155408221251,0.00364719308888173,-0.0087300525364207,0.00556694437199569,0.664560200742705
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,42197,-0.00143167494166738,0.00331267755403746,-0.00792452294758079,0.00506117306424604,0.665617331505185
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,41887,-0.00346788422735907,0.0080306950145008,-0.0192080464557806,0.0122722780010625,0.66587328614976
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41887,0.00168911204006477,0.00392075167952891,-0.0059955612518119,0.00937378533194143,0.666611430429363
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39863,-0.0013178125867959,0.00306009764411472,-0.00731560396926074,0.00467997879566895,0.666735966722328
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41829,0.00214229294823098,0.00498928545430428,-0.0076367065422054,0.0119212924386674,0.667654966718549
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41876,0.00154649311512132,0.00360190808355073,-0.00551324672863811,0.00860623295888076,0.667673024852448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39665,0.00275707875209888,0.00643962074619987,-0.00986457791045287,0.0153787354146506,0.668555794572292
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,40054,-0.00174336197116433,0.00407684280096193,-0.00973397386104972,0.00624724991872105,0.668932271003958
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39881,0.00274180994605613,0.00643873251745894,-0.00987810578816338,0.0153617256802756,0.670239793523619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40021,-0.00198416622174967,0.00468456361383789,-0.0111659109048719,0.00719757846137259,0.671899434432031
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42004,0.0019729627754436,0.00465885762409175,-0.00715839816777623,0.0111043237186634,0.671947539573926
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42213,-0.00408144671057885,0.00972218680889322,-0.0231369328560096,0.0149740394348519,0.674633030108304
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40021,0.00218618479133172,0.00521791452517066,-0.00804092767800278,0.0124132972606662,0.675241446656837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41829,-0.00311541136137233,0.00744958308276242,-0.0177165942035867,0.011485771480842,0.675808423468593
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,42088,-0.00469824157222275,0.0112609034630429,-0.0267696123597868,0.0173731292153413,0.676526559183504
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39784,-0.00205847208416835,0.0049983302589171,-0.0118551993916459,0.00773825522330916,0.680470938493107
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,40021,-0.00254694370059804,0.00619368340610725,-0.0146865631765682,0.00959267577537216,0.680922061046466
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41963,0.000917391712695191,0.00223751634153885,-0.00346814031672096,0.00530292374211134,0.681809543286498
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,42003,0.00149045548321068,0.0036383649473251,-0.00564073981354652,0.00862165077996788,0.682069708041848
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39767,0.00348632581424106,0.00852407780743294,-0.0132208666883275,0.0201935183168096,0.682549840102598
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,40054,0.0018971905247561,0.00464199949229655,-0.00720112848014515,0.0109955095296573,0.682767049364433
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,39881,0.00246041686784328,0.00603144466448018,-0.00936121467453788,0.0142820484102244,0.683332064802885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39986,-0.00179849540949588,0.00441652689003522,-0.0104548881139649,0.00685789729497315,0.683854934244384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,40080,-0.00221966083521096,0.0054508450032148,-0.012903317041512,0.00846399537109005,0.683858767665333
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,40020,-0.00187712730026198,0.00465016749612865,-0.0109914555926741,0.00723720099215017,0.686464295216025
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,42120,0.00191327784081781,0.00475817742898645,-0.00741274991999563,0.0112393056016312,0.687614808293908
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,40021,0.00312194669992823,0.00776835852435869,-0.0121040360078148,0.0183479294076713,0.687780390893558
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39881,0.0026463178253231,0.00660781031199454,-0.0103049903861862,0.0155976260368324,0.688808570342629
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,40097,-0.00113686827743048,0.00283896262543322,-0.0067012350232796,0.00442749846841863,0.688831472521785
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,42213,-0.00245160351346598,0.00612279725448508,-0.0144522861322567,0.00954907910532478,0.688864225310143
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,42083,0.00181315543671679,0.00454480758056136,-0.00709466742118348,0.0107209782946171,0.689935933826482
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,39784,0.00135678979361438,0.0034254805075986,-0.00535715200127889,0.00807073158850764,0.692048505910848
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,40054,-0.00391242603596737,0.0098941538170309,-0.0233049675173479,0.0154801154454132,0.692534771980077
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39665,0.00104973320432085,0.00266202379450888,-0.00416783343291655,0.00626729984155826,0.693340633432857
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,39768,-0.00276030339485617,0.00700118389850183,-0.0164826238359197,0.0109620170462074,0.693395289155711
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,40020,0.00220507534359182,0.00562659501814571,-0.00882305089197378,0.0132332015791574,0.695138141889929
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,40080,-0.00110444925547168,0.00282234069776855,-0.00663623702309804,0.00442733851215469,0.695565523619212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,40021,-0.00109350848616183,0.00280346009693542,-0.00658829027615526,0.0044012733038316,0.696502268926181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42186,0.000957870250081705,0.00245782412879648,-0.00385946504235939,0.0057752055425228,0.696747878553917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,40054,-0.00114136837103425,0.00292893690252521,-0.00688208469998365,0.00459934795791516,0.696775718750189
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,39992,0.00180134706871329,0.00462770082070359,-0.00726894653986574,0.0108716406772923,0.697096573978246
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42162,0.00300000977497874,0.0077113355268757,-0.0121142078576976,0.0181142274076551,0.697253730933323
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,41861,-0.00350265433618645,0.00903811613081725,-0.0212173619525883,0.0142120532802154,0.698361121559308
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,39706,0.00155992738635507,0.00402527391762131,-0.00632960949218269,0.00944946426489283,0.698369338218432
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39768,-0.00331508385950192,0.00862299985003096,-0.0202161635655626,0.0135859958465588,0.700655122454983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,41887,-0.00202007204984353,0.00526835820034076,-0.0123460541225114,0.00830591002282436,0.701403801479474
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39784,0.00249208452462054,0.00652231804093458,-0.0102916588356112,0.0152758278848523,0.702405457237251
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41861,0.00259838293557305,0.00680961346835966,-0.0107484594624119,0.015945225333558,0.702782521520954
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,39863,0.0017390118847912,0.00458516005278547,-0.00724790181866831,0.0107259255882507,0.70449520928426
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42128,-0.0021959838468705,0.00580428104198821,-0.0135723746891674,0.00918040699542638,0.705185247071126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,40080,0.00138844487742314,0.00368211653707876,-0.00582850353525123,0.0086053932900975,0.706123043082937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,42120,-0.000992469316948046,0.00264230664659537,-0.00617139034427498,0.00418645171037888,0.707215124418877
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,40021,0.00214170183169665,0.00571240987180829,-0.0090546215170476,0.0133380251804409,0.707726640921021
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,39706,-0.00192544089639395,0.00514291409170364,-0.0120055525161331,0.00815467072334519,0.708123861111203
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39719,0.00197006217398659,0.00526351011696563,-0.00834641765526605,0.0122865420032392,0.708198517797972
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41834,-0.00110463593045946,0.00298052249959257,-0.00694646002966091,0.00473718816874198,0.710928123195369
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,39784,0.00147601461515761,0.00399274781797728,-0.00634977110807786,0.00930180033839308,0.71163288082036
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42213,0.00174571445445036,0.00472427841313509,-0.00751387123529442,0.0110053001441951,0.711746321217795
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,40080,0.00400096200494979,0.0108383767756068,-0.0172422564752395,0.0252441804851391,0.712024805804719
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39768,-0.0026575386553198,0.00721287043252466,-0.0167947647030681,0.0114796873924285,0.71254958837544
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,42103,0.00264464271490707,0.00719251540474769,-0.0114526874783984,0.0167419729082125,0.713107655022776
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39706,0.00151095378659903,0.00412136824397226,-0.00656692797158659,0.00958883554478465,0.713913891965291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,40021,0.00207169642206389,0.00565236736622321,-0.00900694361573359,0.0131503364598614,0.713985476373267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,41861,-0.00247924078406279,0.00678932248597663,-0.015786312856577,0.0108278312884514,0.714992378511766
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,39665,0.00295134477159335,0.00809269592221378,-0.0129103392359457,0.0188130287791324,0.715348390450834
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,40054,0.00501404534754276,0.0137597919190956,-0.0219551468138846,0.0319832375089701,0.715567668861945
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,39768,0.00298987183702936,0.00820698176730337,-0.0130958124268853,0.019075556100944,0.715635063476107
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41829,0.00217874832888282,0.00598096179962657,-0.00954393679838526,0.0139014334561509,0.715654583951342
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40021,-0.00132002623937542,0.00362562716758556,-0.00842625548784313,0.00578620300909228,0.7158037535667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42186,-0.00166777861916844,0.00458964281883502,-0.0106634785440851,0.00732792130574821,0.716327894052914
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40054,-0.00242915528133347,0.0066901558068033,-0.0155418606626679,0.010683550100001,0.716541750155061
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41861,-0.00336079453373642,0.00927160684283117,-0.0215331439456855,0.0148115548782127,0.716997601952275
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39784,0.00334569603434789,0.00925730955321222,-0.0147986306899481,0.0214900227586438,0.717799231703343
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42103,-0.00226855191466897,0.00637503605624448,-0.0147636225849082,0.0102265187555702,0.721959265030402
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40021,0.00498808314231066,0.0140312857200243,-0.022513236868937,0.0324894031535583,0.722224048557193
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39804,-0.00191070773652915,0.00537581578565851,-0.0124473066764198,0.00862589120336153,0.722277116167804
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,42116,-0.00212118720551391,0.00599783598538005,-0.0138769457368588,0.00963457132583099,0.723600406032723
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,39784,0.000945931761579011,0.00267674402055313,-0.00430048651870513,0.00619235004186315,0.723803902272957
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,39784,0.00178504918733794,0.0050913375202641,-0.00819397235237969,0.0117640707270556,0.725891561169306
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42120,-0.00425657243458253,0.0121653591033941,-0.028100676277235,0.0195875314080699,0.726424797299837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,42184,0.0016342874530194,0.0046768316577133,-0.00753230259609867,0.0108008775021375,0.72676220106609
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42103,-0.00395514525118709,0.0113448406656698,-0.0261910329558999,0.0182807424535257,0.727373221442155
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,41876,0.00174133137714203,0.00499741684079184,-0.00805360563080997,0.011536268385094,0.727510824679922
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,40113,0.00111188529183112,0.00319414437741785,-0.00514863768790786,0.0073724082715701,0.727770940467381
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,41861,-0.00206581501803035,0.00594883573617867,-0.0137255330609405,0.00959390302487985,0.728398949259337
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,39651,0.0014578573060324,0.00420751618694234,-0.00678887442037458,0.00970458903243939,0.728982358601554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39784,-0.00224862084554288,0.00651411872258065,-0.015016293541801,0.0105190518507152,0.729956983553373
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39768,-0.00363586783804773,0.0105429929995806,-0.0243001341172258,0.0170283984411303,0.730205678396586
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42004,-0.00243921965558511,0.00708263038837004,-0.0163211752167904,0.0114427359056202,0.730555203113514
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39706,0.00337031162295993,0.00979496204657423,-0.0158278139883255,0.0225684372342454,0.730788316111677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39768,-0.00130426366172552,0.00380694632686974,-0.00876587846239021,0.00615735113893917,0.731905450938268
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42103,0.00332389648121139,0.00974701661010813,-0.0157802560746006,0.0224280490370233,0.73309647912162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39719,0.00252385967900051,0.00741152969543923,-0.0120027385240604,0.0170504578820614,0.733463065479965
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,42186,0.00213683457660693,0.0063281127432734,-0.0102662664002089,0.0145399355534228,0.735614869282326
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39881,0.00129693583902073,0.00389697069292215,-0.00634112671910668,0.00893499839714814,0.739287138542191
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,39665,-0.00161929741467865,0.00487098519866577,-0.0111664284040636,0.00792783357470625,0.739565693521987
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39719,0.00253396748122231,0.00764425374047854,-0.0124487698501156,0.0175167048125603,0.740283580736867
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39863,0.00107879056247402,0.0032630887776659,-0.00531686344175115,0.00747444456669918,0.740950032941113
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,39706,0.00129227659934761,0.00394291233098542,-0.00643583156938382,0.00902038476807904,0.743109699258506
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41887,0.00220618901593282,0.00677229924553655,-0.0110675175053188,0.0154798955371845,0.744606307747612
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42109,-0.000589422549800448,0.0018125971097254,-0.00414211288486224,0.00296326778526134,0.74504918438413
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,39665,-0.00221085226638301,0.00680659243719948,-0.015551773443294,0.011130068910528,0.745331033473528
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42172,0.00092383412024937,0.00286572672688038,-0.00469299026443618,0.00654065850493492,0.747175012269108
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,41829,0.00192405855948223,0.00601090295989929,-0.00985731124192038,0.0137054283608848,0.748901788251284
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,42197,-0.000978612461332608,0.00309422563362807,-0.00704329470324363,0.00508606978057842,0.751802234554569
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39719,0.00140031842969998,0.00442927578546729,-0.00728106210981591,0.0100816989692159,0.751894430952162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,40080,-0.00343104611255449,0.0108532869437766,-0.0247034885223566,0.0178413962972476,0.751910141703325
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39706,0.00185124184558622,0.00585953833576098,-0.00963345329250531,0.0133359369836777,0.752057003499808
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42120,-0.00139507922903652,0.00441826126054939,-0.0100548712997133,0.00726471284164027,0.75219509588271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39881,0.00143755272786732,0.00457488737970464,-0.00752922653635377,0.0104043319920884,0.753354838910217
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40020,-0.00120784686036068,0.00384801667654611,-0.00874995954639105,0.00633426582566969,0.753612033751423
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40021,-0.00241643507748382,0.00770154843000005,-0.0175114700002839,0.0126785998453163,0.753709643214072
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,40080,0.00104534502698743,0.00334144268201597,-0.00550388262976388,0.00759457268373874,0.754406375381917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,41829,0.00195712319064279,0.00626736963184526,-0.0103269212877739,0.0142411676690595,0.754839074839213
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,40102,0.00207867336307422,0.00667819319516347,-0.0110105852994462,0.0151679320255946,0.755606764505921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39706,-0.00129309606582069,0.00416351539186969,-0.00945358623388527,0.0068673941022439,0.756127651345824
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,42120,-0.00139919793795424,0.00450575845189033,-0.0102304845036593,0.00743208862775081,0.756158777259911
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39706,-0.00145186594009451,0.00467788654479285,-0.0106205235678885,0.00771679168769948,0.756287335818735
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39784,-0.000919107124797685,0.00297688438856939,-0.0067538005263937,0.00491558627679833,0.757519294976665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,40102,-0.00217452747249973,0.00705194014913087,-0.0159963301647962,0.0116472752197968,0.757815252130528
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,42120,-0.00162546847258902,0.00528827778781656,-0.0119904929367095,0.00873955599153144,0.758565196748663
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39706,-0.00111473196580293,0.00363744269866051,-0.00824411965517752,0.00601465572357167,0.75926023334782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39665,0.00114650277715069,0.00374816174177452,-0.00619989423672736,0.00849289979102874,0.759699035129756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41887,0.00109300108701593,0.00357563833665127,-0.00591525005282055,0.00810125222685241,0.759853323846271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,39719,0.00137151017214969,0.00449517021518108,-0.00743902344960524,0.0101820437939046,0.760290308044092
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,40054,-0.00330408095333869,0.0108447553703446,-0.0245598014792141,0.0179516395725367,0.760622682928693
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,39855,-0.00115929775698058,0.0038061991351395,-0.00861944806185399,0.00630085254789284,0.760690873955952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,39768,-0.00188977435728653,0.00621747186989347,-0.0140760192222777,0.0102964705077047,0.761175177402824
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41887,0.00112228673951579,0.00370502439167131,-0.00613956106815997,0.00838413454719156,0.761963866509756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39768,-0.00243654022323758,0.00808519561749207,-0.018283523633522,0.0134104431870469,0.763147269702109
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39863,0.00259066387355896,0.00860257619677494,-0.0142703854721199,0.0194517132192378,0.763306156512911
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,40054,-0.0028434977039184,0.00946425579141773,-0.0213934390550971,0.0157064436472604,0.763842738837125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39768,-0.00125665214058913,0.0041877385320357,-0.00946461966337909,0.00695131538220084,0.764122841448753
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,40054,-0.00149331742316418,0.00497752421464104,-0.0112492648838606,0.00826263003753226,0.764173678735304
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39706,-0.00355707034272767,0.0118946203656364,-0.026870526259375,0.0197563855739197,0.764908825799387
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,42186,0.00212376165607171,0.00712875103552479,-0.0118485903735569,0.0160961136857003,0.765772825248319
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,39783,0.00209415998841564,0.00711696401562562,-0.0118550894822106,0.0160434094590419,0.76857336041752
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40113,-0.000590907162450826,0.0020163989983397,-0.00454304919919664,0.00336123487429499,0.769488958494373
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,42004,0.00105019354136975,0.00359083771587071,-0.00598784838173684,0.00808823546447634,0.769936025889355
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39706,0.00177571186718523,0.00607780397508742,-0.0101367839239861,0.0136882076583566,0.770167460479024
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39784,-0.000645109237230124,0.00221245817323458,-0.0049815272567699,0.00369130878230965,0.770613243860208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42184,0.000861895928130736,0.00296641679774334,-0.00495228099544621,0.00667607285170768,0.771399233812541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41876,0.00172515501086831,0.00595232941229709,-0.00994141063723399,0.0133917206589706,0.771952142307041
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39804,0.00300004834417062,0.0103765831881619,-0.0173380547046268,0.023338151392968,0.772497364912572
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39665,0.00143815229169111,0.00499803564975654,-0.0083579975818317,0.0112343021652139,0.773548780728113
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,40021,0.00128307976757948,0.00447989904797538,-0.00749752236645228,0.0100636819016112,0.774570984323904
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,42004,0.00290178683955627,0.0101379190565532,-0.0169685345112881,0.0227721081904006,0.774705820756052
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,41861,-0.00409139539809107,0.0143047557947246,-0.0321287167557513,0.0239459259595692,0.77487020334201
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,39665,0.00218975705469066,0.00765697052537843,-0.0128179051750511,0.0171974192844324,0.774897434231693
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,40080,0.000879841822974192,0.00308030407441754,-0.00515755416288419,0.00691723780883258,0.775163334906432
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41861,0.00212414120971734,0.00744039448275684,-0.0124590319764861,0.0167073143959208,0.775275183865198
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,40005,0.00255027211017674,0.008944624154505,-0.0149811912326531,0.0200817354530065,0.775559307960042
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,40080,0.000827918860465983,0.00290874867309883,-0.00487322853880772,0.00652906625973968,0.775932584393293
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,42256,-0.00103136579684614,0.00363980502271959,-0.00816538364137653,0.00610265204768425,0.776907348198004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39665,0.00252847946949684,0.00892698268010885,-0.0149684065835165,0.0200253655225102,0.776998390113227
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39665,0.00230004011551619,0.00815067309172078,-0.0136752791442565,0.0182753593752889,0.777803245220448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,39768,-0.000994159145211484,0.00353138730548248,-0.00791567826395714,0.00592735997353417,0.778316449641086
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41829,-0.000846267780574973,0.00301073319539453,-0.00674730484354825,0.0050547692823983,0.778650868103985
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,39881,0.000672316624103829,0.00239188652795498,-0.00401578097068794,0.00536041421889559,0.778652828025182
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40097,0.000723558953961546,0.0025798363509626,-0.00433292029392514,0.00578003820184824,0.77912456365454
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39706,0.00314362591082123,0.0112747879867084,-0.0189549585431272,0.0252422103647696,0.780389162766179
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,42004,-0.00093094897263665,0.00334437989827601,-0.00748593357325764,0.00562403562798434,0.780738820024915
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,40020,0.0011300324606381,0.00406952848308548,-0.00684624336620944,0.00910630828748563,0.781262224542236
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39768,0.00216560326150883,0.0079011402560218,-0.0133206316402939,0.0176518381633116,0.784022784016458
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41486,0.000821928926840525,0.00300568624008478,-0.00506921610372564,0.00671307395740669,0.784505773196715
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42146,-0.000888377857124721,0.00326373593665485,-0.00728530029296823,0.00550854457871878,0.785475187319464
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42128,0.00136903870443887,0.00504153327656458,-0.0085123665176277,0.0112504439265054,0.78597080557333
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,39863,0.00318130918627923,0.0117251342255665,-0.0197999538958312,0.0261625722683897,0.786147172799527
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,40054,-0.000974532171347116,0.00362372290633265,-0.00807702906775911,0.00612796472506488,0.787987731063847
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,40054,-0.00156154054551558,0.00582431433806211,-0.0129771966481173,0.00985411555708616,0.788621904299706
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,39768,0.0016268842217569,0.00610078835560833,-0.0103306609552354,0.0135844293987492,0.789730096105859
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,40097,0.00250335692540831,0.00944320390553317,-0.0160053227294367,0.0210120365802533,0.790940410632282
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,40054,-0.00278269386587013,0.0105196367691068,-0.0234011819333196,0.0178357942015793,0.791381379077002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,40054,-0.000760373247202978,0.0029354788854439,-0.00651391186267302,0.00499316536826706,0.795618014491895
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41829,0.000749897061909426,0.00290040797822333,-0.00493490257540831,0.00643469669922716,0.795987587387999
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39719,-0.00144701085799461,0.00563932251890586,-0.0125000829950501,0.00960606127906088,0.797497970622055
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39665,0.00123896091160672,0.00483174678468295,-0.00823126278637186,0.0107091846095853,0.797630880488215
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,42094,0.00231868137036582,0.00917648182100141,-0.015667222998797,0.0203045857395286,0.800522229751473
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39784,-0.00228807083345633,0.0090634597577349,-0.0200524519586167,0.0154763102917041,0.800698120717051
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,40054,0.00104377415512607,0.0041641197559401,-0.00711790056651653,0.00920544887676867,0.802082492563968
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39881,-0.000976797664839655,0.00390497484468855,-0.0086305483604292,0.00667695303074989,0.802482454431923
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39665,0.00146782123829418,0.00589410408444235,-0.0100846227672128,0.0130202652438012,0.803340819754956
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39768,-0.000924574533833231,0.00372506100339242,-0.00822569410048237,0.0063765450328159,0.803981496822341
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,42184,0.00264917120986036,0.0106757204017252,-0.018275240777521,0.0235735831972417,0.804022911537885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,39865,0.00252308740152703,0.0101777705440004,-0.0174253428647138,0.0224715176677679,0.804215175004862
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,41887,0.00106673794222126,0.00433782209312024,-0.00743539336029442,0.00956886924473694,0.805751575926164
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41876,-0.00127403628978327,0.00522771967518154,-0.0115203668531391,0.00897229427357255,0.807461040084024
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,42103,-0.00206668223531052,0.00848261409365208,-0.0186926058588686,0.0145592413882475,0.807515513882426
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41861,-0.000945178455993838,0.00388987963331636,-0.0085693425372939,0.00667898562530623,0.80802173787947
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41829,0.0021018716542709,0.00868078162645686,-0.0149124603335846,0.0191162036421264,0.808683898399798
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,40021,-0.00365607769313491,0.0151435495101103,-0.0333374347329511,0.0260252793466813,0.809227943487645
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,39768,-0.00130877122256781,0.00542464120287284,-0.0119410679801986,0.00932352553506295,0.809355104750969
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39881,-0.00173254532707446,0.00719147319875099,-0.0158278327966264,0.0123627421424775,0.809624371664025
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,40020,0.00101925854335762,0.00428593026955731,-0.00738116478497471,0.00941968187168996,0.812029077975845
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39665,0.00233065340797755,0.00982669811471241,-0.0169296748968588,0.0215909817128139,0.812525174087813
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,40020,-0.00104730296736282,0.00443781503279817,-0.00974542043164724,0.00765081449692159,0.813440872938441
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,39881,-0.00148676018547725,0.00630353388790451,-0.0138416866057701,0.0108681662348156,0.81354475879227
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,39863,0.000747725013274674,0.00318310197282225,-0.00549115485345693,0.00698660488000628,0.814287356070581
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39719,0.00142476217095888,0.00618289612631469,-0.0106937142366179,0.0135432385785357,0.817757428275028
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,39665,-0.000998532226493966,0.00433824494373365,-0.00950149231621191,0.00750442786322398,0.817964457587061
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41876,0.00205783632471986,0.00897859389703642,-0.0155402077134715,0.0196558803629112,0.818722136787746
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,39768,-0.00211499485417677,0.0093126217406218,-0.0203677334657955,0.016137743757442,0.820342153747522
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39784,0.000654309364455046,0.00288106768937981,-0.00499258330672938,0.00630120203563947,0.820345269021441
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,42120,0.000619142127580542,0.00272786358079889,-0.00472747049078529,0.00596575474594637,0.820450964063955
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,42296,0.000454781759474795,0.00200788716940175,-0.00348067709255263,0.00439024061150222,0.82081790692184
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42091,-0.000627321439782058,0.0027732843046927,-0.00606295867697975,0.00480831579741563,0.821048184839855
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39863,0.000572004663339337,0.0025288621184084,-0.00438456508874112,0.00552857441541979,0.821057568551455
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39768,-0.000830727794116195,0.0036871185827788,-0.00805748021636265,0.00639602462813026,0.821746038944117
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,40113,0.00038943602684742,0.00172904925237835,-0.00299950050781414,0.00377837256150898,0.821803548858316
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39706,-0.00152398740755872,0.00677906720027573,-0.0148109591200991,0.0117629843049817,0.822133141702496
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42094,-0.000577662030065446,0.00257048758330571,-0.00561581769334463,0.00446049363321374,0.82219398731207
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41887,-0.000681543250284553,0.0030517885565545,-0.00666304882113137,0.00529996232056226,0.823285509597598
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39665,0.00141522384443758,0.00645393361892684,-0.011234486048659,0.0140649337375342,0.826435577248921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,42193,0.000689172750152839,0.00316006819944153,-0.00550456092075256,0.00688290642105824,0.82736402046263
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,39548,-0.000509094833268163,0.00234001316158901,-0.00509552062998262,0.00407733096344629,0.827775717534673
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41861,0.00173071116891048,0.00796055754322281,-0.0138719816158062,0.0173334039536272,0.827891718453557
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,39881,-0.00184018564993345,0.00850668096091954,-0.0185132803333358,0.0148329090334689,0.828740577730254
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42094,-0.00184782718324212,0.00855067080398826,-0.0186071419590591,0.0149114875925749,0.828910735012218
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,42093,0.00191925476469146,0.00893506627114822,-0.015593475126759,0.019431984656142,0.829926427822378
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39439,0.00113167840047866,0.00529247952103461,-0.00924158146074917,0.0115049382617065,0.830685725729133
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41876,-0.00156602838087135,0.00740139503526633,-0.0160727626499934,0.0129407058882507,0.832433768561917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39706,-0.00150689687110149,0.00712338617358644,-0.0154687337713309,0.0124549400291279,0.832468297583367
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39706,0.00179475728075504,0.00855961447767462,-0.0149820870954872,0.0185716016569973,0.833923567950202
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41887,0.00113837024895085,0.00544259785974674,-0.00952912155615276,0.0118058620540545,0.834327198403317
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,40054,0.00095045187642663,0.00456324401734883,-0.00799350639757709,0.00989441015043034,0.835010931387528
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41984,-0.000725883548223381,0.00352086355693847,-0.00762677611982278,0.00617500902337602,0.836664262392654
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,42166,0.000897081190349656,0.00441202235946467,-0.0077504826342011,0.00954464501490041,0.838883010952148
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,39784,0.000880220512245649,0.00433347477732795,-0.00761339005131713,0.00937383107580842,0.839044219600912
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,42103,0.00101195309747786,0.00499482001032517,-0.00877789412275947,0.0108018003177152,0.839450481704726
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,41876,0.000498071126114971,0.00246011865092525,-0.00432376142969851,0.00531990368192845,0.839561802443905
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39665,0.0029569660595719,0.0146734166690986,-0.0258029306118613,0.0317168627310051,0.840297018811105
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,42004,-0.00196030101911372,0.00976535669511206,-0.0211004001415334,0.0171797981033059,0.840904802167638
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,40054,-0.000529517907254985,0.00265479575900671,-0.00573291759490813,0.00467388178039816,0.841908919534505
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,40113,-0.000540038979152775,0.0027097795450895,-0.00585120688752819,0.00477112892922264,0.842037587456791
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42184,0.00251402623246218,0.0126203608666117,-0.0222218810660968,0.0272499335310211,0.842106296663777
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,41999,0.00204796101117667,0.0103678897533824,-0.0182731029054528,0.0223690249278061,0.843416565344749
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,41876,0.000944867153575123,0.00487911881331833,-0.0086182057205288,0.010507940027679,0.846448906293621
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42120,0.00076131870272223,0.00394004845654688,-0.00696117627210965,0.00848381367755411,0.846785231977326
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42104,-0.00057463674649507,0.00298822701772746,-0.0064315617012409,0.00528228820825076,0.847510061889133
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,41829,-0.000976087429763091,0.00508516754846006,-0.0109430158247448,0.00899084096521863,0.847786070351577
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,41829,-0.00104678060272137,0.00547594766577124,-0.011779638027633,0.00968607682219025,0.848403534727517
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42167,-0.00133929614412483,0.00714251813792445,-0.0153386316944567,0.0126600394062071,0.851263434466263
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,39719,-0.000709341002296921,0.00380022918275617,-0.00815779020049901,0.00673910819590516,0.851932835015046
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,40054,-0.000900458385329011,0.00483367523572252,-0.0103744618473452,0.00857354507668713,0.85222195993886
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,40020,0.00064836334326355,0.00350132323970157,-0.00621423020655154,0.00751095689307863,0.853093943958454
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39768,0.000599026004193772,0.00325182269492915,-0.00577454647786736,0.00697259848625491,0.853850378811424
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,40054,-0.00103026074247625,0.00559865407317252,-0.0120036227258944,0.00994310124094189,0.854001702485776
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,42094,-0.000397756902977952,0.00218402593110835,-0.00467844772795032,0.00388293392199441,0.85549066039308
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39706,-0.000717377017854787,0.00397100323153866,-0.00850054335167057,0.00706578931596099,0.856642768414436
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,39784,-0.00172132937888496,0.00957729420603603,-0.0204928260227156,0.0170501672649457,0.85736779121025
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39784,0.000551207004138307,0.0030688183282587,-0.00546367691924875,0.00656609092752536,0.857457957297385
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,39784,0.00100530249646348,0.00567898933538925,-0.0101255166008994,0.0121361215938264,0.859494985819768
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,40020,-0.000583705980727751,0.00330943123905678,-0.00707019120927904,0.00590277924782354,0.860001445217598
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39768,0.000910539556298159,0.00517302674730041,-0.00922859286841064,0.011049671981007,0.86028412347937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39784,0.000524355673680132,0.00299741759088881,-0.00535058280446194,0.00639929415182221,0.86113341621905
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42084,0.000608159195786191,0.00350586468820398,-0.00626333559309361,0.00747965398466599,0.862285437340987
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42094,0.000805949114977541,0.00464947264771714,-0.00830701727454806,0.00991891550450314,0.862385293408049
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41861,0.00130429395240322,0.00755940519036285,-0.013512140220708,0.0161207281255144,0.863016379087509
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39706,0.0010442434121705,0.00610203174722302,-0.0109157388123866,0.0130042256367276,0.864124490592893
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,40020,-0.00142675720361161,0.00835613130784445,-0.0178047745669867,0.0149512601597635,0.864428450397044
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39784,-0.000942663420909156,0.00553645447754516,-0.0117941141968977,0.00990878735507937,0.864805129929833
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,40031,0.000653666457558424,0.00384840183251769,-0.00688920113417624,0.00819653404929309,0.865128125941664
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39881,0.000908536394840259,0.0053707678872657,-0.00961816866420051,0.011435241453881,0.865671459821282
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41876,-0.000838763499887515,0.00497180725987275,-0.0105835057292381,0.00890597872946307,0.866032205808085
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,40054,0.00140828787384532,0.00835582084750934,-0.014969120987273,0.0177856967349636,0.866161821380618
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,39768,-0.000718600230529777,0.00428041090842624,-0.00910820561104521,0.00767100514998566,0.866680004214642
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,39719,0.000819813663104111,0.00490516414476398,-0.00879430806063328,0.0104339353868415,0.867268793951008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,40021,-0.000614831026712049,0.00371183703378546,-0.00789003161293156,0.00666036955950746,0.868442863054554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41887,-0.000822129192258227,0.00499265219587945,-0.010607727496182,0.0089634691116655,0.869208063022056
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,39784,0.000800801340943317,0.00490311730505031,-0.0088093085769553,0.0104109112588419,0.870265714594799
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,42197,0.000926920528862895,0.00572048343410301,-0.010285227001979,0.0121390680597048,0.87128053497821
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41829,-0.000608843152158827,0.00378480842640748,-0.00802706766791748,0.00680938136359982,0.872202312512615
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39835,0.000794315526744497,0.0049480365377131,-0.00890383608717319,0.0104924671406622,0.872465489161692
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39804,0.00130273604658372,0.00823678482786386,-0.0148413622160294,0.0174468343091969,0.874333143156275
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41861,0.000783855511335791,0.00497439232497717,-0.00896595344561945,0.010533664468291,0.874791738387477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40080,0.000646431673702515,0.00410449022944532,-0.00739836917601031,0.00869123252341534,0.874858631959419
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,39784,0.000677147529015144,0.00431461148810251,-0.00777949098766578,0.00913378604569606,0.875292861458536
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41829,0.000650711786221524,0.00415636313167771,-0.00749575995186678,0.00879718352430983,0.875595728147921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39768,0.000480917508345918,0.00307223450362044,-0.00554066211875014,0.00650249713544198,0.875612967052962
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,40054,-0.000980849668979099,0.00629582253253449,-0.0133206618327467,0.0113589624947885,0.876198509471057
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,39768,0.0013732045864548,0.00884252748658319,-0.0159581492872483,0.0187045584601579,0.876591339810746
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39768,-0.00113121034219904,0.0073219517934516,-0.0154822358573642,0.0132198151729661,0.877221820443496
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39881,0.000980596428077496,0.00641689633028395,-0.011596520379279,0.013557713235434,0.878547248084894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39768,0.000575654315990827,0.00380845897925541,-0.00688892528334978,0.00804023391533143,0.879859085445429
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,41887,-0.000459833189081706,0.00304325988047701,-0.00642462255481664,0.00550495617665323,0.879900109465205
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,41887,0.000503293057943257,0.00335082133025765,-0.00606431674936175,0.00707090286524826,0.880609284461633
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41876,0.000896003819533894,0.00613086181476411,-0.0111204853374038,0.0129124929764716,0.883808084350197
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,41887,-0.000475434758923527,0.00328405533883704,-0.00691218322304412,0.00596131370519707,0.884894270626501
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,40102,-0.000320333720303359,0.00225885594150778,-0.00474769136565861,0.00410702392505189,0.887230829898579
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39706,-0.000489565273146839,0.0034811581786129,-0.00731263530322813,0.00633350475693445,0.888162672621211
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41861,-0.000701801869863997,0.00508146005958925,-0.0106614635866589,0.00925785984693094,0.890155456938713
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39719,0.000468312904396437,0.00339494153663751,-0.00618577250741309,0.00712239831620597,0.890287061112099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,41683,0.000524061045056664,0.00383389467025324,-0.00699037250863968,0.00803849459875301,0.891276803995867
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,39863,-0.00101768929767263,0.00749924475054604,-0.0157162090087429,0.0136808304133976,0.892056602943927
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39651,-0.00110414466000197,0.0082148086691721,-0.0172051696515793,0.0149968803315753,0.89308170945584
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,40102,-0.000390027286550871,0.00291227921630782,-0.00609809455051419,0.00531803997741245,0.893464272486903
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39706,-0.000606487735216946,0.00455520973832387,-0.00953469882233173,0.00832172335189784,0.894083975300069
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39784,0.000580656475696018,0.00436174367030039,-0.00796836111809274,0.00912967406948478,0.894097171311108
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39768,0.000571429189804681,0.00439485216472934,-0.00804248105306482,0.00918533943267418,0.896551184248076
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,39665,-0.000614433270790951,0.00473567180717799,-0.00989635001285982,0.00866748347127792,0.89677008062291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39804,0.000680069986519388,0.00529900173262373,-0.00970597340942312,0.0110661133824619,0.897882925614763
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39863,0.00135090843518749,0.0105461791824027,-0.0193196027623218,0.0220214196326968,0.898076536357684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,42184,0.000565574189641221,0.00442675890917468,-0.00811087327234115,0.00924202165162359,0.898338832828039
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,42213,-0.000486670738342476,0.00384559532989419,-0.00802403758493508,0.00705069610825013,0.899296335269842
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39881,-0.000701962863209067,0.0055714158295167,-0.0116219378890618,0.0102180121626437,0.899739342864539
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,41876,-0.000569488679903505,0.00454302828023741,-0.00947382410916883,0.00833484674936182,0.900244957089329
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,39804,0.000684165362779512,0.00548087252023372,-0.0100583447768786,0.0114266755024376,0.900662228126454
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39706,0.000614576282851759,0.00492766218739355,-0.0090436416044396,0.0102727941701431,0.900747888496729
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,42004,0.000558575176769367,0.00449421951285958,-0.00825009506843541,0.00936724542197415,0.901089617283053
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,42144,-0.00151538720153914,0.0122998241059793,-0.0256230424492587,0.0225922680461804,0.901947491206458
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,39838,-0.000625872937333098,0.00509731539263155,-0.0106166111068909,0.00936486523222474,0.902279815748923
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,41984,0.000636154815352317,0.00520559014632889,-0.00956680187145231,0.0108391115021569,0.902737723840966
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39665,0.000620334444931123,0.00515911329998942,-0.00949152762304815,0.0107321965129104,0.90429493042653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,40054,-0.000852507129776924,0.00711347779601449,-0.0147949236099653,0.0130899093504115,0.904608999026392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,39768,-0.000783140988683139,0.00661061006293504,-0.0137399367120358,0.0121736547346695,0.905699670119178
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,39651,0.000424557559190243,0.00366088280669487,-0.00675077274193171,0.00759988786031219,0.907677466635068
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42144,-0.000682991561946945,0.00597748194957762,-0.0123988561831191,0.0110328730592252,0.909032868130193
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,39665,-0.000682149526598197,0.00604630089121577,-0.0125328992733811,0.0111686002201847,0.910174656215562
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,40021,-0.000650956792534849,0.00581847106660004,-0.0120551600830709,0.0107532464980012,0.910922502470971
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,39922,-0.000367568334122407,0.00329346141389931,-0.00682275270536505,0.00608761603712024,0.911138316563844
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39881,0.000858461278647287,0.00776172452686714,-0.0143545187940123,0.0160714413513069,0.911934138170099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,41887,0.000656766890360126,0.00594242930307278,-0.0109903945436625,0.0123039283243828,0.911997455030151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,39784,-0.000327900806951162,0.00297007366474827,-0.00614924518985776,0.00549344357595544,0.912092997066952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,39665,-0.000689045367595129,0.00624255807022574,-0.0129244591852376,0.0115463684500473,0.912111169968909
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42186,0.000684147099750757,0.00620315430453987,-0.0114740353371474,0.0128423295366489,0.912180936357245
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39804,-0.000546882858752066,0.0050558596491779,-0.0104563677711407,0.00936260205363661,0.913864374457182
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,39784,0.000322563840555291,0.00300636179919989,-0.00556990528587649,0.00621503296698708,0.914557972727022
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39665,-0.000336753266758612,0.00314541283835774,-0.00650176242993979,0.00582825589642257,0.91474207720662
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,39784,-0.00106804930012755,0.010014775732962,-0.0206970097367331,0.018560911136478,0.915070772402328
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,39881,-0.0013965608692848,0.0131085740927278,-0.0270893660910313,0.0242962443524617,0.915157531049181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,41876,0.000251842339465416,0.00239653213375202,-0.00444536064268854,0.00494904532161937,0.916309109667112
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39768,-0.0012726444150239,0.0122688795369745,-0.0253196483074939,0.0227743594774461,0.917386003535425
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39768,0.000848655825063332,0.00820307448293562,-0.0152293701614905,0.0169266818116172,0.917603171072867
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,40054,0.000782815869968867,0.00759022987486772,-0.0140940346847719,0.0156596664247096,0.917857991611326
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41953,0.000629418099844715,0.00611004832290192,-0.011346276613043,0.0126051128127325,0.917953792723164
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39784,0.000945196723232792,0.00919078769566186,-0.0170687471602644,0.01895914060673,0.918090513628501
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39768,-0.000707115652237202,0.00692054392759672,-0.0142713817503268,0.0128571504458524,0.918618667446316
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39719,-0.00116101443223188,0.011412548072512,-0.0235296086543555,0.0212075797898917,0.918971819968858
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,40054,-0.000814739082365787,0.00830478885741468,-0.0170921252428986,0.015462647078167,0.921850940858418
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39864,0.000533827303228746,0.00546410921441619,-0.010175826757027,0.0112434813634845,0.922174700109158
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,41829,-0.000643370608984026,0.00664595829150962,-0.0136694488603429,0.0123827076423748,0.922881758923931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39706,0.000688402752511572,0.00714622268836422,-0.0133181937166823,0.0146949992217054,0.923259530272935
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40054,-0.00113393302302744,0.0117925356890773,-0.024247302973619,0.0219794369275641,0.923397779113588
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42004,-0.000355216814695504,0.00374382228476969,-0.0076931084928441,0.00698267486345309,0.924410999338124
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,40080,0.000446112556391565,0.00477766408193685,-0.00891810904420466,0.00981033415698779,0.925607673024423
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,39863,0.000701170332681253,0.00779754165635566,-0.0145820113137758,0.0159843519791383,0.928350907659998
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,42180,-0.000617078750430326,0.00691503865988449,-0.0141705545238039,0.0129363970229433,0.928894770921218
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40054,-0.000336767162477389,0.00386713354664027,-0.00791634891389232,0.00724281458893754,0.93060599836174
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42004,-0.000817752213443062,0.00952651146825505,-0.019489714691223,0.0178542102643368,0.931595244596083
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41829,-0.000535627047682889,0.00632007904781943,-0.012922981981409,0.0118517278860432,0.932461443578218
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41829,-0.000531952563533751,0.00629758330176359,-0.0128752158349904,0.0118113107079229,0.932684634957459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39768,0.00047136604515732,0.00561129108787252,-0.0105267644870728,0.0114694965773875,0.933055529077603
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39768,0.000915475585558973,0.0110193250629441,-0.0206824015378115,0.0225133527089294,0.933790218441504
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39719,0.000453646407281791,0.00553397707993532,-0.0103929486693914,0.011300241483955,0.934668348391734
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42094,0.000179482732180001,0.00222543267275537,-0.00418236530642052,0.00454133077078053,0.935720985364911
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39768,0.000690566092357915,0.00861451075732939,-0.0161938749920077,0.0175750071767235,0.936109035719695
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,42145,-0.000848946322077804,0.0106600318667434,-0.0217426087808948,0.0200447161367392,0.936526200230887
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42144,0.000254972636370291,0.0032592330259589,-0.00613312409450915,0.00664306936724973,0.937645614914379
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39804,-0.000542790916014376,0.00696415062174655,-0.0141925261346376,0.0131069443026089,0.937876677487307
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39719,-0.000708198177753382,0.00924679615039954,-0.0188319186325365,0.0174155222770297,0.938952369441996
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,40054,0.000558768364223469,0.0073039078924328,-0.0137568911049448,0.0148744278333918,0.939020609000551
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39665,0.000486324031465715,0.00639783724789266,-0.0120534369744039,0.0130260850373353,0.939409557615241
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42103,-0.000785888622756164,0.010579133032603,-0.0215209893666581,0.0199492121211457,0.940783430167573
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39784,0.000161294785073064,0.00223552706613987,-0.00422033826456109,0.00454292783470721,0.942483361596344
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41876,-0.000256906935292062,0.00357787603433047,-0.00726954396257978,0.00675573009199566,0.942758771647781
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39706,0.000720043427645079,0.0102161239623651,-0.0193035595385905,0.0207436463938806,0.943812101544133
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41829,0.000365261601806062,0.00528338039812728,-0.00999016397852341,0.0107206871821355,0.944883994241063
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,42141,-0.000190849116928004,0.00278976180325738,-0.00565878225131246,0.00527708401745646,0.945459886644411
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39862,-0.000377117713530393,0.00555815451810477,-0.0112711005690157,0.010516865141955,0.945906752508048
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42146,0.000235543670904775,0.00356311668649785,-0.00674816503463101,0.00721925237644056,0.947294391896839
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39804,0.000603696005106566,0.00926751480252083,-0.0175606330078343,0.0187680250180474,0.948062892968021
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39881,0.000484828207023309,0.007623375615942,-0.014456988000223,0.0154266444142696,0.949291851648998
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,39784,0.000110549814683272,0.00176788537109562,-0.00335450551266414,0.00357560514203068,0.950140176432033
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39768,-0.000265553598840389,0.00431143386007652,-0.00871596396459036,0.00818485676690958,0.950888216660692
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42120,0.000243429617373003,0.00398185156614306,-0.0075609994522674,0.0080478586870134,0.951252816098
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39881,0.000323399012575722,0.00535369297586119,-0.0101698392201122,0.0108166372452636,0.95183283913991
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42184,0.000629070859563931,0.0106329629551857,-0.0202115365326001,0.021469678251728,0.952823723700392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,40054,0.000229153047264527,0.00392335154309315,-0.00746061597719804,0.00791892207172709,0.953425137373564
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40020,-0.000261746610855017,0.00452733896085614,-0.00913533097413305,0.00861183775242302,0.953897319262652
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,40054,0.000129166674117185,0.00227611475869473,-0.00433201825292449,0.00459035160115886,0.954746381321966
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41861,0.000232840378777616,0.00415180714445653,-0.00790470162435719,0.00837038238191242,0.955277611385484
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41861,-0.000184731273827357,0.00334570202493786,-0.00674230724270557,0.00637284469505085,0.955968445790378
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41887,-0.000473056154253916,0.00865624497603134,-0.0174392963072753,0.0164931839987675,0.956418866673476
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42103,0.000554162735316877,0.0102463138934269,-0.0195286124957998,0.0206369379664336,0.956868991543194
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,42186,-0.000286187731695502,0.00537739519926167,-0.0108258823222484,0.0102535068588574,0.957557029939567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,42213,0.000339850755954967,0.00641859651907271,-0.0122405984214275,0.0129202999333375,0.957774287527909
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39706,0.000662915876545739,0.0127347566935212,-0.0242972072427558,0.0256230389958473,0.958485350360695
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42120,0.000160979657386792,0.00316775701803093,-0.00604782409795383,0.00636978341272741,0.959471186487514
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39881,-0.000437618048476939,0.00875732244128241,-0.0176019700333905,0.0167267339364366,0.960145896092637
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39865,-0.000503468895039214,0.0104349189858887,-0.0209559101073811,0.0199489723173026,0.961519123123733
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,42144,0.00033071248816949,0.00686778244884417,-0.0131301411115651,0.0137915660879041,0.961594102945832
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40080,0.000145008384878379,0.00310654637204951,-0.00594382250433866,0.00623383927409542,0.962770460944888
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,39804,-0.00040181272838786,0.00874825055054259,-0.0175483838074513,0.0167447583506756,0.963366398826343
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,40020,-0.00036383971024827,0.00802369881821331,-0.0160902893939463,0.0153626099734498,0.963832650472436
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39863,-0.000318726587821824,0.00723404214307164,-0.0144974491882422,0.0138599960125986,0.964857986704983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,40054,0.000170875054420186,0.00392176617320176,-0.00751578664505526,0.00785753675389563,0.965247214040146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,39863,-0.000176297605579226,0.00414238821023696,-0.00829537849764366,0.00794278328648521,0.966053547279394
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39665,-0.000263600699630351,0.00620220446016423,-0.0124199214415522,0.0118927200422915,0.966100021114181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,40054,0.000445456122944003,0.0105249602084435,-0.0201834658856052,0.0210743781314933,0.966241364928547
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39774,-0.000150558803104457,0.00359395562210641,-0.00719471182243301,0.0068935942162241,0.966585403782516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39881,-0.000345085626399205,0.00825946792838249,-0.0165336427660289,0.0158434715132305,0.966674371246833
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40054,0.000408880709514733,0.00987974689434732,-0.018955423203406,0.0197731846224355,0.966989135770918
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,42256,-0.000182651593268096,0.00445955964638305,-0.00892338850017887,0.00855808531364267,0.96733055023605
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39768,0.000139445470548148,0.00343017498143979,-0.00658369749307384,0.00686258843417014,0.967573631711644
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,39881,0.000168547480104363,0.00416278898603446,-0.00799051893252318,0.00832761389273191,0.967703972231083
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,42185,-0.000151914057365259,0.00378523358039575,-0.00757097187494093,0.00726714376021041,0.967987440322056
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,40021,0.000261591903368359,0.00682897173674292,-0.0131231927006478,0.0136463765073845,0.969444260051986
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,40054,0.000342014812323632,0.00911311775266673,-0.0175196959829032,0.0182037256075504,0.970063153735495
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40102,0.000140171198943206,0.0038514618982573,-0.00740869412164111,0.00768903651952752,0.970968637666245
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,42061,0.000217436902411817,0.00610967799188124,-0.0117575319616754,0.012192405766499,0.971610687369296
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42056,-0.000101388292052555,0.00287693585775385,-0.00574018257325009,0.00553740598914499,0.971887507616859
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39784,-0.000100388423858085,0.00287789916794078,-0.005741070793022,0.00554029394530584,0.972174063122975
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42213,0.000101374246339531,0.00292200709982373,-0.00562575966931498,0.00582850816199404,0.972324786990486
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42111,-0.00011376658998382,0.0035566177358574,-0.00708473735226432,0.00685720417229668,0.974482674970267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,39719,-0.000210606827524881,0.00672727465994953,-0.013396065161026,0.0129748515059762,0.975025771033251
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39863,0.000258234171598583,0.00862498720652705,-0.0166467407531944,0.0171632090963916,0.976115274781117
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,41829,-0.000116896516183783,0.00395255363683941,-0.00786390164438903,0.00763010861202147,0.976406522787196
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42004,0.000237173342546662,0.00805275281084027,-0.0155462221667003,0.0160205688517936,0.976504196428074
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39999,0.000106288983519547,0.00402024654623085,-0.00777339424709293,0.00798597221413202,0.978908135028685
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39881,0.000165754407332432,0.00644184105200051,-0.0124602540545886,0.0127917628692534,0.979472452912744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,39768,-0.00010810171507339,0.00424880318402068,-0.00843575595575393,0.00821955252560715,0.979702202966181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42004,0.000277515727762502,0.0110068241345889,-0.0212958595760318,0.0218508910315568,0.979885411864147
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,40054,-0.000114420519099694,0.0048650353609918,-0.00964988982664361,0.00942104878844423,0.981236755555782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42126,0.000124180227756235,0.00535993125737961,-0.0103812850367078,0.0106296454922203,0.981516422029775
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39706,8.03269806977428e-05,0.00357546702072576,-0.00692758837992475,0.00708824234132024,0.982076539467378
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39706,-8.92011765350451e-05,0.00401368535827498,-0.00795602447875401,0.00777762212568392,0.982269489575464
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42296,-7.3185632359026e-05,0.00333096262202223,-0.0066018723715226,0.00645550110680454,0.98247117110662
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39804,-0.000120402401000891,0.00612258914753564,-0.0121206771301707,0.011879872328169,0.984310761513833
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41887,0.00012816943189095,0.00676546546981844,-0.0131321428889532,0.0133884817527351,0.984885551480536
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,40020,-9.57729092728507e-05,0.00526635345213904,-0.0104178256754654,0.0102262798569197,0.98549095696531
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39719,0.000120757291499755,0.00747565801100388,-0.0145315324100678,0.0147730469930674,0.987112318476759
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,41959,-9.37014212543184e-05,0.00584749317243226,-0.0115547880392215,0.0113673851967129,0.987215332907679
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39665,-8.93869937933234e-05,0.00564690624440241,-0.0111573232328221,0.0109785492452354,0.98737081547769
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39768,9.80465705804645e-05,0.00627705537315975,-0.0122049819608126,0.0124010751019736,0.987537976087279
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39706,8.2110213200168e-05,0.0055012728679419,-0.010700384607966,0.0108646050343663,0.988091759434315
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,41770,-9.37592051194991e-05,0.00685540623772912,-0.0135303554310686,0.0133428370208296,0.989088144419872
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39706,5.44122665902036e-05,0.00408485681893085,-0.00795190709851427,0.00806073163169468,0.989372359198155
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39784,5.59618984843544e-05,0.00496447851743865,-0.0096744159956954,0.00978633979266411,0.991006278929697
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41829,-3.68057664030992e-05,0.00332475090053771,-0.00655331753145701,0.00647970599865082,0.99116758736356
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,39719,-7.13632863922705e-05,0.00652698259844908,-0.0128642491793525,0.0127215226065679,0.991276646356381
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,39784,-6.14104021836395e-05,0.0064069072429307,-0.0126189485983278,0.0124961277939605,0.992352549693072
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,42103,6.5185133248993e-05,0.007026350453313,-0.0137064617552445,0.0138368320217425,0.992598083681443
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,39719,-6.2981452779107e-05,0.0074564704343177,-0.0146776635040418,0.0145517005984836,0.993260868121614
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39863,-3.29888152317167e-05,0.00451925280069102,-0.00889072430458612,0.00882474667412269,0.994175936380623
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,40097,-1.42235512498149e-05,0.00236269248389584,-0.00464510081968567,0.00461665371718604,0.995196825973519
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,40021,-2.78687986947275e-05,0.00476457097978514,-0.0093664279190736,0.00931069032168415,0.995333169751272
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42068,2.0538814432562e-05,0.00360257723414802,-0.00704051256449756,0.00708159019336268,0.995451257568931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42186,-1.70744910160015e-05,0.00307854902903044,-0.00605103058791567,0.00601688160588367,0.995574817669411
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,39719,-2.40695921038617e-05,0.00556857961054083,-0.0109384856287639,0.0108903464445562,0.996551321647838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,41861,-3.26115817381927e-05,0.010828602482163,-0.0212566724467777,0.0211914492833013,0.997597129939889
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41887,-1.78113228639005e-05,0.00660711985164684,-0.0129677662320917,0.0129321435863639,0.997849125984888
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42144,-1.70785890969526e-05,0.00683145931953037,-0.0134067388553765,0.0133725816771826,0.998005336097871
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39863,6.87441667393804e-06,0.00293404741223412,-0.00574385851130494,0.00575760734465281,0.9981306173301
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42296,-7.19633609758496e-06,0.0071908791934323,-0.0141013195552249,0.0140869268830297,0.999201525321974
